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ABSTRACT 
Heme-copper oxygen reductases (HCOs) are respiratory enzymes that utilize a heme-
copper center to perform the four-electron reduction of oxygen to water. The HCOs 
share significant structural and sequence homology to another class of metalloenzyme, 
nitric oxide reductase (NOR), that in turn, utilize a heme-nonheme diiron center to 
catalyze the two electron reduction of nitric oxide to nitrous oxide during biological 
denitrification processes. The homology between these two classes of enzymes is not 
just structural but also functional: the NORs can reduce oxygen completely to water and 
vice-versa. In this work, we have probed these similarities, yet certain crucial differences 
within the structure and function of HCOs and NORs, by using their simpler-myoglobin 
(Mb)-based enzymatic models.  
 
To begin with, we have attempted to understand the role of nonheme metal towards 
oxygen activation and reduction in HCOs. While HCOs and NORs have evolved from a 
common ancestral protein, copper is specifically chosen (over iron) as the nonheme 
metal in the catalytic center of HCOs. An elegant method to elucidate this choice would 
be to swap the copper in HCOs with iron or other nonheme metals and probe the 
resulting changes in oxygen reduction reactivity. However, doing so has been 
impossible in HCOs due to the inherent complexity of its membranous structure. As an 
alternate, we have used a myoglobin mutant (FeBMb) that not only possesses a heme-
nonheme metal center similar to HCOs, but can also bind copper, iron and their redox-
inactive analogue zinc at its nonheme metal center. Oxygen reduction enzymatic 
assays reveal that Fe-FeBMb and Cu-FeBMb exhibit 11-fold and 30-fold enhancements 
in oxidase activity, respectively, as compared to Zn-FeBMb suggesting the unequivocal 
role of nonheme metal as an electron donor to oxygen. Moreover, higher reduction 
potential of copper, as well as the enhanced weakening of O-O bond from the higher 
electron density in the d-orbital of copper are central to its higher oxidase activity as 
against iron. Overall, this work resolves a long-standing question in bioenergetics, and 
renders a chemical-biological basis for designing future oxygen reduction catalysts.    
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Moving on, we have focused on the differences in the reduction potential (E°’) of 
catalytic heme iron in HCOs and NORs. While most HCOs exhibit significantly high 
heme E°’ values (+180 to +365 mV), NORs typically exhibit heme E°’ in the lower range 
(-170 to 70 mV). To understand this difference and its impact on enzymatic activity (if 
any), we have systematically tuned heme E°’ values of Mb-based HCO and NOR 
mimics using two strategies: (1) modulation of H-bonding interactions of heme ligands 
and (2) use of different heme types. The resulting HCO/NOR mimics display ~ 200 mV 
variation in heme E°’ values. Detailed kinetic, electrochemical and theoretical studies 
on the HCO mimics reveal that higher heme E°’ favors fast oxygen binding and electron 
transfer to its catalytic center, both of which are required for fast and efficient oxygen 
reduction reaction. The low heme E°’ of NORs, on the other hand, helps them maintain 
required electron density on the heme-bound NO for efficient N-N coupling to form N2O. 
 
Overall, these results show how Nature has efficiently fine-tuned E° in metalloproteins 
to control their substrate affinities, electron transfer rates and overall enzymatic 
activities. In particular, heme proteins exhibit a wide variety of heme E° (spanning over 
1 V), and understanding the reasons behind the same and associated implications on 
their enzymatic activity will help us understand these proteins in greater detail.  
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Chapter 1 
Myoglobin models of heme-copper oxygen reductases and nitric oxide reductases: 
Questions solved and remaining mysteries 
Portions of this chapter are a taken from the final draft of a manuscript in preparation as 
“Understanding structure-function relations in heme-copper oxidases and nitric oxide 
reductases using myoglobin-based enzyme models” (Ambika Bhagi-Damodaran, Igor D. 
Petrik, and Yi Lu) 
 
Abstract: In this chapter, we discuss the design and complete characterization of 
myoglobin-based enzyme models of Heme-copper oxygen reductase (HCO) and NO 
reductases (NOR).  These models not only help understand the contribution of structural 
feature towards the reactivity of these enzymes but also reveal their mechanistic details. 
Moreover, using the approach of bottom-up rational protein design, we show how the 
HCOs and NORs fine-tune their secondary coordination, H-bonding environment, 
electron transfer (ET) rates to control their reactivity, product selectivity and turnovers.  
1.1. Introduction 
It has been estimated that about 90% of the reduction of molecular oxygen in the 
biosphere is catalyzed by heme-copper oxygen reductase (HCOs).1-3 The HCO is a large, 
transmembrane protein complex found in bacteria and the mitochondrion of eukaryotes. 
It is the terminal enzyme in the respiratory electron transport chain that uses a heme-
copper center to perform the four-electron reduction of oxygen to water.4 The HCO 
exhibits high structural and sequence homology with a related class of metalloenzyme, 
Nitric Oxide Reductases (NORs) that utilizes a heme-nonheme diiron center to perform 
the two electron reduction of NO to N2O.5,6 The NORs form an integral part of the 
denitrification processes involving the conversion of nitrates/nitrites to nitrogen forms an 
alternative route to oxygen respiration as means of energy generation in anaerobic 
bacteria.7,8 The homology between the two classes of enzyme is not just related to their 
structure but extends to their function as well: HCOs and NORs exhibit cross-reactivity 
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i.e. NORs can perform oxygen reduction to water and vice-versa.9,10 At the same time, 
some important differences between the two enzyme families are: (1) the identity of  
 
Figure 1.1.  The complete structure of HCO P. stutzeri cbb3 oxidase (a) and its catalytic heme-
copper center (b) PDB: 5DJQ. The complete structure of cNOR (c) and its catalytic heme-
nonheme diiron center (d) PDB: 3O0R. The structure of heme-copper center in CuBMb (e) and 
heme nonheme diiron center in FeBMb (f).  
 
nonheme metals: HCOs use copper while NORs use iron while as the nonheme metal 
ion11,12 (2) coordination of nonheme metals: copper in HCOs is coordinated to three 
histidines while the nonheme iron in NORs is coordinated to a glutamate in addition to 
three histidines5,13 (3) conserved secondary coordination sphere residues: HCOs contain 
a conserved tyrosine crosslinked to a copper coordinating histidine while NORs contains 
several conserved glutamates14,15 (4) the heme types: NORs use only heme b at their 
catalytic center while HCOs utilize a variety of heme types like heme a, o, b and d.16-18 
These differences yet similarities within the structure and function of HCOs and NORs 
raises a fundamental question as to what structural features are responsible for fine-
tuning the specific and cross-reactivities between HCOs and NORs (Fig. 1.1).  
An elegant way to test and understand the structure-function relations within the two 
classes of enzyme will be by reproducing their structural features within each other. For  
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Scheme 1.1. Comparison of Native HCOs/NORs with their synthetic models and Mb-
based models 
Native HCOs/NORs Synthetic models Mb-based models 
Difficult to obtain homogeneous 
sample in large quantities 
Multiple steps for synthesis of 
heteronuclear centers 
Easy to obtain large quantities in 
short times 
Function under physiological 
conditions 
Usually functional under non-
physiological conditions 
Function under physiological 
conditions 
SCS interactions differ in same 
enzymes from different sources 
Very difficult to incorporate 
SCS interactions into model 
Role of SCS interactions can be 
studies through SDM 
Residing in different protein 
environments hampers the 
comparison between similar 
enzymes 
Different active centers can be 
designed within the same 
overall scaffold 
Different active centers can be 
designed within the same overall 
scaffold 
Difficult to crystallize Easy to crystallize Easy to crystallize 
Overlapping features of other 
metal cofactors 
Focus only on the active 
center 
Focus only on the active center 
Difficult to remove cofactors such 
as heme or nonheme metal ions 
without loss of function and/or 
structure 
Can use different cofactors Easy to replace heme, nonheme 
metal ion, or other cofactors 
Difficult to trap intermediates 
using site specific labeling 
Intermediates can be trapped Site specific labeling is easily 
achievable via techniques such 
as UAA incorporation 
Difficult to perform systematic 
studies of specific features such 
as heme E°, pKa of residues, and 
ET rates 
Amenable to systematic 
studies using different ligands 
or reaction conditions 
Amenable to systematic studies 
using cofactor replacement or 
UAA incorporation 
 
example, we replace copper in HCOs by nonheme iron and probe how it impacts the 
activity, and other mechanistic characteristics of the enzyme. However, doing so is 
difficult if not impossible as the HCOs and NORs are large (MW ~ 100-200 KDa) 
membrane-bound proteins that are assembled in presence of their respective metal ions. 
Furthermore, HCOs and NORs contain multiple metal centers that makes it difficult to 
focus and specifically study the catalytic center. To overcome these issues with studying 
the native HCOs and NORs, a number of small-molecule based model systems of the 
catalytic center have been designed and have contributed immensely in the 
understanding the mechanism of oxygen and NO activation in the two protein systems.19-
28 Alternatively, we have also designed enzyme models of HCOs and NORs in a small 
(MW ~ 17.4 KDa), easy-to-purify, soluble protein, myoglobin (Mb) called CuBMb and 
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FeBMb respectively (Fig. 1.1c-e). Scheme 1 shows the comparison between native 
HCOs/NORs, their small-molecule models and myoglobin-based methods to investigate 
HCOs/NORs. As can be discerned from the table, Mb-based models have key 
advantages over both native proteins and synthetic models and are excellent systems to 
elucidate the structure-function relations of HCOs and NORs. 
In the remaining chapter, we discuss the design and complete characterization of 
myoglobin-based enzyme models of HCO and NORs, the questions that have been 
solved using these models and remaining mysteries that should be addressed. 
1.2.   Developing a structural and functional HCO mimic in myoglobin 
1.2.1. First generation HCO mimics: Design of a copper binding center in Mb 
Mb serves as an excellent model to design the catalytic heme center of HCOs as the 
protein already contains a high-spin heme iron coordinated to histidine and binds oxygen 
with high affinity similar to HCOs.29,30 The catalytic center of HCOs utilize three histidines 
to coordinate a copper in a triagonal geometry distal to heme called as CuB (Fig. 1.1b). 
To begin with, the WTMb already contains a H64 distal to heme iron. Based on visual 
inspection and comparison with the catalytic center of bovine CcO, L29 and F43 
residueswere picked and mutated to His. The resulting mutant, F43HL29HMb that 
possessed three histidines capable of coordinating copper, similar to CuB center in HCOs, 
was called CuBMb (Fig. 1.2a).31 The binding of copper to the CuB center in Mb was 
observed through UV-Vis titrations that revealed that CuBMb bound Cu(II) with changes 
in heme Soret and visible band and a KD of 9 M (Fig. 1.2c). Further investigation of the 
heme-copper center was performed using CN- as a ligand. The presence of Cu(II) at the 
CuB center increased affinity for negatively charged CN- by approximately 20-fold. 
Furthermore, the addition of ~ 1.4 eq. of Cu(II) to cyanide bound CuBMb resulted in 
attenuation of low-spin heme Fe signals at g= 2.06 suggesting spin-coupling of heme-
copper center similar to HCOs (Fig. 1.2d). Control EPR experiments performed with 
Cu(II)-added WTMb or Zn(II)-CuBMb showed no decrease in heme signal. Finally, a 
crystal structure of copper-bound CuBMb variant showed that the copper binds to the 
three histidines in triagonal geometry ~ 5Å away from heme iron (Fig. 1.2b).32 Thus, the 
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CuBMb is a good structural model of HCO that binds copper at the CuB center similar to 
HCOs. 
The design of a CuB site in Mb scaffold helps us probe and differentiate the O2 reactivity 
of heme iron, with and without nonheme metals like Cu- and their redox inactive controls 
Zn and Ag.33 To begin with these comparisons, the oxygen affinity of empty CuBMb (or 
simply E-CuBMb) was compared with Ag(I)-added CuBMb. The addition of Ag(I) in CuB 
center increased the O2-binding affinity: while the deoxy E-CuBMb when exposed to O2, 
formed only partial heme-oxy (with ~50% protein in O2-free deoxy-form), the addition of 
Ag(I) resulted in complete heme-oxy formation (Fig. 1.3a). Next, the reaction of Cu(II)- 
Figure 1.2.  X-ray crystal structure of E-CuBMb (a) and Cu-CuBMb variants (b). c) UV-Vis difference 
spectra for Cu(II) titration in CuBMb and double reciprocal, hill plots used to determine the binding affinity 
for copper. d) X-band EPR spectra of 0.6 mM CuBMb-CN before (dotted line) and after the addition of 
0.72 mM CuSO4 (solid line) and 1.2 mM ZnSO4 (dashed line).  
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CuBMb was investigated with oxygen under turnover conditions in the presence of 
reductant TMPD/ascorbate using kinetic UV-Vis spectroscopy. These measurements 
showed a gradual decay in the Soret band of CuBMb (at ~408 nm) and concomitant 
increase in absorption at 680 nm. The UV-Vis analysis of the product along with mass-
spectrometry confirmed a gradual (k= 0.028 s-1) degradation of heme to form verdoheme 
similar to heme-oxygenase (Fig. 3B-C). Similar experiments when performed with Ag(I) 
and Zn(II) added to CuBMb showed no verdoheme formation suggesting that the redox 
activity of Cu(II) was required for the heme degradation reaction. These results suggest 
a pathway wherein the heme-copper center activates oxygen to form a peroxy-form (the 
Figure 1.3. a) UV-vis spectra of reduced Cu
B
Mb in air (solid line), reduced Cu
B
Mb in air after 
the addition of AgNO
3
 (dashed line), and reduced WTMb in air (dotted line). b) UV-vis spectra 
of reaction of Cu
B
Mb (6M) with oxygen in the presence of 1,000 equivalents of ascorbate and 
100 equivalents of TMPD in 20 mM Tris buffer (pH 8) at 25°C with copper. c) Time-dependent 
absorbance changes at 418 and 678 nm with copper (solid line), without copper (dotted line), 
Ag(I) (short dashed line), and Zn(II) (dotted and dashed line). d) Proposed reaction mechanism 
of Cu
B
Mb with oxygen. 
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two electron added-oxygen). The heme-peroxy can then break the O-O bond in presence 
of significant H-bonding as observed in cyt. P450s and HCOs to form a ferryl species. 
However, in the absence of H-bonding as in CuBMb, the highly reactive heme-peroxo can 
attack the heme and follow heme-oxygenase pathway to obtain verdoheme (Fig. 1.3d). 
To further probe the impact of nonheme metal ions on the reactivity of heme-peroxy 
species, the oxidized CuBMb variants were reacted with H2O2 (2e-, 2H+ added oxygen). 
The reaction of WTMb with H2O2 results in the formation of heme-compound II (Fe(IV)=O) 
with k=0.018/s presumably by the cleavage of O-O bond of the peroxo-species. Similar 
experiments when performed with CuBMb increased the rate of ferryl formation by ~20-
fold (k=0.17/s) suggesting the essential role of H-bonding environment in O-O bond 
cleavage. Interestingly, the addition of Cu(II) to CuBMb did not bring about much changes 
in the rate of heme compound II formation (k=0.13 /s).  
1.2.2. Second generation HCO mimics: Impact of conserved tyrosine on enzyme 
activity and robustness 
Given the changes in O2 reactivity imparted by rational design of the primary CuB 
site, we sought to more closely model the active site of native HCOs, by modeling the 
secondary coordination sphere (SCS) of HCOs. One of the key and novel structural 
features of HCOs is a conserved tyrosine residue near the CuB site, which forms a 
covalent bond with one of the CuB coordinating His ligands (Fig. 1.1b).4,34-36 The 
incorporation of tyrosine into our CuBMb models was based on analysis of different types 
of HCOs. In type A and B HCOs, the tyrosine is located on a helix, four residues 
downstream from one of the His ligands to which it is covalently attached.4,34 In C-type 
HCOs, the conserved tyrosine is located on an adjacent helix.36 Therefore, two different 
models were designed to incorporate tyrosine into the active site of CuBMb: (1) F33Y-
CuBMb, in which the tyrosine is four residues downstream from His 29, on the same helix, 
and (2) G65Y-CuBMb, in which the tyrosine is on a helix adjacent to the one containing 
His 29 and the position of the Tyr65 hydroxyl group is predicted to be in approximately 
the same position with respect to the heme as seen in C-type HCOs.32 The experimental 
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or modeled structures of these proteins compared with the native HCOs show good 
agreement (Figure 1.4a-b).32 
The functional properties of F33Y-CuBMb and G65Y-CuBMb were evaluated by 
kinetic assays of oxygen consumption using an oxygen electrode (Figure 1.4c).32 These 
assays were carried out using the previously reported TMPD and ascorbate as the 
reductant system, at pH 6.0, with ROS scavengers, catalase and SOD. Formation of 
water was additionally confirmed by detecting isotopically labeled H217O in the presence 
of 17O2 (Figure 1.4d). The results of these assays showed that presence and positioning 
of tyrosine in the active site of CuBMb plays a significant role in improving oxygen 
reduction to water.32 Moreover, F33Y-CuBMb and G65Y-CuBMb were able to achieve over 
Figure 1.4. Structural overlays of F33Y-Cu
B
Mb (crystal structure, 4FWX) and G65Y-Cu
B
Mb 
(molecular model), with their inspirational native HCO structures. c) Oxygen consumption rates 
of indicated proteins leading to formation of water or ROS, as indicated. d) NMR detection of 
H
2
17
O produced by reaction of proteins with 
17
O
2
 under reductive conditions. 
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500 and 1000 turnovers of oxygen reduction, respectively. Strikingly, the activity of these 
designed proteins was independent of presence and identity of metal ion (Figure 1.4c).32 
The observed importance of Tyr in the function of our models motivated us to study the 
role it may play in promoting oxygen reduction. It is proposed that in native HCOs, the 
conserved tyrosine participates by donating an H-radical during turnover.3,37-40 
Additionally, the conserved tyrosine in the CuB site constitutes the end of the K-proton 
channel, which is responsible for delivering two of the catalytic protons for complete 
oxygen reduction.4,34 EPR of F33Y-CuBMb under reductive conditions in the presence of 
O2 was performed, and revealed the formation of tyrosyl radical (Fig. 1.5d).41 This 
observation provides strong support for the direct involvement of Tyr in the redox process 
of O2 reduction in CuBMb. Further investigations into the role of tyrosine were carried out 
Figure 1.5. a) pK
a
 and E°’ of Tyr and its analogs affects oxidase activity. Correlation of oxidase 
activity of Phe33Tyr-Cu
B
Mb, Phe33ClY-Cu
B
Mb, Phe33F
2
Y-Cu
B
Mb, and Phe33F
3
Y-Cu
B
Mb vs pK
a
 
of phenols on the Tyr and its analogs, R
2
 = −0.98. b) Correlation of water produced in oxygen 
reduction reaction performed by these proteins vs the pK
a
 of phenols on the Tyr and its analogs, 
R
2
 = 0.94. c) Correlation of oxidase activity of Phe33Tyr-Cu
B
Mb, Phe33ClY-Cu
B
Mb, Phe33F
2
Y-
Cu
B
Mb, and Phe33F
3
Y-Cu
B
Mb vs peak potential at pH 13 (E
p
) of the corresponding Tyr and Tyr 
analogs, R
2
 = 0.95. d) EPR spectra of ferric F33Y-Cu
B
Mb reacted with 1 equiv. of H
2
O
2
 (red) and 
ferrous F33Y-Cu
B
Mb with oxygen (red).  
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by incorporating unnatural tyrosine analogues with a range of pKa’s and reduction 
potentials,42 and observing the effects on activity (Figure 1.5a-c). The investigation 
revealed (1) that the overall rate of reductive oxygen consumption increases with 
increasing reduction potential, and (2) that the ratio of water produced increases with 
decreasing pKa. Together, these results suggest that tyrosine likely plays a role in both 
electron and proton transfer to oxygen. 
 
Finally, the structural interactions that promote oxygen activation in F33Y-CuBMb 
were investigated using EPR of cryoreduced oxy-F33Y-CuBMb (Figure 1.6).43 This 
technique gives information about the electronic structure of the heme-bound oxygen and 
it’s interactions with the active site.44-53 The results showed that oxygen bound to F33Y-
CuBMb can be more polarized than in WTMb, withdrawing electron density from the Fe 
onto the O2, likely due to strong hydrogen bond donation. A significant hydrogen bonding 
network consisting of waters and connecting the tyrosine and histidine residues with the 
oxygen was indeed confirmed in oxy-F33Y-CuBMb by X-ray crystallography. This study 
Figure 1.6. EPR spectra of oxy-wtMb and oxy-F33Y-Cu
B
Mb after radiolytic reduction, 
subsequent stepwise annealing for one minute at indicated temperatures. 
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further supports that a key role of tyrosine in CuBMb activity is the activation and 
protonation of oxygen by hydrogen bonding. 
1.2.3. Role of different heme types and chloride in modulating HCO functionalities 
The HCOs use a variety of heme types at their catalytic center. In particular, A- and B-
type HCOs contain heme o and heme a, which possess a hydroxyethylfarnesyl side chain 
attached to the heme b structure.54,55 The HCOs remained mostly active when heme 
substitution occurred between a- and o-type hemes, however, when either a- or o-type 
heme was replaced by heme b at the catalytic center, the enzyme lost its activity.56 
Moreover, defects in the maturation of this hydroxyethylfarnesyl chain was found to be an 
important cause of disease in yeast and humans.57 These observations showed the 
importance of hydroxyethylfarnesyl towards HCO activity and reactivity. As for the 
biological function of the side-chain, the highly hydrophobic farnesyl group is generally 
considered to anchor the heme at the correct position in the enzyme and the hydroxyl 
group of the farnesyl side chain is suggested to be an essential part of the active site 
hydrogen-bonding network, with internal water molecules bridging the gap between the 
hydroxyl group of cross-linked tyrosine and the bound oxygen at the heme-copper site.58 
Given the importance of this heme o hydroxyl group in tuning the oxygen chemistry, we 
decided to incorporate a heme o mimic (heme b that possessed a hydroxyethyl group 
similar to heme o) in CuBMb. This substitution resulted in ∼4 nm blue shift in the heme 
Soret band and ∼20 mV decrease in the heme E°’ suggesting that the addition of a 
hydroxyethyl group only mildly impact the electronic properties of heme iron. However, 
such replacement caused a significant difference in oxygen reactivity: The heme 
degradation reaction of CuBMb was slowed by ∼19-fold in the heme o mimic-substituted 
CuBMb (from 0.028 /s to 0.0015 /s for heme b). These results strongly suggest the critical 
role of the hydroxyl group of heme o in modulating HCO activity through participation in 
an extra hydrogen-bonding network (Fig. 1.7 a-b).  
Spectroscopic studies on HCOs suggest that chloride binds to the heme-copper center in 
cases where the HCO purification processes are not rendered rigorously chloride-free.59 
This binding of chloride to the heme-copper center causes interesting changes in the 
spectroscopy and reactivity of the enzyme such as lowering the redox potential of catalytic 
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heme center60 and preventing fast reactions with CN- and NO.61 Based on these studies, 
the possible role of chloride as a mimic of hydroxide ligand to the CuB center has been 
suggested.62 To test this hypothesis, the spectroelectrochemical titration of Cu-CuBMb 
was performed in the presence of 500 molar equivalents of chloride.63 Upon the first 
Figure 1.7. a) Heme o and b found in HCOs. Heme o mimics used in the study. b) Rates of 
heme degradation for different heme types. The changes of Soret band absorbance plotted 
against the reaction time at 418 nm for Cu
B
Mb(heme b) (solid line), at 410 nm for Cu
B
Mb(heme 
o) (dashed line), and at 404 nm for Cu
B
Mb(meso-heme) (dashed-dotted line). Redox-
dependent structural changes of the Cu
B
 center in the absence of chloride (c) and in the 
presence of excess chloride (d).  
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electron transfer to the CuB center, one of the His ligands of CuB center dissociates and 
coordinates to the heme iron, forming a six-coordinate low-spin ferric heme center and a 
reduced CuB center. The second electron transfer reduces the ferric heme and causes 
the release of the coordinated His ligand. Thus, the fully reduced state of the heme-copper 
center contains a five-coordinate ferrous heme and a reduced CuB center, ready for O2 
binding and reduction to water to occur. In the absence of chloride ion, formation of the 
low-spin heme species was not observed. These results showed that binding of chloride 
to the CuB center can induce redox-dependent structural changes, and the bound chloride 
and hydroxide in the heme-copper center may play different roles in the redox-linked 
enzymatic reactions of heme-copper oxidases, probably because of their different binding 
affinity to the CuB center and the relatively high concentration of chloride under 
physiological conditions (Fig. 1.7 c-d). 
1.2.4. Using Mb-based HCO mimics to perform electrocatalytic oxygen reduction 
reaction 
A recent DFT study compared the best platinum-based oxygen reduction catalysts with 
HCO and concluded that HCO is a better catalyst for fuel-cell based energy applications 
as it exhibits much lower overpotential than current platinum-based catalysts.64 
Additionally, the HCO also uses earth-abundant metal ions (iron and copper) for catalysis. 
However, the large size and membrane nature render them as inefficient electrocatalysts 
that not very stable and exhibit low site density on electrochemical surfaces. We have 
also tested the performance of G65Y-CuBMb as an electrocatalyst by immobilizing a 
single layer of protein on gold electrode surface using modified porphyrin groups.65 The 
rate of oxygen reduction and product selectivity of G65Y-CuBMb (k= 1.98 x 107 M-1 s-1, 
6% ROS) immobilized on the electrode was far superior as compared to a HCO synthetic 
model (k=1.2 x 105 M-1 s-1, 10% ROS) tested under same conditions. Moreover, the first-
order oxygen reduction rate of G65Y-CuBMb (~5000 /s) is at least 10-fold higher than that 
of native HCO on electrode. In situ resonance Raman analysis of these reactions suggest 
that electron transfer shunt from the electrode circumvents the slow dissociation of a ferric 
hydroxide species, which slows down native HCOs in comparison to its Mb-based mimic. 
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1.2.5. NO reduction cross-reactivity of Mb-based HCO mimic 
NO reduction cross-reactivity of HCOs is very interesting in that only certain HCOs like 
ba3/ caa3 oxidases from Thermus thermophilus and cytochrome cbb3 oxidase from 
Pseudomonas stutzeri, display NOR reactivity.66,67 While other families, such as 
cytochrome c oxidase from bovine heart, show no NOR activity and instead get inhibited 
by nanomolar concentrations of NO.68 To begin understanding such differences in HCO 
cross-reactivity, we tested the NO reduction reactivity of CuBMb by GC-MS. In the 
presence of Cu(I), CuBMb catalyzed the selective reduction of NO to N2O, as shown by 
the appearance of a second peak at a longer retention time in the GC, which corresponds 
to a 44 MW peak (N2O) in the MS (Figure 1.8).69 The relative GC peak intensity of N2O:NO 
increased as a function of time, indicating further reduction of NO to N2O as the reaction 
proceeds. The turnover number for NO reduction was calculated to be ∼2 mol NO /mol 
CuBMb /min, close to the 3 mol NO /mol enzyme /min reported for the ba3 oxidases from 
T. thermophilus.18 Control experiments performed with CuBMb alone or with WTswMb in 
the presence of Cu(I) showed no reduction of NO. These results demonstrated that Cu(I) 
plays a critical role in the reduction of NO to N2O in CuBMb.     
1.3. Developing a structural and functional NOR mimic in myoglobin 
1.3.1. First generation NOR mimics: Design of iron binding FeB center in Mb 
The NORs contain a heme and a nonheme diiron catalytic center that catalyzes the two-
electron NO to N2O reduction, an important step in biological denitrification reaction. At 
Figure 1.8. GC/MS chromatogram of NO reduction by Cu(I)-added Cu
B
Mb and control Cu(I).  
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the time the Mb model of NOR was designed, the crystal structure of NOR was not 
obtained. Nevertheless, the structural and sequence homology of NORs predicted that 
all six His ligands in HCOs (two to low-spin heme, one to high-spin catalytic heme and 
three to CuB) were conserved in the same position in NORs.70 Additionally, the NORs 
contained several conserved glutamates (not found in HCOs) that were required for the 
nonheme iron binding and/or catalysis.15 Based on this information, and the knowledge 
that nonheme iron typically prefers an octahedral geometry where one of the ligands is a 
carboxylate (Glu/Asp), we embarked to design the putative nonheme iron binding site  
(FeB) in Mb, consisting of three histidines and one glutamate. The histidine residues were 
introduced first, as crystal structures of HCOs containing three conserved histidines were 
readily available (e.g., bovine CcO). Based on overlays of the minimized structure of 
swMb and CcO, the distal His64 in swMb was chosen as one of the histidines, while 
Leu29 and Phe43 were mutated to histidines, to produce a nonheme metal binding site 
same as CuBMb. Next, V68E mutation to swMb was chosen based on its proximity and 
angle to the heme and the three His. The minimized computer model of the resultant triple 
mutant (swMb L29H, F43H, V68E), named FeBMb, is shown in Fig. 1.9a. The FeB site 
(modeled as Zn(II)) was found within bonding distance to Nε of all three His residues (2.13 
Å to H29, 2.20 Å to H43, and 2.09 Å to H64) and both O atoms of E68 (2.11 Å and 1.96 
Å), indicating that the proposed mutations would support iron binding in myoglobin, 
forming an FeB site.  
Following the computational design, FeBMb was tested for nonheme iron binding via UV-
Vis and EPR spectroscopy. The modulation of heme Soret and visible bands in the UV-
Vis spectra (Fig. 1.9c-d) of FeBMb along with the attenuation of g=6 EPR signals 
suggested the binding of nonheme iron in the designed FeB center. Further evidence of 
Fe2+ binding to the designed FeB site comes from a high resolution crystal structure (1.72 
Å) of Fe(II)-FeBMb (Fig. 1.9b). The nonheme iron in the FeBMb was five coordinate, with 
bonds to all three histidines (2.18 Å to H29, 2.12 Å to H43, and 2.20 Å to H64), one O 
atom of E68 (2.19 Å) and one water molecule (2.11 Å). The crystal structure was found 
to be consistent with the proposal that a glutamate in the active site of NOR helps stabilize 
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iron binding to the FeB site. In addition to structural roles, the glutamate and water in the 
active site may also provide the two protons required for NO reduction. To test the NO 
reactivity of FeBMb, GC-MS assays were conducted. The FeBMb performed selective two-
electron reduction of NO to N2O in presence of nonheme iron, while similar experiments 
performed with only nonheme iron or E-FeBMb produced residual N2O (Fig. 1.9d). 
Overall, FeBMb was the first designed protein that modeled both the structure and function 
of NOR, offering insight that the active site glutamate is required for both iron binding and 
activity. These results also showed that structural and functional metalloproteins can be 
rationally designed in silico. 
To understand the implications of nonheme metal in modulating NO reactivity, the 
reaction of one molar equivalent NO with E-, Zn-, Cu- and Fe-FeBMb was investigated by 
UV-Vis, EPR, resonance Raman and FTIR spectroscopies. These experiments revealed 
the binding of first NO molecule to the ferrous heme in all cases, but while the E-, Cu- or 
Zn-loaded proteins showed characteristic EPR signatures of S = 1/2 six-coordinate heme 
{FeNO}7 species, the nonheme Fe-loaded proteins were EPR silent. Vibrational modes 
Figure 1.9. a) Minimized computer model of Fe
B
Mb with Zn(II) in the Fe
B
 site. b) Crystal structure 
of Fe(II)-Fe
B
Mb collected at Fe-edge absorption (1.7309 Å). UV-vis spectra of 10 μM of deoxy 
Fe
B
Mb and deoxy WTMb (d) with 1 eq. Fe(II)-added. (e) Time dependent GC/MS measurements 
of N
2
O formation by Fe(II)-Fe
B
Mb. (f) FTIR difference spectra (dark minus illuminated) of E-
Fe
B
Mb(NO) and Fe(II)-Fe
B
Mb(NO) at 10 K: NO (black),
15
NO (red), and NO minus 
15
NO difference 
spectra (blue).  
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from the heme [Fe-N-O] unit were identified in the RR and FTIR spectra using 15NO and 
15N18O. The E- and Cu(I)-bound proteins exhibit ν(FeNO) and ν(NO) that were only 
marginally distinct from those reported for native myoglobin. However, binding of Fe at 
the FeB site shifts the heme ν(FeNO) by 17 cm-1 and the ν(NO) by ~50 cm-1 to 1549 cm-
1. This low ν(NO) was without precedent for a six-coordinate heme {FeNO}7 species and 
suggested that the NO group adopts a strong nitroxyl character stabilized by electrostatic 
interaction with the nearby nonheme Fe (Fig. 1.9f). A similarly low ν(NO) was detected in 
the Zn(II)-loaded protein that supported this interpretation.71  
1.3.2. Second generation NOR mimics: Role of secondary coordination sphere 
(glutamates) towards NOR activities 
Further structural investigations and mutagenesis studies of native NORs revealed that 
the presence of additional glutamates near the FeB site are important for NOR 
activity.15,26,72,73  Based on this, a second generation model of FeBMb was engineered, in 
which Glu was introduced near the heme at position 107. The resulting mutant called 
I107E-FeBMb retained binding of metal ions, including Fe2+ to the FeB site, as was 
confirmed crystallographically (Fig. 1.10a).74 Moreover, the new mutant retains the 
position of Fe(II) and it’s coordination, as compared to FeBMb. EPR of fully oxidized Fe-
FeBMb revealed a decrease in the heme signals, suggestive of spin coupling between the 
metals, as observed in native NORs. Titration of Cu2+ resulted in similar apparent 
coupling, while titration of Zn2+ resulted in an increase in the heme signals, suggestive of 
weakening of the heme-Fe coordination (Fig. 1.10b). Binding of these metals and their 
interactions were again confirmed crystallographically. Cu retained similar geometry, 
while Zn showed absence of the metal-coordinating water molecule and weakening of the 
Fe-glutamate coordination, consistent with EPR results. The heme of I107E-FeBMb as 
measured at -134 mV vs. NHE, ~20 mV higher than -158 mV measured for FeBMb itself. 
The heme E°’ with Fe(II), Cu(II), and Zn(II) bound were measured to be -64 mV, -137 mV, 
and -105 mV respectively. 
I107E-FeBMb showed an approximately 100% increase in NOR activity compared 
to FeBMb (Fig. 1.10c). This increase is likely due to the presence of a 2.32Å hydrogen 
bond between the mutated I107E and a FeB water ligand, which was observed 
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crystallographically.74 Such a hydrogen bonding network might be expected to activate 
NO by hydrogen bonding to the oxygen atom and facilitating protonation. NOR activity 
was also observed in the presence of Cu(I), but not Zn(II). EPR of these proteins upon 
reaction with NO showed formation of five-coordinate Fe-NO, due to His-Fe bond 
cleavage, unlike the weakening observed in FeBMb, suggesting it may be important for 
NOR activity. 
Subsequent studies using stopped-flow UV-Vis and freeze-quench rR 
spectroscopies showed that the presence of Glu107 stabilizes the six-coordinate heme-
nitrosyl state and prevents dissociation of the proximal histidine, which leads to a dead-
end product.75 In Fe(II)-FeBMb two sets of rR signal were observed after reaction with NO 
- ν(FeNO)heme and ν(NO)heme at 522 and 1660 cm–1, from five-coordinate heme-NO, and 
ν(NO)FeB at 1755 cm–1, for nonheme FeB-NO. Transient kinetics studies showed that this 
5-coordinate species is a result of His dissociation from the transient 6-coordinate NO-
bound state. This dissociation is substantially slowed in I107E-FeBMb, allowing the heme-
nitrosyl to combine with the non-heme nitrosyl and decompose to the desired product, 
N2O, with a rate of 0.7 s–1 at 4 °C (Fig. 1.10d). These observations support the trans-
mechanism of NOR function. 
1.3.3. Complete characterization of a nonheme iron nitrosyl center in FeBMb 
A major barrier to understanding the binding and interaction of NO with FeB center is the 
strong spectroscopic signals of heme iron that make it difficult to investigate the FeB 
Figure 1.10. a) Overlay of Fe(II)-I107E Fe
B
Mb (cyan) (PDB ID code 3M39) with Fe(II)-Fe
B
Mb 
(orange) (PDB ID code 3K9Z). b)Time-dependent N
2
O production by Fe(II)-I107E FeBMb (▴) 
and Fe(II)-FeBMb (●) with ∼50 eq. NO under single turnover conditions. The yield was 
determined by a comparison of the ratio of NO∶N
2
O peaks from the GC/MS chromatograms. c) 
Reaction steps leading to the production of N
2
O in I107E-Fe
B
Mb 
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center. To overcome this challenge, iron containing protoporphyrin IX (heme) in FeBMb 
was replaced by Zn protoporphyrin IX (ZnPP) to yield ZnPPFeBMb (Fig. 1.11a).76 The low 
affinity of ZnPP for NO along with lack of spectroscopic signals of Zn2+ was expected to 
help focus on the nonheme iron specifically. The binding of nonheme Fe2+ at the FeB 
center of ZnPPFeBMb was confirmed using UV-Vis spectroscopy along with X-ray 
crystallography (Fig. 1.11b-c). The NO binding properties of nonheme iron was 
investigated using EPR and Mossbauer spectroscopy. More specifically, EPR spectra of 
20 molar equivalents of NO added Fe-ZnPPFeBMb shows two well-resolved doublets at 
g=4.36, 3.58, and 4.13, 3.73, respectively (Fig. 1.11d). These two different components 
were ascribed to different orientations of NO bound to the FeB site, or slight changes in 
Figure 1.11. a) Schematic representation of the replacement of Fe-protoporphyrin IX from Fe
B
Mb 
(green) with Zn-protoporphyrin IX, yielding ZnPPFe
B
Mb (magenta). b) UV-vis spectra of Fe
B
Mb 
(green), ZnPPFe
B
Mb (magenta), and ZnPPFeBMb in the presence of 1.0 equivalent Fe(II) (blue) 
in 50 mM Bis-Tris buffer pH 7.3. c) 1.52 Å X-ray structure of Fe(II)-ZnPPFe
B
Mb. d) X-band EPR 
spectrum of a sample containing 0.7 mM ZnPPFe
B
Mb in the presence of 1.0 eq. FeCl
2
 and 20 
equivalents of NO (blue trace) in 50 mM Bis-Tris buffer pH 7.3, and simulated spectra (red trace).  
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the orientation of FeB ligands upon NO binding. The electronic and spin state of the FeB 
nitrosyl species was further characterized by field-dependent Mossbauer measurements 
which revealed 35% unreacted Fe(II) species along with 65% iron-nitrosyl component. 
The Mossbauer parameters (EQ)= (1.70 ± 0.01) mm/s, and Fe=(0.69 ± 0.01) mm/s, of 
the iron-nitrosyl component was indicative of an S=3/2 six-coordinate {FeNO}7 species 
found in other proteins as well as small molecule models. To obtain further insight into 
the electronic structure of the {FeNO}7 moiety, the Mulliken spin populations was 
calculated at the Fe and NO centers of the structures obtained from quantum 
mechanical/molecular mechanical (QM/MM) calculations as well as partially optimized 
active-site structures. The computational calculations supported the assignment of 
nonheme iron-nitrosyl species in FeBMb as a HS ferrous center (S=2) 
antiferromagnetically coupled to an NO radical (S=1/2) [Fe2+-NO.]. Overall, these findings 
are consistent with trans-mechanism of NO reduction wherein the radical nature of the 
NO in FeB-nitrosyl would facilitate the radical coupling of the second heme-bound NO to 
promote N-N bond formation. 
1.3.4. Impact of FeB coordination on NOR activity: Design of 2His-1Glu FeB center 
A sequence alignment of a unique quinone-oxidizing NOR, gNOR predicted that it may 
exhibit a novel FeB site, with one of the 3-His ligands replaced by an Asp residue.77 This 
finding is quite interesting, as an inspection of the active site of nonheme iron containing 
enzymes in Nature indicates that the majority use a similar conserved 2-His-1-carboxylate 
(Asp/Glu) facial triad for iron binding and substrate oxidation. To test whether the unique 
2-His-1-Asp/Glu nonheme metal center could be utilized to mimic NOR for NO reduction, 
a 2-His-1-Glu metal center was designed in swMb by replacing His29 in FeBMb with a Glu 
residue while keeping Val68 intact (FeBMb H29E, E68V, or swMb L29E, F43H, H64, 
called FeBMb(-His)). UV-Vis and EPR spectroscopic measurements along with 
crystallography showed that FeBMb(-His) could bind either iron and copper, with 2 His- 
and 1-Glu coordinating to the nonheme metal (Cu) in a tetrahedral geometry (Fig. 1.11). 
The NO reduction function of FeBMb(-His) when probed using GC/MS under single 
turnover conditions showed that Cu(I)-FeBMb-(-His) when exposed to excess NO 
produced N2O with increased yield over time as estimated from the ratio of N2O: NO 
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peaks (∼32% at 20 h). N2O production was also observed for Fe(II)-FeBMb(-His) (∼6% at 
20 h). In contrast, no N2O formation was observed for Zn(II)-FeBMb(-His), metal alone, 
and WTMb with Cu(I) or with Fe(II). Overall, the study presented a novel structural and 
functional protein model of NOR and provided insights into the newly discovered member 
of the NOR family, gNOR. 
1.4. Remaining questions and outline of the thesis 
While studies of native HCOs and NORs have and will continue to provide valuable insight 
into their function, they are unable to address many fundamental questions of their 
function. We have shown, that these questions can be addressed using small protein 
models of each of their active sites. For instance, we have shown that while HCO activity 
does not fundamentally require a metal, the presence and positioning of tyrosine is 
critically important.32 Moreover, we have shown the first evidence for the formation of a 
Tyr radical upon reaction of a functional HCO mimic with oxygen.41 We have also directly 
demonstrated the key role of heme E°’ on HCO activity in a system that decouples this 
Figure 1.12. a) UV-vis titration of ferric E-FeBMb(-His) with Cu(II) (b) X-band EPR spectra of ferric 
E-FeBMb(-His) (0.5 mM) in the same buffer as in (a) and that in the presence of 1.0 or 3.0 equiv 
of Cu(II). (c) Crystal structure of Cu(II)-CN--FeBMb(-His) at 1.65 Å resolution (PDB entry 3MN0). 
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from other effects of the protein.78 In understanding NOR reactivity, FeBMb provided a 
valuable structural insight into a functional NOR before the structure of a native NOR was 
obtained.79 This model has proven invaluable for unraveling the mechanism of NO binding 
and N-N bond formation is most likely at heme-nonheme diiron sites.75,76 In both designed 
proteins, the importance of secondary coordination H-bonding effects was elegantly 
demonstrated using spectroscopic studies and rational engineering.74,78 
The success of these system also enables the next generation of studies that are difficult 
to address in native HCOs and NORs. Some remaining questions that can potentially be 
solved using these models are discussed below along with an outline of thesis in attempts 
to solve these questions: 
(1)  The role of nonheme metal in influencing HCO activity: The discovery and 
characterization of cyt. bd oxidases that perform oxygen reduction without any 
nonheme metal, neither copper nor iron, makes one question what exactly is the 
role of copper.17 This observation is also supported by various synthetic HCO 
models including Mb-based models that perform oxygen reduction to water 
without any copper in the CuB center.32,80 Chapter 2 along with parts of chapter 3 
try to address this question by showing that the nonheme metal acts as an electron 
donor, binds to oxygen to further activate it for its efficient O-O bond cleavage. 
(2)  The preference of copper over iron for oxygen reduction in HCOs: The HCOs and 
NORs evolved from a common ancestral protein with copper chosen for the 
catalytic heme-copper center of HCOs and iron chosen for the catalytic heme-
nonheme diiron center of NORs.81 However, the choice of copper and the 
chemical or functional reason for choosing it over iron in HCOs remains unknown. 
The ability to substitute metals in Mb-models can help us solve this question. 
Chapter 3 attempts to address this question by showing that Cu is superior to Fe 
in oxygen reduction by exhibiting higher E°’ and by activating the O-O bond of 
bound oxygen much more strongly due to its higher d electron density. 
(3) The mechanism by which different HCO-types tune their heme E°’: HCOs from 
different species exhibit a wide range of heme E°’ with the highest reported E°’ of 
+365 mV for bovine CcO82 and lowest reported E°’ of -59 mV for cbb3 oxidase.83 
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This variation in heme E°’ of catalytic heme center of various HCOs begets a 
fundamental question as to how and why do HCOs exhibit such wide range of 
heme E°’. Chapter 4 attempts to solve this question by showing that HCOs use H-
bonding interactions and different heme types to tune their heme E°’. 
(4) The functional reason behind high heme E°’ in HCOs and low heme E°’ in NORs: 
Most HCOs exhibit heme E°’ values within +150 to +365 mV (Table 5.1) while the 
NORs exhibit low E°’ values between -170 to 60 mV (Table 6.1).  The reasons for 
this variation in heme E°’ for homologous HCOs and NORs is not understood. 
Chapter 5 attempts to address these question by showing that the higher E°’ in 
HCO mimic helps them achieve fast oxygen binding as well as electron transfer 
rates. Chapter 6 focusses on E°’ tuning in NORs and shows that the low heme E°’ 
in NORs helps them achieve high electron density on heme-bound NO for efficient 
N-N coupling. These results also explain why certain HCOs with high heme E°’ 
(like bovine CcO) get inhibited by NO while others with low heme E°’ reduce NO 
to N2O. Finally, the NOR mimic with high E°’ (FeBMb (MF-heme)) is able to 
selectively reduce NO to N2O with at least 25 turnovers.  
(5)  Mechanism of oxygen reduction by NORs: While the mechanism of oxygen 
reduction by HCOs is widely investigated, little is known on how oxygen is 
activated and reduced by NORs. In chapter 7, we investigate the reaction of Fe(II)-
FeBMb (NOR mimic) with oxygen and capture heme compound I as one of the 
intermediates by UV-Vis, EPR and Mössbauer spectroscopy. This result implies 
that the O-O bond cleavage by NORs is heterolytic with 3e donation from heme 
iron and 1e donation by nonheme iron.  
All of these results provide broader insight into the chemical properties driving evolution 
of bioenergetics reactions, as well as into structural features that will allow more efficient 
fuel cell catalysts. 
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Chapter 2 
Role of copper and tyrosine in heme-copper oxygen reductases using a rationally 
designed myoglobin-based mimic 
Portions of this chapter are a taken from the final draft of a manuscript in preparation as 
“Understanding the role of copper and tyrosine in Heme-copper oxidases using a 
rationally designed myoglobin-based mimic” (Ambika Bhagi-Damodaran, Shuyan Wang, 
Braddock A. Sandoval and Yi Lu) 
Abstract: Heme-copper oxygen reductase (HCO) is the terminal enzyme in the 
mitochondrial electron transport chain that uses a heme-copper catalytic center to 
perform the four electron reduction of oxygen to water. In this chapter, we use a structural 
and functional model of HCO in myoglobin to elucidate the role of copper and tyrosine - 
a highly conserved residue in native HCO’s, towards oxidase activity. Here, we 
systematically introduce copper and tyrosine into the catalytic heme center of the 
myoglobin-based HCO mimic and investigate their impact on catalytic activity, product 
selectivity and enzyme stability. Our studies reveal the role of copper an electron donor 
resulting in a four-fold enhancement of catalytic activity. Incorporation of the tyrosine 
residue results in a further three-fold enhancement of catalytic activity, along with a 
dramatic ten-fold improvement in enzyme stability. Overall, this work clearly establishes 
the role of copper as an electron donor and tyrosine as an H-radical donor for reduction 
of oxygen in HCOs.   
2.1. Introduction 
Heme-copper oxygen reductases (HCO) are the terminal enzymatic complexes of aerobic 
respiratory chain that catalyze kinetically difficult reduction of oxygen to water and, in 
doing so, generate a trans-membrane proton gradient that drives the important process 
of ATP synthesis.1-3 The catalytic site of HCO, where oxygen binding, activation and 
reduction occurs, is a binuclear heme-copper center, which consists of a histidine 
coordinated to a high spin heme iron and a copper (CuB) coordinated to three histidines, 
one of which is cross-linked to a tyrosine residue.4-7 Despite significant investigation on 
the structure and function of HCOs, the role of copper and tyrosine in the catalytic center 
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of HCOs remains unclear.8 While Karlin and coworkers suggest that copper acts as an 
electron donor and increases the rate of oxygen binding to heme-copper catalytic center9-
11 Nam and coworkers have recently hypothesized copper to act as a lewis acid which 
merely activates and helps in the cleavage of the O-O bond to obtain water.12 
Furthermore, the crosslinked Tyr is thought to function merely as an H-bond donor to 
activate oxygen to an H-radical donor to cleave the O-O bond.13,14 This debate regarding 
the role of copper and tyrosine in HCOs is mainly due to the inherent complexity of the 
HCO structure with the presence of multiple metal centers which makes the study of 
heme-copper catalytic center rather difficult. Moreover, both tyrosine and copper are 
required for the folding and assembly of the catalytic center; mutation of tyrosine or 
depriving the HCO expressing cells of copper leads to misfolded HCO.15 Hence, it is 
difficult to investigate the role of copper and tyrosine in HCOs separately and individually. 
To alleviate such challenges, a number of synthetic models of HCOs have been prepared 
but no such model has been able to clearly establish the role of copper and tyrosine to-
wards the reaction and turnovers in HCOs.9,16-18 
Complementary to synthetic models of HCOs, we have also designed a heme-copper 
center in a small, soluble and easy-to-purify protein, myoglobin called CuBMb.19-21 The 
CuBMb bound Cu(II) with micromolar affinities as was shown structurally as well as via 
spectroscopy.19,22 However, addition of more than 2 equivalents of Cu(II) to the met-form 
of CuBMb caused significant precipitation of the protein. Thus, the investigation of Cu(II)-
CuBMb was limited to the addition of maximum two molar equivalents of Cu(II) to CuBMb 
which was not enough to saturate the CuB center in HCOs. The proteolytic degradation 
of CuBMb on Cu(II) addition was probably due to the interaction of “naked” Cu(II) with 
amino acid residues as has been shown previously.23  We reasoned we could avoid such 
degradation of CuBMb by adding tetrakisacetonitrile Cu(I) to myoglobin mutants as the 
reduced form of copper coordinated to acetonitrile will have lower probability to oxidize 
and degrade the protein. In this work, we use Cu(I)-added CuBMb as a model system to 
probe the role of copper and tyrosine in HCOs separately as well as in combination with 
each other. Our studies reveal that the copper at the CuB center facilitates the O-O bond 
cleavage by acting as an electron donor and exhibits a four-fold enhancement in the 
oxidase activity as compared to its redox inactive Ag(I)-based analogue. Furthermore, the 
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presence of tyrosine in the catalytic heme-copper center not only acts as an H-radical 
donor and enhances the oxidase activity by approximately five-fold but also increases the 
enzymatic turnovers and makes it more robust.   
2.2. Materials and methods 
All chemicals, unless otherwise specified, were obtained from Sigma (St. Louis, MO) or 
Fisher Scientific (Hampton, NH). 
2.2.1. Purification of proteins 
CuBMb and F33Y-CuBMb was expressed and purified as reported previously.22 Briefly, 
apo-protein was expressed and localized to the inclusion bodies of BL21(DE3) cells. The 
cells were then lysed by sonication and denatured with 6 M guanidine chloride. Heme b 
was added to the denatured cell solution, which was then dialyzed against 10 mM TRIS-
H2SO4 pH 8 at least 4 times. The resulting protein solution was concentrated by Amicon 
with a 10,000 MWCO filter, and passed through a size exclusion column to achieve 
homogeneity.  Protein fractions with r/z value greater than 4 were then combined and 
chelexed to remove any metal ions at the CuB site as per a procedure reported 
previously.21 Final yield of the protein was ~ 40 mg/L. WTMb was expressed and purified 
as reported previously24 and its yield was typically ~100 mg/L. 
2.2.2. Characterization of CuBMb variants via UV-Vis spectroscopy  
UV-vis data were collected on a Hewlett-Packard 8453 spectrometer. Table 2.1. enlists 
the spectral features of oxidized and reduced forms of CuBMb and WTMb variants utilized 
in this work. The oxidized form of the proteins show a Soret band at 400 nm range 
followed by  and  bands in the visible region, typical of a well-folded met-myoglobin.25 
Extinction coefficient of the proteins was determined by hemochromogen assay where 
the wavelength maximum (in nm) and extinction coefficient in used for the  peak of heme 
b was 556 and 36.5 mM-1 cm-1 respectively.  
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Table 2.1. UV-Vis spectral features of FeBMb and WTMb   
  ferric*  deoxy*  
 Soret vis   Soret vis 
CuBMb 408 501 630 433 556 
WTMb 408 502 628 429 556 
 
*wavelength maxima reported (in nm) 
2.2.3. Metal titration and analysis 
The Cu(I) and Ag(I) bound CuBMb variants were prepared as described previously with 
slight modifications.26 Briefly, the met-form of CuBMb was degassed and transferred in 
anaerobic glovebag, where they were reduced using dithionite and exchanged with a 
PD10 column equilibrated with 50 mM Bis-TRIS buffer at pH 7.3. To obtain Cu(I)-CuBMb, 
5 equivalent of tetrakis(acetonitrile)Cu(I)hexafluorophosphate dissolved in acetonitrile 
was added to E- CuBMb and any unbound Cu(I) ions were removed by a PD10 column  
equilibrated with 50 mM Bis-TRIS buffer at pH 7.3.  
 
Bathocuproine was used to determine the amount of Cu(I) bound to FeBMb. An extinction 
coefficient of 13,800 M-1 cm-1 at 480 nm was used for the Cu(I)-bathocuproine complex, 
as per which ~3 equivalents of Cu(I) bound to each equivalent of CuBMb. Similar 
experiment ran for WTMb yielded ~2 equivalents of Cu(I) bound to each equivalent of 
WTMb suggesting that the third equivalent of Cu(I) binds to the CuB center in Cu(I)-
Figure 2.1. UV-Vis spectroscopic titration of CuBMb with Cu(I). (A) Representative spectra of 
0 eq. and 3 eq. Cu(I)-added CuBMb. (B) The differential spectra used to calculate the binding 
affinity of Cu(I) to CuBMb (C) The binding affinity curve.  
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CuBMb. The binding of the metal ion at the nonheme center of CuBMb was confirmed by 
bathochromic shifts in the UV-Vis spectra as can be seen in Fig. 2.2. The metal titration 
experiments were conducted in presence of dithionite as described previously.26 Results 
are shown in Fig. 2.1. The affinity of CuBMb for Cu(I) was found to be 18 M.  
2.2.4. Oxygen consumption assay using an oxygen electrode.  
The rate of water and ROS production was measured and calculated as reported 
previously with slight modifications as described here.22,27 The oxygen consumption 
assay was initiated by the addition of 18 M or 6 M of CuBMb to 18 mM/10 mM ascorbate 
and 1.8 mM/ 1 mM of TMPD incubated in air saturated 100 mM phosphate buffer at pH 
6. To calculate the percentage of water with respect to H2O2 (ROS) formation, we 
repeated the measurement of oxygen reduction in the presence of catalase (7 M), which 
selectively react with H2O2 to produce oxygen. By comparing the rates of reduction in the 
absence of and in the presence of catalase, the portion of oxygen reduction that is due to 
water formation can be calculated, using a protocol reported previously. For experiments 
with Cu(I) added CuBMb in particular, we found that catalase removed the Cu(I) ions from 
the CuB center and decreased the rates significantly. To avoid that, the Cu(I) binding sites 
in catalase were saturated by adding 24 equivalents of Cu(I) in the glovebag prior to the 
assay. The Cu(I) bound catalase was checked for its activity by performing assays with 
H2O2 in the oxygen electrode before using it for the determination of H2O2 produced in 
experiments with Cu(I)-CuBMb.  
2.2.5. UV-Vis kinetic measurements  
Experiments were performed on a Hewlett-Packard 8453 spectrometer. A water bath, 
connected to the cuvette holder and set to 25ºC, provided temperature control.  
2.2.6. EPR data collection 
X-band EPR spectra were collected on a Varian E-122 spectrometer at the Illinois EPR 
Research Center (IERC). The samples were run at ∼30 K using liquid He and an Air 
Products Helitran cryostat with 20% glycerol. Magnetic fields were calibrated with a 
Varian NMR gaussmeter, and the frequencies were measured with an EIP frequency 
counter. 
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2.3. Results and discussion 
2.3.1. Preparation and characterization of Cu(I)-added CuBMb 
The CuBMb was expressed and purified without any copper in the CuB center such that 
different metal ions like copper and silver can be added at the CuB center to probe the 
importance of copper in the catalytic center of HCOs. The Cu(I) ions were then 
incorporated in the reduced deoxy-form of the CuBMb in anaerobic conditions to avoid its 
oxidation by the met-ferric heme and oxygen respectively. The titration of Cu(I) to the 
deoxy-CuBMb, as observed by UV-Vis spectroscopy, caused a small shift in the Soret 
max (from 434 to 435 nm) and visible bands suggesting the incorporation of Cu(I) close 
to the heme center (Fig. 2.1.). However, three equivalents of Cu(I) addition was required 
to see any changes in the UV-Vis spectra indicating that at least two copper ions bound 
non-selectively to the protein periphery. This was confirmed by adding 5 equivalents of  
Cu(I)  to WTMb and performing a PD10 (which removes unbound Cu(I) from the protein) 
followed by analyzing the number of Cu(I) ions using a ratiometric Cu(I) sensor, 
bathocuproine. Bathocuproine was specifically chosen for these experiments as it binds 
Cu(I) with a femtomolar binding affinity and absorbs at 480 nm (with a high extinction 
coefficient of 13,800 M-1 cm-1), where myoglobin and its mutants do not absorb.28  The 
addition of excess bathocuproine to the Cu(I) added WTMb reveals that each equivalent 
of protein binds two equivalent of Cu(I) ions. Similar assay when performed for CuBMb 
reveals the binding of three molecules of Cu(I) to it, suggesting that the additional Cu(I) 
binds to the CuB center in CuBMb.  
To further confirm the presence of copper at the CuB center in proximity to the heme iron, 
we investigated the Cu added CuBMb mutants with EPR. The air-oxidized heme-copper 
center in the HCOs exhibit an antiferromagnetic exchange coupling between Cu(II) 
(S=1/2) and high spin Fe (S=5/2) such that a large part of the g=6 high spin Fe signal is 
EPR-invisible.29 To investigate if similar spin-coupling exists in oxidized form of Cu-
CuBMb, we added different equivalents of Cu(I) to deoxy-CuBMb and oxidized the pro-
tein with a high potential Azurin variant16 with E°= ~600 mV). The complete oxidation of 
both heme and copper center in the Az oxidized Cu-CuBMb samples was ensured by 
taking their UV-Vis spectra which shows a prominent Soret peak at 408 nm indicative of 
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oxidized ferric heme. Following this, the EPR spectra obtained on these samples showed 
minimal attenuation of the g=6 signal on addition of two equivalents of copper. However, 
we saw large decrease in the signal on increasing the Cu equivalents up to ~3, suggesting 
the binding of the third Cu (equivalent to the protein) to the CuB center. This observation 
in conjunction with the UV-vis absorbance and crystallography results confirm the 
presence of Cu at the CuB center spin-coupled to the heme iron.     
2.3.2. Functional role of copper in HCOs: Oxygen reduction assays with CuBMb and 
WTMb variants 
Having obtained a protein mimic of HCO, which contains a similar exchange-coupled 
heme-copper center, we investigated its oxygen reduction reactivity using 
TMPD/ascorbate as the reductant as reported for native HCO and its synthetic mimics.22 
The rates of oxygen reduction by CuBMb and its metal bound variants in the presence of 
the reductant ascorbate and redox mediator, N,N,N′,N′-tetramethyl-p-phenylenediamine 
(TMPD) were measured using an oxygen electrode and a protocol reported previously for 
both native CcO’s and their models. For the oxidase to function efficiently, it is required 
to perform a complete 4e− reduction of oxygen into water; any incomplete reduction, such 
as 2e− reduction of oxygen to peroxide will result in not only lower efficiency in oxygen 
reduction, but also ROS that is detrimental to the biomolecules in living cells. Therefore, 
Figure 2.2. (A) Crystal structure of heme-copper center in Cu
B
Mb showing the distance 
between heme iron and copper which is approximately 5 Å (B) The EPR spectra of different 
equivalents of Cu-added Cu
B
Mb which is oxidized 10 eq. of high potential Azurin mutant. The 
attenuation of g=6 high spin heme iron signal suggests coupling between the heme-copper 
center as has been found in native CcOs. (C) Changes in the UV-Vis spectral features of 
deoxy CuBMb on addition of 3 eq. Cu(I).  
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we measured the ratio of water formation with respect to peroxide as previously reported, 
by repeating the oxygen reduction experiments in the presence of catalase, which 
selectively reacts with peroxide oxidizing it to oxygen. The reduction of oxygen by E-
CuBMb under these conditions proceeded non-selectively producing more than 50% 
ROS. Addition of redox inactive Ag+ (which binds at the CuB center) neither changes the 
rate of the reaction nor improves the product selectivity. In contrast, the addition of Cu(I) 
to the CuB center not only increased the rate of oxygen reduction by more than four times 
but also selectively reduced more than 95% of oxygen to water. Thus, while the presence 
of redox inactive Ag(I) at the CuB center makes no impact on oxygen reduction rates, the 
addition of redox active Cu(I) dramatically improves the rates per-forming complete four-
electron reduction of oxygen to water. These results clearly establish the role of the 
copper as an electron donor to oxygen in the catalytic cycle of HCOs.    
 
The above spectroscopic and enzymatic investigations suggest that Cu-CuBMb is an 
excellent structural and functional mimic of a heme-copper center in Mb. Moving further, 
we investigated the reaction of Cu-CuBMb with oxygen using UV-Vis spectroscopy under 
turnover conditions as shown in Fig. 3.3. (B). The absorption at the Soret peak at 408 nm 
decreased with time with a subsequent increase at 680 nm suggesting the degradation 
of heme cofactor to verdoheme over time as has been previously reported for Cu(II)-
Figure 2.3. (A) Oxygen reduction reactivity studies of WTMb, CuBMb and their metal- added 
variants to form either H2O (blue) or ROS (red). The experiments were performed with 18 mM 
protein in 100 mM phosphate buffer (pH6) containing 258 μM O2, 1.8 mM TMPD, and 18 mM 
ascorbate. (B) UV-Vis spectroscopic investigation of the reaction of Cu-Cu
B
Mb with oxygen 
under turnover conditions (similar to the oxygen reduction enzymatic assays) for over 30 
minutes. Inset shows the same spectra in the 600-800 nm wavelength range.   
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bound CuBMb.21,30 The formation of verdoheme was further confirmed via time-dependent 
mass spectroscopy. The increase in 680 nm peak in the UV-Vis spectra was concomitant 
with the decrease in the heme signal (mass = 616 g/mol) and an increase in the signal 
for verdoheme (mass = 619 g/mol). Due to such heme degradation, the Cu-CuBMb can 
only perform up to twenty turnovers of oxygen reduction to produce water.  
2.3.3. Role of conserved Tyr in HCOs: Oxygen reduction assays with F33Y-CuBMb 
variants. 
Moving ahead, we mimicked the conserved Tyr in CcOs by introducing the F33Y mutation 
close to the heme-copper center in Mb (Fig. 2.4.).22 The introduction of Tyr33 in myo-
globin has previously shown to increase the rate of oxygen reduction by approximately 
twice and also improve the selectivity of oxygen reduction to water. Following up on Cu-
CuBMb results, we added three eq. of Cu(I) to F33Y-CuBMb and performed oxygen 
reduction enzymatic assays as described above. The incorporation of Tyr close to the 
heme-copper center increased the rate of oxygen consumption by about four-fold 
reducing oxygen almost completely to water suggesting that both the copper and Tyr are 
required for effective oxygen activation and reduction in HCOs. This result in conjugation 
with a previous report which shows that the reaction of reduced deoxy-F33Y-CuBMb with 
oxygen obtains a Tyr33 radical31 confirms the role of Tyr as an H radical donor to oxygen 
in HCOs to perform its four-electron reduction to water.  
Next, we investigated the role of Tyr33 toward the O2 reduction turnovers. As discussed 
before, the Cu-CuBMb on reaction with oxygen in the presence of excess reductant 
formed verdoheme characterized by an increase in the absorbance at 680 nm. The rate 
of increase of the 680 nm absorbance (which is directly proportional to the concentration 
of verdoheme formed) fitted first order kinetics to give a rate constant of 0.01 /s. The Cu-
F33Y-CuBMb when reacted with oxygen similarly also formed verdoheme, however, the 
increase in the absorbance of 680 nm peak with time was much lower than that observed 
for Cu-CuBMb. The normalized absorbance at 680 nm when fitted with first order kinetics 
gave the rate of verdoheme formation as 0.001/s.  Thus, the incorporation of Tyr in the 
catalytic heme-copper center also reduced the rate of heme degradation to verdoheme 
by more than ten-fold. As a result, the Cu-F33Y-CuBMb performed up to 200 turnovers of 
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oxygen reduction reaction. Thus, the conserved Tyr in HCOs not only increases the 
turnover frequency of the enzyme but also makes it more robust increasing its total 
turnover number. 
2.3.4. Mechanistic role of CuB and conserved Tyr in oxygen reduction reaction 
In order to understand the mechanism by which Tyr33 makes the HCO mimic more robust 
and increases its turnover numbers, we look at its mechanism of oxygen reduction (Fig. 
2.3.). In HCOs, the heme Fe(II) and Cu(I) can potentially donate one electron each to 
obtain a Fe(III)-O-O-Cu(II) species.32 This species can then take an H radical from the 
conserved Tyr and another electron from heme Fe(III) to cleave the O-O bond and form 
compound I with a Tyr radical.2 We have observed similar formation of Tyr radical on 
reacting E-F33Y-CuBMb with oxygen suggesting that Tyr33 is indeed H radical donor to 
oxygen. Building upon these hypothesis, we propose that in the absence of Tyr33, the 
Fe(III)-O-O-Cu(II) species formed in the reaction of Cu-CuBMb with oxygen takes one 
electron from heme iron and one from porphyrin to obtain heme compound I with a radical 
cation on porphyrin. The heme compound I species is considered to be a reactive 
intermediate in heme oxygenase during the formation of verdoheme. Our results suggest 
the role of Tyr as an H radical donor to oxygen to aid in its four electron reduction. In the 
absence of Tyr, the porphyrin may donate an electron to form heme compound I which 
Figure 2.4. (A) Oxygen reduction reactivity studies of CuBMb, F33Y-CuBMb and their Cu(I)- added 
variants to form either water (blue) or ROS (red). The experiments were performed with 6 M 
protein in 100 mM phosphate buffer (pH6) containing 258 μM O2, 1 mM TMPD, and 10 mM 
ascorbate. (B) Rate of verdoheme formation as determined by the increase in absorbance at 680 
nm from the UV-Vis spectroscopic investigation of the reaction of Cu-CuBMb and Cu-F33Y-CuBMb 
with oxygen under turnover conditions (similar to the oxygen reduction enzymatic assays) for over 
30 minutes. (C) Proposed reaction mechanism of Cu-CuBMb and Cu-F33Y-CuBMb with oxygen. 
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may lead to heme degradation and fewer turnovers of the enzyme.  Hence, the conserved 
Tyr in HCOs not only increases its enzymatic turnover frequency but also its turnover 
numbers (Fig. 2.4.). 
2.4. Conclusion 
In summary, we have obtained first structural and functional mimic of HCO in myoglobin. 
The mimic can selectively bind Cu(I) or its redox inactive mimic Ag(I) distal to heme iron 
as in HCOs. The comparison of oxygen reduction activity with Cu(I) and Ag(I) establishes 
the role of copper as an electron donor to oxygen. Furthermore, the conserved Tyr in 
HCOs acts as an H radical donor which not only enhances the oxygen reduction activity 
of the enzyme but also makes it more robust. 
2.5. References 
 (1) Ferguson-Miller, S.; Babcock, G. T. Heme/Copper terminal oxidases. Chemical Reviews 
1996, 96, 2889-2907. 
 (2) Kaila, V. R. I.; Verkhovsky, M. I.; Wikström, M. Proton-coupled electron transfer in 
cytochrome oxidase. Chemical Reviews 2010, 110, 7062-7081. 
 (3) Garcia-Horsman, J. A.; Barquera, B.; Rumbley, J.; Ma, J.; Gennis, R. B. The superfamily of 
heme-copper respiratory oxidases. Journal of Bacteriology 1994, 176, 5587-5600. 
 (4) Yoshikawa, S.; Shinzawa-Itoh, K.; Tsukihara, T. X-ray structure and the reaction 
mechanism of bovine heart cytochrome c oxidase. Journal of inorganic biochemistry 2000, 82, 1-7. 
 (5) Yoshikawa, S.; Shinzawa-itoh, K.; Nakashima, R.; Yaono, R.; Yamashita, E.; Inoue, N.; Yao, 
M.; Fei, M. J.; Libeu, C. P.; Mizushima, T.; Yamaguchi, H.; Tomizaki, T.; Tsukihara, T. Redox-coupled crystal 
structural changes in bovine heart cytochrome c oxidase. Science 1998, 280, 1723-1729. 
 (6) Iwata, S.; Ostermeier, C.; Ludwig, B.; Michel, H. Structure at 2.8 Å resolution of 
cytochrome c oxidase from Paracoccus denitrificans. Nature 1995, 376, 660-669. 
 (7) Muramoto, K.; Ohta, K.; Shinzawa-Itoh, K.; Kanda, K.; Taniguchi, M.; Nabekura, H.; 
Yamashita, E.; Tsukihara, T.; Yoshikawa, S. Bovine cytochrome c oxidase structures enable O2 reduction 
with minimization of reactive oxygens and provide a proton-pumping gate. Proc. Natl. Acad. Sci. U. S. A. 
2010, 107, 7740-7745, S7740/7741-S7740/7747. 
 (8) Ray, K.; Heims, F.; Schwalbe, M.; Nam, W. High-valent metal-oxo intermediates in energy 
demanding processes: from dioxygen reduction to water splitting. Current Opinion in Chemical Biology 
2015, 25, 159-171. 
 (9) Kim, E.; Chufan, E. E.; Kamaraj, K.; Karlin, K. D. Synthetic models for heme-copper 
oxidases. Chemical Reviews 2004, 104, 1077-1133. 
 (10) Karlin, K. D.; Fox, S.; Nanthakumar, A.; Murthy, N. N.; Wei, N.; Obias, H. V.; Martens, C. F. 
Copper-dioxygen chemistry and modeling the Fe-Cu center in cytochrome c oxidase. Pure and Applied 
Chemistry 2009, 67, 289-296. 
 (11) Halime, Z.; Kotani, H.; Li, Y.; Fukuzumi, S.; Karlin, K. D. Homogeneous catalytic O2 
reduction to water by a cytochrome c oxidase model with trapping of intermediates and mechanistic 
insights. Proc. Natl. Acad. Sci. U. S. A. 2011, 108, 13990-13994, S13990/13991-S13990/13998. 
40 
 
 (12) Lee, Y.-M.; Bang, S.; Kim, Y. M.; Cho, J.; Hong, S.; Nomura, T.; Ogura, T.; Troeppner, O.; 
Ivanovic-Burmazovic, I.; Sarangi, R.; Fukuzumi, S.; Nam, W. A mononuclear nonheme iron(III)-peroxo 
complex binding redox-inactive metal ions. Chem. Sci. 2013, 4, 3917-3923. 
 (13) McCauley, K. M.; Vrtis, J. M.; Dupont, J.; van der Donk, W. A. Insights into the functional 
role of the tyrosine-histidine linkage in cytochrome c oxidase. Journal of the American Chemical Society 
2000, 122, 2403-2404. 
 (14) MacMillan, F.; Kannt, A.; Behr, J.; Prisner, T.; Michel, H. Direct evidence for a Tyrosine 
radical in the reaction of cytochrome c oxidase with hydrogen peroxide. Biochemistry 1999, 38, 9179-
9184. 
 (15) Das, T. K.; Pecoraro, C.; Tomson, F. L.; Gennis, R. B.; Rousseau, D. L. The Post-Translational 
Modification in Cytochrome c Oxidase Is Required To Establish a Functional Environment of the Catalytic 
Site. Biochemistry 1998, 37, 14471-14476. 
 (16) Collman, J. P.; Wang, Z. Synthetic heme chemistry: the cradle of functional molecules and 
catalysts. Chemtracts 1999, 12, 229-263. 
 (17) Collman, J. P.; Boulatov, R. Electrocatalytic O2 reduction by synthetic analogues of the 
heme/Cu site of cytochrome oxidase incorporated in a lipid film. Angewandte Chemie, International 
Edition 2002, 41, 3487-3489. 
 (18) Lee, S. C.; Holm, R. H. Synthesis and characterization of an asymmetric bridged assembly 
containing the unsupported [FeIII-O-CuII] bridge: an analog of the binuclear site in oxidized cytochrome c 
oxidase. Journal of the American Chemical Society 1993, 115, 11789-11798. 
 (19) Sigman, J. A.; Kwok, B. C.; Lu, Y. From myoglobin to heme-copper oxidase: Design and 
engineering of a CuB center into sperm whale myoglobin. J. Am. Chem. Soc. 2000, 122, 8192. 
 (20) Sigman, J. A.; Kwok, B. C.; Gengenbach, A.; Lu, Y. Design and creation of a Cu(II)-binding 
site in cytochrome c peroxidase that mimics the CuB-heme center in terminal oxidases. Journal of the 
American Chemical Society 1999, 121, 8949-8950. 
 (21) Sigman, J. A.; Kim, H. K.; Zhao, X.; Carey, J. R.; Lu, Y. The role of copper and protons in 
heme-copper oxidases: Kinetic study of an engineered heme-copper center in myoglobin. Proceedings of 
the National Academy of Sciences of the United States of America 2003, 100, 3629-3634. 
 (22) Miner, K. D.; Mukherjee, A.; Gao, Y.-G.; Null, E. L.; Petrik, I. D.; Zhao, X.; Yeung, N.; 
Robinson, H.; Lu, Y. A designed functional metalloenzyme that reduces O2 to H2O with over one thousand 
turnovers. Angewandte Chemie, International Edition 2012, 51, 5589-5592, PMCID: PMC3461324. 
 (23) Allen, G. Specific protein degradation by Cu(II) ions. 2001, Metal Ions Biol Syst., 197-212. 
 (24) Sigman, J. A.; Wang, X.; Lu, Y. Coupled oxidation of heme by myoglobin is mediated by 
exogenous peroxide. Journal of the American Chemical Society 2000, 123, 6945-6946. 
 (25) Varadarajan, R.; Zewert, T. E.; Gray, H. B.; Boxer, S. G. Effects of buried ionizable amino 
acids on the reduction potential of recombinant myoglobin. Science 1989, 243, 69-72. 
 (26) Chakraborty, S.; Reed, J.; Ross, M.; Nilges, M. J.; Petrik, I. D.; Ghosh, S.; Hammes-Schiffer, 
S.; Sage, J. T.; Zhang, Y.; Schulz, C. E.; Lu, Y. Spectroscopic and computational study of a nonheme iron 
nitrosyl center in a biosynthetic model of nitric oxide reductase. Angewandte Chemie International edition 
2014, 126, 2449-2453. 
 (27) Yu, Y.; Lv, X.; Li, J.; Zhou, Q.; Cui, C.; Mukherjee, A.; Nilges, M. J.; Lu, Y.; Wang, J. Defining 
the role of tyrosine and rational uning of oxidase activity by genetic incorporation of unnatural tyrosine 
analogs. Proc. Natl. Acad. Sci. USA 2014, acceptance pending revisions. 
 (28) Xiao, Z.; Brose, J.; Schimo, S.; Ackland, S. M.; La Fontaine, S.; Wedd, A. G. Unification of 
the Copper(I) Binding Affinities of the Metallo-chaperones Atx1, Atox1, and Related Proteins DETECTION 
PROBES AND AFFINITY STANDARDS. Journal of Biological Chemistry 2011, 286, 11047-11055. 
 (29) Tsubaki, M.; Matsushita, K.; Adachi, O.; Hirota, S.; Kitagawa, T.; Hon, H. Resonance Raman, 
infrared, and EPR investigation on the binuclear site structure the heme-copper ubiquinol oxidases from 
41 
 
Acetobacter aceti: Effect of the heme peripheral formyl group substitution. Biochemistry 1997, 36, 13034-
13042. 
 (30) Wang, N. Y.; Zhao, X.; Lu, Y. Role of heme types in heme-copper oxidases: Effects of 
replacing a heme b with a heme o mimic in an engineered heme-copper center in myoglobin. Journal of 
the American Chemical Society 2005, 127, 16541-16547. 
 (31) Yu, Y.; Mukherjee, A.; Nilges, M. J.; Hosseinzadeh, P.; Miner, K. D.; Lu, Y. Direct observation 
of a Tyrosyl radical in a functional oxidase model in myoglobin during both H2O2 and O2 reactions by EPR. 
Journal of the American Chemical Society 2014, 138, 3869-3875. 
 (32) Kim, E.; Helton, M. E.; Wasser, I. M.; Karlin, K. D.; Lu, S.; Huang, H.-w.; Moënne-Loccoz, P.; 
Incarvito, C. D.; Rheingold, A. L.; Honecker, M.; Kaderli, S.; Zuberbühler, A. D. Superoxo, μ-peroxo, and μ-
oxo complexes from heme/O2 and heme-Cu/O2 reactivity: Copper ligand influences in cytochrome c 
oxidase models. Proceedings of the National Academy of Sciences of the United States of America 2003, 
100, 3623-3628. 
 
42 
 
Chapter 3 
 Why is copper preferred over iron for oxygen activation and reduction in heme-
copper oxygen reductases? 
Portions of this chapter are a taken from the final draft of a manuscript in preparation as 
“Role of nonheme-metal in heme-copper-oxidases: Why is copper preferred over iron for 
oxygen activation and reduction?” (Ambika Bhagi-Damodaran, Matthew A. Michael, 
Qianhong Zhu, Julian Reed, Braddock A. Sandoval, Pierre Moënne-Loccoz, Yong Zhang, 
Yi Lu) 
Abstract: Heme-copper oxygen reductase (HCO) catalyzes the natural reduction of 
oxygen to water via a heme-copper center. Despite decades of research on HCO’s, the 
role of nonheme-metal and Nature’s choice of copper over other metals like iron remains 
unclear. Here, we use a biosynthetic mimic of HCO in myoglobin that selectively binds 
different nonheme-metals to demonstrate 30-fold and 11-fold enhancements in the 
oxidase activity of Cu- and Fe- bound HCO mimics respectively, as compared to Zn-
variants. Detailed electrochemical, kinetic and vibrational spectroscopic studies, in 
tandem with theoretical DFT calculations establish the role of nonheme-metal as an 
electron donor as well as a Lewis acid for oxygen activation and reduction. Furthermore, 
the higher reduction potential of copper, as well as the enhanced weakening of O-O bond 
from the higher electron density in the d-orbital of copper are central to its higher oxidase 
activity as against iron. This work resolves a long-standing question in bioenergetics, and 
renders a chemical-biological basis for designing future oxygen reduction catalysts. 
3.1. Introduction 
HCOs are important terminal oxidases involved in aerobic respiration in all forms of life 
from bacteria to eukaryotes1, and utilize a heterobinuclear heme-copper center to 
catalyze the four-electron reduction of oxygen to water. They share significant structural 
and sequence homology to another class of metalloenzyme, the nitric oxide reductases 
(NORs), that use a heterobinuclear heme-nonheme diiron center to perform the two-
electron reduction of NO to N2O (Fig. 1.1.).2 Several phylogenetic studies have suggested 
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that HCOs and NORs have evolved from a common ancestral protein by “tinkering” of its 
catalytic center to select a copper for HCOs and a nonheme iron for NORs.3 The 
homology between these two classes of enzymes extends to their function as well - the 
HCOs and NORs exhibit cross-reactivity, i.e. NORs can reduce O2 to H2O albeit with 
significantly lower rates and vice-versa.4 The high structural homology and similar active 
site of HCOs and NORs raises a fundamental question as to why is copper preferred over 
iron for O2 reduction in HCOs. While deterministic experimental routes to probe such a 
preference has been inaccessible till date, even questions of a broader nature such as 
the function of the nonheme metal itself towards oxidase activity has been a matter of 
debate. In this regard, some reports suggest that copper acts as an electron donor to 
oxygen,5,6 while others propose the role of copper merely as a Lewis acid that activates 
the oxygen molecule to favor the cleavage of O-O bond to produce water.7-9  
A possible approach to answer these questions involve the direct replacement of 
copper with iron and other nonheme metals in native HCO systems, followed by 
subsequent investigations of its impact on the electronic structure of heme as well as the 
formation of O2 reaction intermediates, all of which can impact oxidase activity. However, 
there are numerous challenges related to the large size of native HCO’s (MW ~100-200 
KDa), their membranous nature and inherent complexity including the presence of 
multiple metal centers of HCOs, rendering such a replacement extremely difficult without 
significantly changing the structure of the binuclear metal-binding site and affecting it 
activity. Under such constraints, biosynthetic approaches10 wherein structural and 
functional models of the active site of complex proteins are replicated in small (MW ~ 17.4 
KDa), easy-to-purify, and water soluble proteins such as myoglobin (for instance, HCO 
and NOR mimics called CuBMb and FeBMb, respectively)11-15 emerges as an important 
route to answer this and potentially many other unresolved questions of significance in 
the realm of chemical biology. In this work, we focus on the synthetic protein FeBMb that 
can selectively bind to iron, copper or even the redox-inactive Zn at its nonheme (FeB) 
center, and systematically probe the role of the nonheme metal and also explore the 
chemical preference, if any, for the presence of Cu in native HCO’s. 
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3.2. Materials and methods 
All chemicals, unless otherwise specified, were obtained from Sigma (St. Louis, MO) or 
Fisher Scientific (Hampton, NH).  
 
3.2.1. Purification of proteins 
FeBMb was expressed and purified as reported previously.16 Briefly, apo-protein was 
expressed and localized to the inclusion bodies of BL21(DE3) cells. The cells were then 
lysed by sonication and denatured with 6 M guanidine chloride. Heme b was added to the 
denatured cell solution, which was then dialyzed against 10 mM TRIS-H2SO4 pH 8 at 
least 4 times. The resulting protein solution was concentrated by Amicon with a 10,000 
MWCO filter, and passed through a size exclusion column to achieve homogeneity.  
Protein fractions with r/z value greater than 4 were then combined and chelexed to 
remove any metal ions at the FeB site as per a procedure reported previously.17,18 Final 
yield of the protein was ~ 40 mg/L. WTMb was expressed and purified as reported 
previously19 and its yield was typically ~100 mg/L. 
3.2.2. Characterization of FeBMb variants via UV-Vis spectroscopy 
UV-vis data were collected on a Hewlett-Packard 8453 spectrometer. Table 3.1. enlists 
the spectral features of oxidized and reduced forms of FeBMb and WTMb variants utilized 
in this work. The oxidized form of the proteins show a Soret band at 400 nm range 
followed by  and  bands in the visible region, typical of a well-folded met-myoglobin.20 
Extinction coefficient of the proteins was determined by hemochromogen assay where 
the wavelength maximum (in nm) and extinction coefficient in used for the  peak of heme 
b was 556 and 36.5 mM-1 cm-1 respectively.  
Table 3.1. UV-Vis spectral features of FeBMb and WTMb   
  ferric(nm)  deoxy(nm)  
 Soret vis   Soret vis 
FeBMb 406 501 630 432 556 
WTMb 408 502 628 429 556 
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3.2.3. Metal titration and analysis 
The Zn(II), Fe(II) and bound FeBMb variants were prepared as described previously with 
slight modifications. Briefly, the met-form of FeBMb was degassed and transferred in 
anaerobic glovebag, where they were reduced using dithionite and exchanged with a 
PD10 column equilibrated with 50 mM Bis-TRIS buffer at pH 7.3. To obtain Zn(II) and 
Fe(II)-bound FeBMb variants, 1 equivalent (with respect to protein) each of ZnCl2 and 
FeCl2 solution was added to E- FeBMb respectively. To obtain Cu(I)-FeBMb, 5 equivalent 
of tetrakis(acetonitrile)Cu(I)hexafluorophosphate dissolved in acetonitrile was added to 
E- FeBMb and any unbound Cu(I) ions were removed by a PD10 column  equilibrated 
with 50 mM Bis-TRIS buffer at pH 7.3. Bathocuproine was used to determine the amount 
of Cu(I) bound to FeBMb. An extinction coefficient of 13,800 M-1 cm-1 at 480 nm was used 
for the Cu(I)-bathocuproine complex, as per which 3 equivalents of Cu(I) bound to each 
equivalent of FeBMb. Similar experiment ran for WTMb yielded 2 equivalents of Cu(I) 
bound to each equivalent of WTMb suggesting that the third equivalent of Cu(I) binds to 
the FeBMb center in Cu(I)-FeBMb. The binding of the metal ion at the nonheme center of 
FeBMb was confirmed by bathochromic shifts in the UV-Vis spectra as can be seen in 
Fig. 3.3. 
3.2.4. Spectroelectrochemical measurements 
The reduction potential (E°) was measured by a spectroelectrochemical method using an 
optically transparent thin-layer cell (OTTLE) and the analysis of the data was performed 
as described previously.19  
3.2.5. Oxygen consumption assay using an oxygen electrode 
The rate of water and ROS production was measured and calculated as reported 
previously with slight modifications as described here.21 The oxygen consumption assay 
was initiated by the addition of 18 M of metal-bound FeBMb to 18 mM ascorbate and 1.8 
mM of TMPD incubated in air saturated 100 mM phosphate buffer at pH 6. To calculate 
the percentage of water with respect to H2O2 and O22- (ROS) formation, we repeated the 
measurement of O2 reduction in the presence of catalase (7 M), which selectively react 
with H2O2 to produce O2. By comparing the rates of reduction in the absence of and in 
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the presence of catalase, the portion of O2 reduction that is due to H2O formation can be 
calculated, using a protocol reported previously. For experiments with Cu(I) added FeBMb 
in particular, we found that catalase removed the Cu(I) ions from the FeB center and 
decreased the rates significantly. To avoid that, the Cu(I) binding sites in catalase were 
saturated by adding 24 equivalents of Cu(I) in the glovebag prior to the assay. The Cu(I) 
bound catalase was checked for its activity by performing assays with H2O2 in the oxygen 
electrode before using it for the determination of H2O2 produced in experiments with Cu(I)-
FeBMb.  
3.2.6. Cyclic Voltammetry Measurements on Cu(I)- and Fe(II)- incorporated 
ZnPPIXFeBMb  
The Zn protoporphyrin IX incorporated FeBMb (ZnPPIXFeBMb) was prepared and 
characterized as described previously.22 The Fe(II) and Cu(I) metal ions were 
incorporated at the FeB center in a similar manner as described for FeBMb. The addition 
of metal ions caused a shift in the bands of UV-Vis spectra of ZnPPIXFeBMb as shown 
in Fig. 3.1. The resulting protein was subjected to a PD-10 column equilibrated in 50 mM 
Figure 3.1. (A) The UV-Vis spectrum of E-(in black) and Fe(II)-ZnPPIXFe
B
Mb (in red). (B) The 
UV-Vis spectrum of E-(in black) and Cu(I)-ZnPPIXFe
B
Mb (in blue). 
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Bis-TRIS pH 7.3 to remove any excess/unassociated metal ions. The reduction potential 
(E°) of the nonheme metal in ZnPPIXFeBMb was measured by cyclic voltammetry 
experiments. The Cu(I)- and Fe(II)- incorporated ZnPPIXFeBMb variants were adsorbed 
onto PGE electrodes and subjected to a potential sweep from -400 mV to 600 mV v/s 
Ag/AgCl electrode in 50 mM phosphate buffer at pH6. Fig. 3.3 shows the cyclic 
voltammogram obtained from these measurements. 
3.2.7. Stopped-flow UV-Vis kinetic measurements  
Experiments were performed on an Applied Photophysics Ltd. (Leatherhead, U.K.) 
SX18.MV stopped-flow spectrometer equipped with a 256 element photodiode array 
detector. Two-syringe mixing was employed to mix equal volumes of FeBMb variants with 
volumetrically prepared oxygen saturated solutions. All reported data sets originally 
consisted of 200 spectra collected over 50 s using logarithmic sampling. The integration 
period and minimum sampling period were both 1 ms. A water bath, connected to the 
syringe compartment and set to 4ºC, provided temperature control. The actual 
temperature in the syringe compartment was measured to be between 6.3 and 6.5ºC. 
The instrument was prepared for anaerobic stopped-flow by rinsing its lines out several 
times with buffer that had been degassed by bubbling argon gas through it. Special glass 
outer syringes fit with Teflon stoppers into which an argon line was run maintained an 
oxygen free environment. The protein was degassed prepared in an anaerobic glovebag 
as described before. The oxygen saturated solutions were degassed on the Schlenk line 
followed by bubbling with argon gas for 20 min in containers with only a small opening, to 
allow gases to escape.  
3.2.8. Rapid freeze quench-resonance Raman studies on FeBMb variants 
Attempt to prepare O2-complex with E-FeBMb and Zn(II)-FeBMb through manual mixing 
of the reduced proteins with O2 saturated buffer led to poor enrichment in the oxy complex 
and contamination with auto-oxidized protein. In contrast, rapid-freeze quench (RFQ) 
samples with a few milliseconds to 2 second freezing time showed highly reproducible 
accumulation of the oxy complexes. Detailed procedure for the preparation of RFQ 
samples have been described previously.9 Solutions of FeBMbs at 0.6 mM  in 50 mM Bis-
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TRIS, pH 7.0, were loaded in RFQ glass syringes inside an anaerobic glovebox (Omnilab 
System,. Vacuum Atmospheres Co.). O2 saturated buffer solutions were prepared by 
injecting 7 mL of 16O2 or 18O2 gas in 10-mL serum bottles containing 2.5 mL of degassed 
buffer and loaded in RFQ syringes after ~1 h incubation. Two syringes were mounted to 
the System 1000 Chemical/Freeze Quench Apparatus (Update Instruments) and 
immersed in a water bath at 4 °C. Reaction times were controlled by adjusting the 
displacement rate and the length of the reactor. For RFQ time points in the millisecond 
scale, a total of 250 μL of mixed solution was sprayed from the exit nozzle to a glass 
funnel connected with NMR tubes and filled with liquid ethane at -120 °C. Samples with 
reaction time on the second scale were injected directly inside the NMR tube before rapid 
freezing in liquid ethane. RR spectra were collected before and after removal of the 
cryosolvent by incubating the sample at -80°C for 2 hours. 
The RR spectra were obtained with a 407 nm excitation from a Kr laser (Innova 302C, 
Coherent) using a custom McPherson 2061/207 spectrograph equipped with a liquid-
nitrogen cooled CCD detector (LN-1100PB, Princeton Instruments). A long-pass filter 
(RazorEdge, Semrock) was used to attenuate Rayleigh scattering. Measurements were 
performed in a backscattering geometry with the samples maintained at 110 K inside a 
liquid N2 cooled sample holder and with the laser focused on the sample with a cylindrical 
lens. The photosensitivity of each sample was evaluated by collecting short spectral 
acquisition with low laser power and spinning the NMR tube and comparing the porphyrin 
skeletal modes in the high-frequency region. While E-FeBMb-O2 showed no significant 
photosensitivity, sample spinning was required for Zn(II)-FeBMb-O2. The frequencies 
were calibrated relative to aspirin and are accurate to ±1 cm-1.  
3.2.9. Computational studies on FeBMb variants 
A number of O2 bound HCO models including Zn-FeBMb-O2, Fe-FeBMb-O2, and Cu-
FeBMb-O2 were studied computationally using the DFT method B3LYP with 6-311G* for 
all heavy atoms and 6-31G* for hydrogens, which is similar to the ones reported 
previously for heme and non-heme and copper protein model studies.23,24 The initial 
structural models were built from the following X-ray structures with PDB files 3M3B, 
3M39 and 3M3A respectively. All first coordination shell residues are included in the 
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models and the residues are truncated to C positions. The heme substituents are 
replaced with hydrogens. The labile water ligand in the original X-ray structures of Fe-
FeBMb and Cu-FeBMb were allowed to be displaced by the incoming O2 ligand. All models 
were subject to partial geometry optimizations with only protein residue C atoms fixed 
at the X-ray structure positions to mimic the protein environment, based on the previous 
work.25 In the initial setup for Zn-FeBMb-O2, heme iron and O2 moiety are of FeIII(S=1/2) 
anti-ferromagnetically coupled with O2- (S=-1/2) as reported recently.26 In case where the 
second metal is Fe and Cu, the initial set up of non-heme site metal is in its oxidized state 
(i.e. FeIII and CuII) with O2 being set up as peroxide. In addition, both ferromagnetic and 
antiferromagnetic coupling modes between this site and heme iron were studied, as 
indicated by F or AF after the above respective model names. In addition to the electronic 
energy (E), the zero-point energy corrected electronic energy (EZPE), and the enthalpy 
and Gibbs free energies at the ambient conditions were also calculated in each case. All 
calculations were performed using the Gaussian 09 program.27 
 The optimized molecular structures of Zn(II)-FeBMb-O2-, Fe(III)-FeBMb-O22-, Cu(II)-
FeBMb-O22- are shown in Fig. 3.5. The corresponding geometric, charge, and spin 
densities listed in Table 3.2. The spin density of heme iron (ρFe) in all models clearly 
indicates that it is oxidized to the ferric state (S=1/2), with the electron transferred to O2 
to activate it, since more electron populated into the frontier anti-bonding orbital of O2 
increases the bond length to help break it. For Zn-FeBMb-O2, although Zn is coordinated 
with O, the bond is very long, 2.340 Å. The spin density of the second metal (ρM) shows 
that Zn is redox-inert, and the heme iron-O2 group is best described as FeIII(S=1/2) anti-
ferromagnetically coupled with O2- (S=-1/2), similar to those seen with single heme O2 
complexes. When the second metal becomes the redox-active iron, as seen from Table 
3.2, spin density data (eshow that the non-heme iron is in-between FeII (S=2, with 
 e) and FeIII(S=5/2 with  e).28 The similar properties observed for both 
ferromagnetic and anti-ferromagnetic coupling modes suggest that these two couplings 
may be of similar energies, which is indeed the case as shown by energetic data in Table 
3.2. Therefore, the anti-ferromagnetic coupling mode was chosen to further evaluate the 
most favorable spin state for the non-heme iron. As shown in Table 3.4, other spin states 
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(S=3/2 and 1/2) have ~5 and ~20 kcal/mol higher energies, respectively. So, the sextet is 
most favorable. In the case of Cu as the second metal which is also the metal in HCO, 
much elongated OO bonds by ~0.10-0.12 Å compared to the Zn-FeBMb-O2 were found. 
These results clearly indicate Cu is superior than other metals studied here to activate 
O2, with the most lengthened OO bond length, which is also accompanied by shortest 
MO bond length and concomitantly most shortened FeO bond length. The latter shows 
that Cu not only activates O2 by donating its electron to O2 with Cu being oxidized to CuII 
(its spin density is consistent with those reported in other Cu(II) systems29), but also 
synergistically increased heme iron’s activation on O2 potentially through p-d 
backbonding. As a matter of fact, O2 (QO2 in Table 3.2) charges has an excellent 
correlation with OO bond lengths. Here, the two spin coupling modes are also of similar 
energies and geometries. However, in the anti-ferromagnetic ones, the O2 moiety is close 
to a peroxide state than in the ferromagnetic coupled ones, due to almost zero spin 
densities in the former case. Another interesting feature for Cu is that after O2 
coordination, as illustrated in Figure 3.5., the His64 ligand moves out of the coordination 
sphere compared to the X-ray structure of Cu-FeBMb without O2. Actually, in our initial 
setups for O2 bound models, His64 is like at the X-ray structure used, i.e. it is coordinated 
with Cu, but the geometry optimization always end with it leaving the coordination sphere. 
In comparison, the geometry optimization of the X-ray structure without O2 yields a 
structure with His64 still coordinated. These results suggest that in the biosynthetic model 
Cu-FeBMb, the binding of O2 kicks off His64. A further analysis of the geometric 
parameters around this Cu center shows that, after His64 moves of the coordinate 
sphere, the Cu center is basically square planar. The four ligand set is a typical 
coordination structure seen with CuII, and also the same as seen in Cu-CuBMb-O2 model 
studied here and the HCO model30 reported previously. These results further support the 
current results for Cu-FeBMb-O2. In addition, the geometric changes in the case of Cu-
FeBMb-O2 models result in significantly more space available for subsequent proton 
transfer than both Zn-FeBMb-O2 and Fe-FeBMb-O2 models, which further supports that 
Cu is superior to Fe and Zn in this series of studies. 
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Table 3.2. Key parameters of optimized models 
 
 
Table 3.3. Relative energies between anti-ferromagnetic, ferromagnetic spin coupling 
 
Table 3.4. Relative energies of different spin states for Fe-FeBMb-O2 
Spin State 
E  EZPE   H  G  
(kcal/mol) (kcal/mol) (kcal/mol) (kcal/mol) 
doublet 16.50 17.30 16.75 19.85 
quartet 5.19 4.90 5.20 4.84 
sextet 0.00 0.00 0.00 0.00 
 
 
Model O2 ROO RFeO RMO RFeM FeOO MOO QO2 
(e) (Å) (Å) (Å) (Å) (degree) (degree) (e) 
Zn-FeBMb-O2 -1.008 1.298 1.863 2.340 4.891 118.2 116.7 -0.528 
Fe-FeBMb-O2-AF 0.755 1.334 1.843 1.997 4.606 118.1 118.5 -0.699 
Fe-FeBMb-O2-F 0.759 1.351 1.881 1.960 4.620 118.4 118.5 -0.773 
Cu-FeBMb-O2-AF 0.000 1.379 1.784 1.914 4.091 119.0 116.3 -0.883 
Cu-FeBMb-O2-F 0.488 1.391 1.791 1.913 4.132 117.2 114.7 -0.917 
Model 
E  EZPE   H  G  
(kcal/mol) (kcal/mol) (kcal/mol) (kcal/mol)  
Fe-FeBMb-O2-AF 0.00 0.00 0.00 0.00  
Fe-FeBMb-O2-F -0.27 -0.32 -0.48 -0.06  
Cu-FeBMb-O2-AF 0.00 0.00 0.00 0.00  
Cu-FeBMb-O2-F 1.78 1.47 1.64 -0.11  
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3.3. Results and discussion  
3.3.1. Characterization of FeBMb variants and oxygen reduction activity assays 
We first expressed and purified FeBMb without any nonheme metal at the FeB site 
(henceforth referred to as the empty-FeBMb or simply E-FeBMb) into which any of the 
desired nonheme metal (either Fe(II), Cu(I) or Zn(II)) could be selectively incorporated to 
yield the three different FeBMb variants (Fe(II)-FeBMb, Cu(I)-FeBMb and Zn(II)-FeBMb, 
respectively) (see SI for more information on the protocol of preparation). The 
incorporation of a nonheme metal close to the heme center is easily discernable in UV-
vis studies (Fig. 3.2D) as a shift in the heme Soret (bathochromic shift from 433 nm to 
434 nm) and a peak splitting in visible absorption regions (the 557 nm peak of E-FeBMb 
splits into two shallow bands at 550 nm and 572 nm after nonheme metal incorporation). 
A controlled study of the role of the nonheme metal is possible only if difference between 
the various FeBMb variants is the identity of the nonheme metal ion itself, while all other 
structural features including the nonheme metal coordination sphere and metal-metal 
distances remain unchanged. To confirm that this is indeed the case, we have compared 
the crystal structures for the synthesized FeBMb variants (Fig. 3.2A-C), which show that, 
for all three variants, the nonheme metals are coordinated to three histidines (H64, H43, 
H29) and a glutamate (68E) in a distorted trigonal-bipyramidal geometry, thereby 
conserving the desired coordination sphere. Furthermore, the heme-nonheme metal 
distances remain the same (~4.5 Å) within the experimental error of the x-ray 
crystallography resolution (~1.7 Å). In all, these studies confirm that the FeBMb variants 
constitute a model system to probe different nonheme metals within the same protein 
scaffold, and holds potential to elucidate the preference for copper exhibited by native 
HCOs. 
Armed with such a model system of FeBMb variants, we proceed to directly probe 
the role of nonheme metal on oxidase activity (Fig. 3.2E). This includes the overall oxygen 
reduction rates (k), as well as the product selectivity (S) – an indicator of the quality of the 
oxygen reduction reaction. S is defined as the ratio of water produced (the desired end 
product and a consequence of a 4e- oxygen reduction process) to products of incomplete 
oxygen reduction to form partially reduced products such as peroxide and superoxide  
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(collectively known as reactive oxygen species or ROS). From a biological perspective, 
the formation of ROS not only decreases HCO efficiency, but also damages cellular 
biomolecules. In this study, we measured the overall oxygen reduction rates for various 
FeBMb variants under multi-turnover conditions using an O2 electrode (with N,N,N',N'-
tetramethyl-p-phenylenediamine (TMPD) as a redox mediator, and ascorbate as a 
Figure 3.2. Crystal structure of Fe
B
Mb mutant (I107E- Fe
B
Mb) showing the catalytic heme-
nonheme heterobinuclear metal center with Zn(II) (A, PDB: 3M3B), Fe(II) (B, PDB: 3M39) and 
Cu(II) (C, PDB: 3M3A) nonheme metal ions bound. The heme and amino acid residues as 
shown in licorice while the nonheme metal ions are shown in VDW representation as a sphere. 
(D) The UV-Vis spectroscopic  measurements on Fe
B
Mb variants displaying the changes in the 
Soret (420-445 nm) and visible (500-700 nm) region on incorporation of nonheme Fe(II) and 
Cu(I) metal ions. (E) The rates of O
2 
 reduction to form either H
2
O (blue) or ROS (red) catalyzed 
by 18 M Fe
B
Mb variants in 100 mM phosphate buffer (pH 6) containing ~250 M O
2
, 1.8 mM 
TMPD, and 18 mM ascorbate. 
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reductant) and a protocol reported previously for both native HCOs and their models.16,19 
A slightly modified approach employing catalase16 was used to determine the product 
selectivity in these reactions. We also included E-FeBMb in addition to the three FeBMb 
variants as a control. The oxygen reduction reaction with E-FeBMb (18 μM) showed an 
initial rapid decrease in O2 concentration (by an amount corresponding to ~1 equivalent 
of protein concentration) from the binding of O2 to the heme. This was followed by a slow 
consumption of O2 with an initial rate of 0.21 (± 0.03) M/s of which only ~59% of O2 was 
converted to water and rest to ROS (Fig. 3.3A). The oxygen reduction rates and product 
selectivity for the Zn(II)-FeBMb (k=0.22(± 0.02), S = 57%) are similar to those of E-FeBMb. 
 In contrast, both Fe(II)- and Cu(I)- substituted FeBMb variants showed dramatic 
enhancements in oxygen reduction rates and product selectivity (k= 1.15 ± 0.07 M/s and 
S = 96% for Fe, and k = 2.72 ± 0.1/s and S=94% for Cu). More specifically, the oxidase 
activity (defined as the rate of water production) of Fe(II)-FeBMb and Cu(I)-FeBMb were 
11-fold and 30-fold higher, respectively, than that of Zn(II)-FeBMb. We also note that 
controls with wild-type myoglobin (WTMb, without the engineered FeB center) and in the 
presence of Zn(II), Fe(II) and Cu(I) ions showed similar water production rates as E-
FeBMb, but with a high excess of undesirable ROS production (Fig. 3.3B)35, further 
Figure 3.3. (A) The results of the oxygen reduction enzymatic assay performed on the 
oxygen electrode. The experiments were performed on 18 M FeBMb variants in 100 mM 
phosphate buffer (pH 6) containing 250 M oxygen, 1.8 mM TMPD, and 18 mM ascorbate. 
(B) The rates of oxygen
 
 reduction to form either water (blue) or ROS (red) catalyzed by 18 
M FeBMb variants in 100 mM phosphate buffer (pH 6) containing 250 M oxygen, 1.8 mM 
TMPD, and 18 mM ascorbate. 
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confirming that enhancements in oxidase activity occur only when Fe(II) and Cu(I) are 
coordinated to the nonheme FeB center. 
These experiments beget several important conclusions. To begin with, they 
confirm that the synthesized Fe(II)- and Cu(I)- FeBMb variants are excellent functional 
mimics of native HCO’s. Second, the fact that the oxidase activity of redox-inactive Zn(II)-
substituted variant remains the same as E-FeBMb as compared to dramatic 
enhancements seen in its redox active analogues (Fe(II)- and Cu(I)) establishes, for the 
first time, the unequivocal role of the non-heme metal as a an electron donor in the oxygen 
reduction. In addition, these experiments also demonstrate the superior performance of 
Cu over Fe as a nonheme metal for oxygen reduction reactions, and suggest a functional 
reason for Nature’s choice of Cu in HCO’s. We can proceed to understand the chemical 
origin for the superior performance of Cu over Fe by considering all differences that can 
arise from the identity of the non-heme metal. These include: 1) an increase in the redox 
potential (E°ˊ) of either the heme or nonheme metal ion that can enhance electron transfer 
rates at the catalytic center and 2) changes to the O-O bond length that can arise from 
differences in the electronic configuration of the nonheme metal. In the sections that 
follow, we explore in detail each of these possibilities using a combination of 
electrochemical, kinetic and computational approaches. 
3.3.2. Copper v/s iron: Difference in redox potential of heme and nonheme metals 
We begin by investigating the effect of nonheme metal on heme reduction 
potentials. Spectroelectrochemical19,36 measurements of the heme reduction potential 
(E°ˊ) of E-FeBMb showed a value of -159 ± 5 mV. On incorporation of any of the nonheme 
metals revealed a ~100 mV enhancement of heme E°ˊ with nearly equal values of -45 ± 
2 mV, -58 ± 3 mV, -64 ± 4 mV measured for Zn(II)-, Fe(II)-, and Cu(I)-FeBMb variants, 
respectively (Fig. 3.4A). Based on this, we can conclude that nature of the nonheme metal 
has little impact on the heme E°ˊ and is not the mechanism for the observed trends in 
oxidase activity of FeBMb variants. We next focus our attention on the E°ˊ of redox-active 
nonheme metals in FeBMb. We employed cyclic voltammetry (CV) to measure the E°’ of 
the nonheme Fe(III)/Fe(II) or Cu(II)/Cu(I) redox couples at the FeB site. Since the CV 
signals from redox-active heme iron could interfere with those of the nonheme metal, we  
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replaced heme with redox-inactive Zn protoporphyrin to obtain ZnPPIXFeBMb using a 
previously reported protocol.22 The titration of Fe(II) and Cu(I) metals into the FeB center 
of ZnPPIXFeBMb resulted in similar changes in the Soret and visible bands of the UV-Vis 
spectra, suggesting similar coordination environments of nonheme Fe(II) and Cu(I) in 
ZnPPIXFeBMb (Fig 3.1).  The CV experiments conducted on Fe(II)-ZnPPIXFeBMb and 
Cu(I)-ZnPPIXFeBMb showed a single, reversible redox transition corresponding to an E°’ 
value of 253 ± 23 mV and 365 ± 21 mV for nonheme Fe(III)/Fe(II) or Cu(II)/Cu(I) redox 
couples, respectively (Fig. 3.4B and C). We note that E°’ values of nonheme metals 
measured in these experiments are consistent with those reported in literature for 
nonheme Fe in cNOR (~300 mV)37 and for Cu in HCOs (380-450 mV)1. The higher E°’ of 
copper as compared to iron at the nonheme site leads to faster electron transfer to the 
heterobinuclear catalytic center, and is an important contributor to enhanced oxidase 
activity of Cu-FeBMb. 
3.3.3. Copper v/s iron: Difference in reactivity with oxygen 
Having probed redox potential-based effects related to nonheme metals, we move 
on to understand their interaction with oxygen at the catalytic center via stopped-flow UV-
Vis absorption spectroscopy under single turnover conditions. The reaction of the reduced 
E-FeBMb with O2 showed a clean transition from ferrous heme to heme-oxy complex with 
a Soret blue shift from 432 nm to 414 nm and well-defined Q bands at 541 and 578 nm 
Figure 3.4 (A) Nernst fit of the spectral plot for FeBMb and its variants. Dotted lines represent the 
point where the fraction of protein reduced is equal to that oxidized and the corresponding value 
is the Eº of the protein. (B) Cyclic voltammogram of Fe- and (C) Cu-(bottom) incorporated 
ZnPPIXFeBMb. The experimental data is shown in grey while the baseline corrected data is 
shown in red and blue for Fe- and Cu- respectively. 
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typical of hemeFe(II)-O2 complexes38 (Fig. 3.5A). A similar spectral transition (Fig. 3.5B) 
was observed on reacting reduced Zn(II)-FeBMb with O2, indicating the formation of a 
stable heme-oxy complex in the Zn-bound FeBMb variant. On the other hand, formation 
of heme-oxy was not observed in the case of the Fe(II)- and Cu(I)- bound FeBMb variants, 
as these nonheme metals rapidly donate electrons to the bound oxygen to obtain ferric-
heme (Fig. 3.6). Nevertheless, a comparison between the O-O bond length of the heme-
oxy complex for the E- and Zn- FeBMb can provide insights into potential oxygen 
activation mechanisms that can arise from the presence of a nonheme metal. For this, 
Figure 3.5. The stopped-flow UV-Vis measurements of the reaction between 10 M of E-Fe
B
Mb 
(A) and Zn(II)-Fe
B
Mb (B) and O
2
 saturated buffer between 0.001s to 0.8s. The isosbestic points are 
represented by a star. The intermediate spectra are shown in grey. The inset shows the structures 
of the starting and the ending species shown via blue and red spectra respectively. The dotted lines 
in blue represent the distal amino acid residues in E-Fe
B
Mb that are capable of H-bonding to the 
bound O
2
. The low-frequency RR spectra of E-Fe
B
Mb(O
2
) (C) and Zn(II)-Fe
B
Mb(O
2
) (D) obtained 
with a 413 nm excitation at room temperature. 
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we conducted vibrational studies of these heme-oxy complexes using resonance Raman 
spectroscopy. The heme-oxy samples were prepared using 18O2 and 16O2 -saturated 
buffers to identify the iron-O2 stretching modes (Fe-O2) . The heme-oxy complex of E-
FeBMb showed a (Fe-O2) of 575 (-25) cm-1 that is typical of heme-oxy species in 
myoglobin mutants (Fig. 3.5C). On the other hand, the heme-oxy complex of Zn-FeBMb 
showed a remarkably high (Fe-O2) of 594 (-28) cm-1 corresponding to a much stronger 
Fe-O bond, and indicative of a weaker O-O bond as compared to E-FeBMb (Fig. 3.5D). 
In general, these results highlight the potential role of the nonheme metal as a Lewis acid 
that can bind and weaken O2 for its ready cleavage to produce water. 
3.3.4. Copper v/s iron: Activation of oxygen molecule at catalytic center 
Based on such an understanding of oxygen activation in Zn-FeBMb, we utilize 
density functional theory (DFT) to further explore effects related to identity of the nonheme 
metal towards such effects. In these calculations, we modeled the structures of Zn-, Fe- 
and Cu-FeBMb up to the C-alpha (C) of each residue to match the crystal structure (refer 
Fig. 3.2A-C) for the respective protein systems. The O2 molecule was then added and the 
resulting structures were stabilized to their lowest energy form. While the nonheme Zn  
Figure 3.6. The DFT-optimized structure of O
2
-added Zn(II)- (A), Fe(II)- (B) and Cu(I)-Fe
B
Mb 
(C). The porphyrin is shown in licorice the porphyrin, peroxide and metal ions are shown as 
a sphere.  
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and Fe retained its ligands (i.e., three histidines and one glutamate) (Fig. 4a and b, 
respectively), the Cu lost the His64 ligand adopting a square planar geometry similar to 
the DFT simulated structure of native HCO (Fig. 4c). In all of the optimized molecular 
structures, the hemeFe was oxidized to its ferric state with an electron transferred to O2. 
The Zn-FeBMb structure, in particular, stabilized O2 as O2- such that the distal oxygen 
could interact and bind to Zn at the nonheme site. Consistent with the resonance Raman 
studies, the computed O-O bond length of Zn- variant (1.298 Å) was elongated as 
compared to O2-bound E-FeBMb (1.277 Å). The lowest energy form for Fe- and Cu-FeBMb 
variants was found to be O22- supporting the role of nonheme Fe and Cu as an electron 
donor to oxygen. Furthermore, the O-O bond length was found be even higher in Fe-
FeBMb variant (1.334 Å), and the highest in the Cu-FeBMb (1.391 Å). These studies 
demonstrate highly enhanced activation of O2 (both in terms of charge and O-O bond 
length) with Cu as the nonheme metal, as compared to Fe and Zn (Table 1). This can be 
attributed to the d-electron configuration of Cu(II) (d9) as compared to Fe(III) (d6), that 
enables Cu to push a higher degree of d-electron density to the HOMO orbital of O2 via 
dπ-pπ back bonding. In all, these studies further confirm the functional and chemical 
preference for Cu over Fe as the nonheme metal in HCOs. 
 
Table 3.5. Bond length and charge parameters of O2 added Zn-, Fe- and Cu- FeBMb 
variants. RM-O is the bond length of nonheme metal and distal oxygen, RO-O is the O-O 
bond length and QO-O is the charge on oxygen in the optimized structures.    
 
 RM-O 
(Å) 
RO-O 
(Å) 
QO-O 
(e) 
Zn- 2.34 1.298 -0.528 
Fe- 1.96 1.334 -0.773 
Cu- 1.91 1.391 -0.942 
 
3.4. Conclusion 
The reduction of oxygen to water requires fast and concomitant electron transfer as well 
as efficient O-O bond cleavage. Our results show that copper is superior to iron in favoring 
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both fast electron transfer and weakening of the O-O bond and hence, a suitable choice 
as the nonheme metal in HCOs.39 In fact, a comparison of copper with other 3d transition 
metals suggest that it’s the only metal in the group that is both redox active and contains 
the maximum number of d electrons for O-O bond activation. We also resolve a long-
standing debate regarding the role of nonheme metal in HCOs by showing that it acts 
both as an electron donor and a lewis acid that binds and activates oxygen. These results 
have an extensive impact in the field of evolutionary biology as they provide a functional 
basis for biochemical changes that occurred as earth’s anaerobic atmosphere became 
oxygen-rich.40 We also anticipate our work to be a starting point for more focused efforts 
directed towards understanding Nature’s choice of specific metal ions for various 
biochemical reactions, that can aid the design of novel catalysts required in alternative 
energy technologies and other industrial applications.  
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Chapter 4 
Systematic tuning of heme reduction potential in a designed oxidase in myoglobin 
Portions of this chapter are a taken from a J. Am. Chem. Soc. 2014 communication titled 
“Systematic Tuning of Heme Redox Potentials and its Effects on O2 Reduction Rates in 
a Designed Oxidase in Myoglobin” (Ambika Bhagi-Damodaran, Igor D. Petrik, Nicholas 
M. Marshall, Howard Robinson, Yi Lu) 
Abstract: Heme-copper oxygen reductase (HCO) is known to catalyze the reduction of 
O2 to H2O efficiently with a much lower over-potential than almost all other O2 reduction     
catalysts. However, the methods by which the enzyme fine-tunes the reduction potential 
(E°’) of its active site and its influence on the O2 reduction activity are not well understood. 
In this work, we report systematic tuning of the heme E°’ in a functional model of HCO in 
myoglobin containing three histidines and one tyrosine in the distal pocket of heme. By 
removing H-bonding interactions between Ser92, and the proximal His ligand through 
Ser92Ala mutation, we have increased the heme E°’ from 95 ± 2 mV to 123 ± 3 mV. 
Additionally, replacing the native heme b in the protein with heme a analogs, diacetyl, 
monoformyl and diformyl heme, resulted in an E°’ value of 175 ± 5 mV, 210 ± 6 mV and 
320 ± 10 mV, respectively. The methods of tuning the heme E°’ through a combination of 
secondary sphere mutations and heme substitutions can be applied to tune E°’ of other 
heme proteins, allowing for comprehensive investigations of the relationship between E°’ 
and enzymatic activity.   
4.1. Introduction 
Heme proteins are one of the largest classes of metalloproteins. It is admirable how they 
use the same cofactor, protoporphyrin IX, for a variety of functions including electron 
transfer (cytochromes), storage and transfer of oxygen (myoglobin and hemoglobin), 
oxygen activation and utilization (cytochrome oxidases, cytochrome P450), and more1-3 
Current research in heme proteins places a strong emphasis on elucidating the role of 
their structure and physicochemical properties towards biological functions. Some of the 
important physicochemical aspects that affect the functionalities of heme proteins are 
their oxidation state, spin state, proximal coordination, redox potential and affinity of the 
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heme iron for various ligands.1 The overall catalytic activity of these proteins involves a 
complex interplay among these physicochemical properties. A systematic study of how 
each of these properties can be tuned in heme proteins and their impact on the overall 
catalytic activity is necessary for understanding complex enzymatic pathways. A prime 
example of a complex metalloenzyme with an important biological function are heme–
copper oxidases (HCOs)4-6, which catalyze the kinetically difficult reduction of oxygen to 
water and, in doing so, generates a trans-membrane proton gradient that drives the 
important process of ATP synthesis.7 The catalytic site of HCO, where oxygen binding, 
activation and reduction occurs, is a binuclear heme-copper center, which consists of a 
high spin heme and a copper (CuB) coordinated to three histidines, one of which is cross-
linked to a tyrosine residue.8,9 The thermodynamic efficiency of O2 reduction reaction in 
HCOs is determined by the reduction potential (E°’) of the catalytic heme iron.10 In order 
to maximize the energy efficiency of this reaction and reduce its overpotential, it is 
desirable to tune the heme E°’ such that it is as high and as close to that of O2 (810 mV 
at pH7).11 However, while the E°’ of the heme (Fe3+/Fe2+ couple) is known to vary from -
Figure 4.1. Overlay of the X-ray crystal structure of F33Y-CuBMb (4FWX, cyan) and S92A-
F33Y-CuBMb (4TYX, orange). Heme b and side chains of His29, His43, His64, Tyr33, His93 
and Ser/Ala92 are shown in licorice. Ser92 forms an H-bond with heme propionate and 
His93. 
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59 mV in cbb3 oxidase12 to +365 mV in bovine heart CcO,13 the structural features 
responsible for such tuning of the E° is not well understood. In addition, while the role of 
heme E° in controlling electron transfer rates has been investigated extensively,14-16 its 
impact on O2 reduction reactions, as in the case of HCOs, remains unexplored. 
Understanding how the heme E° in HCOs is tuned is not only important for designing 
efficient O2 reduction catalysts with lower overpo-tential, but also for gaining insight into 
how different oxidases are able to tune their heme E°’s to match with those of their redox 
partners so that the electron flow is in the right direction for efficient O2 reduction. A slight 
change of heme E° in terminal oxidases could potentially reverse the electron transfer 
direction, resulting in no or partial O2 reduction. Such investigations are difficult in the 
native HCO due to the presence of multiple metal cofactors, which renders the 
spectroscopic and electrochemical characterization of the heme-copper center 
challenging. To overcome these difficulties, synthetic HCO models have been 
prepared.17,18 However, to our knowledge; no study has investigated ways to fine-tune 
the E° of the catalytic heme and its effects on O2 reduction activity in HCO or its synthetic 
models. 
In a complementary approach to studying native HCOs and synthetic models, we have 
engineered a heme-copper center in a much smaller (MW = 17.4 KDa) O2-binding protein 
sperm whale myoglobin (called CuBMb),19 and showed that the presence of a Tyr in the 
active site through F33Y mutation (called F33Y-CuBMb) resulted in a catalyst that reduces 
O2 to H2O with hundreds of turnovers and minimal release of other reactive oxygen 
species (ROS) (Fig. 4.1).20 In addition to being smaller, this functional mimic of HCO in 
Mb is much easier to purify and is free of other metal-binding sites as in HCO, and thus 
represents an ideal candidate to investigate how to tune the E°’ of heme in a HCO-like 
environment, and to observe its impact on the O2 reduction rates. Herein, we report 
successful tuning of heme E° in F33Y-CuBMb through either introducing a hydrophobic 
residue that perturbs H-bonding interactions in the proximal side of heme, or by replacing 
the native heme b with heme analogs with high E°, resulting in O2 reduction catalysts with 
E°’ values within ~215 mV range.  
 
67 
 
4.2. Material and methods 
All chemicals, unless otherwise specified, were obtained from Sigma (St. Louis, MO) or 
Fisher Scientific (Hampton, NH). Fe(III)-incorporated non-native heme cofactors were 
purchased from  Frontier Scientific (Logan, UT). 
4.2.1. Purification of proteins and incorporation of non-native heme cofactors 
F33Y-CuBMb and S92A-F33Y-CuBMb were expressed and purified as reported 
previously.20 Briefly, apo-protein was expressed and localized to the inclusion bodies of 
BL21(DE3) cells. The cells were then lysed by sonication and denatured with 6 M 
guanidine chloride. Heme b was added to the denatured cell solution, which was then 
dialyzed against 10 mM TRIS-H2SO4 pH 8 at least 4 times. The resulting protein solution 
was concentrated by Amicon with a 10,000 MWCO filter, and passed through a size 
exclusion column to achieve homogeneity.  Final yield of the protein was ~ 20 mg/L. 
WTMb was expressed and purified as reported previously and its yield was typically ~100 
mg/L.21 Heme b was removed from F33Y-CuBMb and WTMb via acidified butanone 
extraction as per Teale’s method.22 Complete removal of heme b was ensured by taking 
a UV-Vis spectra of the apo-protein, and only when the concentration of heme b (ɛ408nm 
~150 mM-1cm-1) was less than 1% of the concentration of protein (ɛ280nm ~30 mM-1cm-
1), non-native heme cofactors were incorporated.   
Fe(III)-2,4-diacetyl deuterioporphyrin IX (DA-heme), Fe(III)-2,4 (4,2) formyl vinyl  
deuterioporphyrin IX (MF-heme) and  Fe(III)-2,4-diformyl deuterioporphyrin IX (DF-heme) 
were characterized by mass spectrometry before being incorporated into the apo-protein. 
The non-native heme cofactors were dissolved in dimethyl sulfoxide and titrated into the 
apo-WTMb/apo-F33Y-CuBMb until the ratio of the absorption of the heme band (408-430 
nm depending on the cofactor) to that of the protein (280 nm) stopped increasing (usually 
3 equivalent of heme was added to the apo-protein). Heme-protein mixture was then 
dialyzed against subsequently increasing concentration of pH 7 potassium phosphate 
buffers to ensure proper folding of the protein. The excess heme was then removed by a 
DEAE-Sepharose and size exclusion column. F33Y-CuBMb variants were finally chelexed 
to remove any metal ions at the CuB site as per a procedure reported previously.21 
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4.2.2. Characterization of F33Y-CuBMb and WTMb variants via UV-Vis spectroscopy 
and circular dichroism 
Table 4.1. enlists the spectral features of oxidized and reduced forms of F33Y-CuBMb 
variants. The oxidized form of the proteins show a Soret band at 400 nm range followed 
by  and  bands in the visible region, typical of a well-folded oxidized myoglobin. Table 
4.1 enlists the wavelength maxima for all transitions in the oxidized and reduced form of 
F33Y-CuBMb variants. Extinction coefficient of the proteins was determined by 
hemochromogen assay where the wavelength maximum (in nm) and extinction coefficient 
(in mM-1 cm-1) used for the  peak of heme b, DA-, MF- and DF-heme were 556 (36), 576 
(25),  583 (28) and 587 (20.5) respectively.  Even though a racemic mixture of Fe(III)-2,4 
(4,2)-formyl vinyl  deuterioporphyrin IX (MF-heme) was titrated into the apo-F33Y-CuBMb, 
comparison of the UV-Vis spectroscopic properties of F33Y-CuBMb (MF-heme) (e.g. 
Soret wavelength maxima and the wavelength maxima of the hemochromogenic assay) 
with literature values reveals that only Fe(III)-2,4-formyl vinyl  deuterioporphyrin IX got 
incorporated in the protein. It should be noted that the wavelength maxima of MF-heme  
Table 4.1. UV-Vis spectral features of F33Y-CuBMb variants  
 
  ferric*  deoxy*  
 Soret vis   Soret vis 
F33Y-CuBMb 
 
407 501 628 431 553 
S92A- F33Y-CuBMb 
 
407 502 628 429 556 
F33Y-CuBMb  
(DA-heme) 
 
416 507 635 444 562 
F33Y-CuBMb 
(MF-heme) 
 
422 542 656 443 585 
        F33Y-CuBMb 
(DF-heme) 
430 509 662 460 575 
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and DF-heme in the hemochromogenic assay exhibit a bathochromic shift as compared 
to heme b and match well with that of native heme a in cytochrome c oxidase (585 nm).23 
Circular dichroism (CD) measurements as a function of wavelength were obtained using 
a JASCO J-715 spectrometer at 20°C in a standard 1-cm path length cuvette with protein 
samples in 100 mM phosphate buffer pH 6.0 at a protein concentration of 2-3 M. The 
Mean Residue Ellipticities [Ɵ]222nm was calculated with the following equation: 
                     [Ɵ]222nm = Ɵ222nm / L (cm) x C (decimole) x n (deg.cm2.dmol-1) 
Helical content of the protein was determined as described by Chen et al, and compared 
to the literature record of wild type sperm whale myoglobin.24  
L: length of light path of cuvette; C: protein sample concentration; n: total number of the 
amino acid residues in the protein. 
Table 4.2. Circular Dichroism results for F33Y-CuBMb variants 
Protein Conc (M) CD222nm [Ɵ] * 103 Deg. cm2 
 dmol-1/residue 
α helical 
content (%) 
Sw WT Mb - - 24-25 80-856 
F33Y-CuBMb 2.15 -84.79 25.82 86 
S92A-F33Y-
CuBMb 
1.97 -85.33 28.28 94 
F33Y-CuBMb 
(DA-heme) 
1.95 -84.35 28.27 94 
F33Y-CuBMb 
(MF-heme) 
1.95 -82.55 27.56 91 
F33Y-CuBMb 
(DF-heme) 
1.93 -82.55 27.90 91 
 
4.2.3. Spectroelectrochemical measurements  
The reduction potential was measured by a spectroelectrochemical method using an 
optically transparent thin-layer cell (OTTLE). The working electrode was made from a 
70 
 
piece of 52 mesh platinum gauze. A 1 mm diameter platinum wire was used as the 
auxiliary electrode, while a piece of Pasteur pipet filled with agar gel containing 0.2 M KCl 
was used a salt bridge to connect the Ag/AgCl (3 M KCl) reference electrode to the bulk 
solution containing the working and auxiliary electrodes. Generally, the redox titration was 
performed using ~ 0.6 mL of working solution containing 0.2 mM protein, 40 mM 
phenazine methosulfate, 40 mM anthraquinone-2-sulfonate, and 20 mM N,N,N',N'-
tetramethyl-p-phenylenediamine (TMPD) as redox mediators in 100 mM phosphate 
buffer, pH6. The working solution was purged gently with Argon before transferring to the 
OTTLE cell. A model 362 potentiostat from Princeton Applied Research was used to 
control the potential of working electrode. After the potential was applied (typically with 
25 mV increments), the UV-vis spectra were recorded using a Cary 3E spectrophotometer 
until no further spectral changes occurred. The Ag/AgCl (3M KCl) reference electrode 
was calibrated using ferrocene carboxylic acid as the standard and was found to be 220 
mV versus NHE. All reduction potentials mentioned in this work are reported against NHE. 
The system was calibrated using WT Mb; the measured Eº of 61 ± 2 matched closely to 
reported literature values.25 
4.2.4. Data analysis for spectroelectrochemical measurements 
The spectroelectrochemical titration data over the entire spectra were analyzed by global 
analysis using singular value decomposition (SVD) and nonlinear regression modeling 
with SpecFit/32 (Spectrum Software Associates, Inc.) using a method followed 
previously.26 All of the data were fit with a model of A ↔ B as the Nernst plot at a single 
wavelength gave a straight line fit with n (no. of electrons transferred) value close to 1. 
4.2.5. X-ray crystallography 
Crystals were set up and grown at 4ºC on hanging drops containing 0.1M MES pH 6.57, 
0.2M NaOAC.3H2O, 30% PEG 6K as well buffer. Drops contained an equal volume of 1 
mM S92A-F33Y-CuBMb in 20 mM TRIS.H2SO4 pH 8 and the well buffer. Prior to 
mounting, the S92A-F33Y-CuBMb crystals were soaked in buffer containing 0.1M MES 
pH 6.0, 0.2M NaOAC.3H2O, 30% PEG 6K for ~ 30 min and then frozen in a cryoprotectant 
solution of 50 mM MES pH 6.0, and 30% PEG 400.  Diffraction data were collected at the 
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Brookhaven National Lab Synchrotron Light Source x29 beamline. The crystal structure 
was solved using the same method as for F33Y-CuBMb (Table 4.3.).20 
Table 4.3. Diffraction and refinement data for S92A-F33Y-CuBMb 
 
 
Data Collection Statistics 
X-ray source x29 NSLS 
X-ray detector ADSC Q315r 
X-ray wavelength (Å) 1.075 
Space group P212121 
Unit Cell (Å) a=39.467, b=47.910, c=76.854 
Molecules in asymmetric unit 1 
Resolution range (Å) 50-1.64 (1.73-1.64) 
Total reflections 278363  
Unique Reflections 18486 (1682) 
Overall B-factor, ML (Å2) 20.70 
Completeness (%) 99.3 (92.9) 
Redundancy 15.1 (13.3) 
<I/σI> 31.8 (6.1) 
Linear R-merge 0.097 (0.462) 
  
Refinement Statistics  
Program Phenix 
Resolution (Å) 40.66-1.64 (1.66-1.64) 
Reflections used in refinement 34403 
  Test set 3447 
Completeness (%) 99.76 
Rall 0.160 
Rwork 0.156 (0.182) 
Rfree 0.198 (0.260) 
Coordinate error (ML) 0.17 
  
Wilson B-factor 21.06 
TLS groups (6) 1-35|36-51|52-58|59-100 
101-124|125-153 
Atoms  
  Protein 1240 
  Water 178 
  Heme 42 
RMSD  
  Bonds (Å) 0.017 
  Angles (º) 1.784 
Ramachandran outliers (%) 0.00 
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4.3. Results and discussion 
4.3.1. Tuning H-bonding interactions to increase heme E°’ 
The F33Y-CuBMb was expressed and purified without a copper ion at the CuB site.20 No 
copper ion was added in this work, as previous studies have shown that the presence of 
copper does not have any influence on the oxidase activity of F33Y-CuBMb,27 similar to 
the CuB-independent cytochrome bd oxidase.28 The E° of F33Y-CuBMb was determined 
using a UV-Vis spectroelectrochemical method as described previously;26 such a method 
was shown to be able to maintain the integrity of the protein while providing the benefit of 
direct monitoring of spectral transition from the oxidized form of the enzyme (Fe3+) to its 
reduced form (Fe2+) upon sweeping the potential (Fig. 4.2A). The E°’ of F33Y-CuBMb was 
obtained by global analysis fitting of the spectral transition to the Nernst equation (black 
Figure 4.2. (A) Spectra obtained for F33Y-CuBMb starting from the oxidized form (green) 
going to the reduced form (yellow) in 100 mM phosphate buffer, pH6. Isosbestic points are 
indicated as a star (*). Inset shows a magnified view of the same spectra in 500-650 nm 
wavelength. (B) Nernst fit of the spectral plot for F33Y-CuBMb and its variants. Dotted lines 
represent the point where fraction reduced is equal to oxidized and corresponding potential 
value is the E° of the protein. 
73 
 
curve, Fig. 4.2B). The E°’ of 95 ± 2 mV determined from this process lies between the -
59 mV in cbb3 oxidase and +365 mV in bovine HCO. This finding motivated us to explore 
ways to increase E° of F33Y-CuBMb to match that of HCO in order to lower the 
overpotential for O2 reduction reaction. 
  
A previous study has shown that replacing the neutral Val68 residue in the distal pocket 
of human Mb with negatively charged Glu or Asp can decrease the E° by up to ~200 
mV.25 Since this work, most mutations in Mb have resulted in change of E° much less 
than 200 mV; even fewer reports of mutations have been shown to increase the E°.16 
More importantly, since the distal pocket plays a critical role in binding and reducing O2, 
it is even more difficult to tune the E° without affecting its oxidase activity. Under such 
constraints, we focus our attention to modifications on the proximal side of heme. 
Previous studies have demonstrated that increasing hydrophobicity and tuning H-bonding 
around the secondary coordination sphere of the metal-binding site can increase the E° 
of metalloproteins.29 Applying the same methodologies towards Mb, we began to look for 
possible sites to alter on the proximal side of heme. NMR studies on WTMb have 
suggested that the Nɛ H+ of the proximal His93 ligand forms a weak H-bond with the lone 
pair of Ser92 (Fig. 4.1). Therefore, disrupting this H-bond may increase the positive 
character of the Nɛ H+ of His93, thereby reducing the overall electron donating ability of 
the imidazole ring towards the heme iron, leading to an increase in the heme E°. Based 
on this hypothesis, we replaced the Ser92 with Ala, which being more hydrophobic may 
Figure 4.3. Overlay of the crystal structure of F33Y-Cu
B
Mb (cyan) and S92A-F33Y-Cu
B
Mb 
(orange) (A) Proximal side of the heme. (B) Distal side of the heme.  
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also raise heme E° through preferential stabilization of Fe2+ over Fe3+. UV-vis spectra of 
both oxidized and reduced S92A-F33Y-CuBMb are very similar to those of F33Y-CuBMb, 
suggesting that the S92A mutation exerted minimal perturbation on the protein structure. 
A 1.64 Å resolution crystal structure of this mutant indicates that the S92A mutation did 
indeed eliminate the H-bonding interaction between Ser92, His93 and heme propionate, 
resulting in the negatively charged propionate moving away from the mutation site of 
Ser92 and heme iron (Fig. 4.1, 4.3). The E° of S92A-F33Y-CuBMb was found to be 123 
± 3 mV (Fig. 4.2,4.4A), suggesting that introducing the hydrophobic resi-due and the 
associated changes in the H-bonding interac-tions are responsible for the observed 
Figure 4.4. Spectroelectrochemical reduction of F33Y-Cu
B
Mb variants (A) S92A- F33Y-Cu
B
Mb 
(B) F33Y-Cu
B
Mb (DA-heme) (C) F33Y-Cu
B
Mb (MF-heme) (D) F33Y-Cu
B
Mb (DF-heme). The 
inset shows the Nernst plot from the dependence of the absorbance at 429 nm (A), 444 nm (B), 
443 nm (C) and 460 nm (D) on the applied potential.  
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enhancements in the heme E°. This finding correlates with a recent study in cbb3 oxidase, 
in which perturbing H-bonding interactions of proximal histidine ligand of catalytic heme 
b3 lead to a variation in E°’ values by ~40 mV.12 
4.3.2. Use of different heme types to increase heme E°’ 
While the increase of E°’ from 95 to 123 mV is encouraging, it is still much less than the 
365 mV of bovine CcO. To increase the E°’ further, we noticed a major difference between 
the heme in our protein model in Mb and that in bovine CcO: while heme b is present in 
our Mb model system, various A- and B-type HCOs with high E° values use heme a (Fig. 
4.5).30 The presence of an electron-withdrawing C-8 formyl group conjugated to the 
porphyrin ring can destabilize the oxidized form of the heme and thus increase the heme 
E°. For example, Gibney and coworkers replaced the heme b in a de novo designed a-
helical bundle protein with heme a and observed an increase in E° value by 157 mV.31 
While this result is exciting in the de novo designed protein, replacing the heme b with 
heme a in Mb resulted in a misfolded protein,32 due to lack of space in the Mb to 
accommodate the C-14 farnesyl chain (Fig. 4.5). 
 
Figure 4.5. (A) Protein Scaffold of F33Y-CuBMb (B) Heme b cofactor present in WTMb (C) 
Heme a3 present in the binuclear complex of bovine heart CcO. (D) Diacetyl heme (E) 
Monofomyl heme (F) Diformyl heme incorporated in F33Y-CuBMb apo- protein.  
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Based on the above comparison and findings, we embarked on a systematic study of 
increasing heme E°’ by using a different strategy of replacing the native heme b in Mb 
with heme a analogues of high E°. Mb is an ideal system for such a strategy because the 
heme b can be readily extracted and replaced with non-native heme cofactors of similar 
structures and sizes. We therefore decided to replace heme b in F33Y-CuBMb with 
diacetyl (DA-), monoformyl (MF-) and diformyl (DF-) derivatives of heme that are similar 
in structure as heme b in Mb, but resemble the heme a in the elec-tronic properties (Fig. 
4.5.).The extraction of heme b and in-corporation of the above three heme analogs into 
F33Y-CuBMb were carried out using the protocol reported previously with slight 
modification. The UV-vis absorption spectra of the three F33Y-CuBMb variants reveal an 
intense Soret band around 400 nm, along with α and β transitions in the visible region 
(Table 4.1.), which are typical of the oxidized form of Mb. The secondary structures of the 
heme substituted proteins were confirmed by circular di-chroism spectra, which showed 
minima at 222 and 209 nm consistent with well folded  helical protein containing native 
heme b (Fig. 4.6, Table 4.2.).  
Having confirmed that the F33Y-CuBMb variants are well- folded in the presence of non-
native heme cofactors, we carried out UV-Vis spectroelectrochemical measurements to 
determine their E°’s. The spectroelectrochemical reduction of each of these three variants 
exhibited a clean transition from its oxidized form to reduced form (Fig. 4.4) and global fit 
of data to the Nernst equation (Fig. 4.2B) revealed E° values of 175 ± 5 mV, 210 ± 6 mV 
Figure 4.6. Circular Dichroism spectra of F33Y-Cu
B
Mb variants 
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and 320 ± 10 mV for F33Y-CuBMb (DA-heme), (MF-heme) and (DF-heme), respectively. 
Thus, by incorporation of non-native heme cofactors, we have been able to increase the 
E° for F33Y-CuBMb by approximately 80, 115 and 215 mV respectively, with the E° of the 
F33Y-CuBMb with DF-heme (320 ± 10 mV) very close to that of bovine CcO (365 mV). 
4.4. Conclusion 
We have demonstrated effective methods to systematically increase the E° of the heme 
in a functional model of HCO in myoglobin, by up to ~215 mV. The methods include 
removing hydrogen bonding interactions and increasing hydrophobicity in the proximal 
side of the heme and replacing the native heme b with heme analogs that possess higher 
E°. The methods of tuning E° shown in this study can be applied to other heme proteins 
allowing systematic investigation of the relationship between heme E° and other 
enzymatic activities. 
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Chapter 5 
Role of heme redox potential in controlling oxygen reduction reactivity 
Portions of this chapter are a taken from a J. Am. Chem. Soc. 2014 communication titled 
“Systematic Tuning of Heme Redox Potentials and its Effects on O2 Reduction Rates in 
a Designed Oxidase in Myoglobin” (Ambika Bhagi-Damodaran, Igor D. Petrik, Nicholas 
M. Marshall, Howard Robinson, Yi Lu) and a draft of manuscript under preparation titled 
“Role of heme redox potential in controlling enzymatic activities: A case study with 
myoglobin-based functional oxidase” (Ambika Bhagi-Damodaran, Maximilian Kahle, Pia 
Adelroth, Yi Lu) 
 
Abstract Heme-copper oxygen reductase (HCOs) are a respiratory enzyme that utilize a 
heme-copper center to catalyze the reduction of oxygen to water. Here we use a set of 
myoglobin-based functional HCO mimics to elucidate the role of heme of redox potential 
(E°’) in controlling HCO activity. Oxygen reduction enzymatic assays reveal a six-fold 
increase in oxygen reduction rates with ~210 mV increase in heme E°’. By using ultra-
fast electron transfer measurements in tandem with flow-flash spectroscopy, we show 
that such an increase in due to ~30-fold increase in electron transfer rates. At the same 
time, increasing heme E°’, increases the rate of oxygen binding by ~12-fold and oxygen 
dissociation rates by ~40-fold. These results suggest efficient tuning of E° in HCOs and 
other heme enzymes to modulate their substrate binding, product selectivity and overall 
enzymatic activity. 
5.1. Introduction 
Heme-copper oxygen reductases (HCOs) catalyze the kinetically difficult reduction of 
oxygen to water and, in doing so, generate a trans-membrane proton gradient that drives 
the important process of ATP synthesis.1-3 The catalytic site of HCO, where oxygen 
binding, activation and reduction occurs, is a binuclear heme-copper center, which 
consists of a high spin heme iron and a copper (CuB) coordinated to three histidines, one 
of which is cross-linked to a tyrosine residue. HCOs from different species exhibit 
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differences in their structure which makes significant impact in their function. For instance, 
the A-type and HCOs use two pathways for the transfer of protons while the B-type and 
C-type HCOs only use a single pathway for proton transfer. Moreover, different HCOs 
use different heme types at the catalytic heme center such as heme a, b, d and o.4-6 In 
this regard, it is important to elucidate how differences in these structural features impact 
physical and chemical properties along with functions of these enzymes. One such 
property is the reduction potential (E°) of active site heme iron (Fe3+/Fe2+) in HCOs which 
varies by ~400 mV in different HCO types. Table 5.1. shows the E°’ of the catalytic center 
of various HCO types and while the heme E°’ of different HCOs vary considerably, the 
E°’ of CuB remains more or less within the same range. Thus, question arises as to (1) 
what is the reason for such variation of heme E° in HCOs and (2) how does heme E° 
impact HCO activity. An efficient method to answer these questions would be by 
systematically tuning the heme E° and probing the resulting changes in its functional 
activity. However, such experiments are difficult, if not impossible, to perform in native 
HCOs due to their large size (~100-200 KDa), membranous nature, and presence of 
multiple cofactors that makes spectroscopic characterization of the catalytic heme-copper 
center challenging. To address these challenges, a number of small-molecule based 
models of HCOs have been constructed7,8 but none to our knowledge have attempted to 
explain the importance of tuning heme redox potential in HCOs. In complementary 
Figure 5.1. (A) The catalytic active site of F33Y-CuBMb showing the heme b and side chains 
of His29, His43, His64, His93 and Tyr 33 in licorice. The protein backbone is shown in grey 
in cartoon representation. (B) The heme E° range of CcOs which varies from -59 mV to +365 
mV is represented as a blue bar, while the green brackets show the heme cofactor present in 
the native CcOs displaying the heme E° values. The heme E° of F33Y-CuBMb variants are 
shown in red. 
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approach to studying native HCOs and their small-molecule models, we have designed 
a functional model of HCO in a small (17.4 KDa), easy-to-purify protein, myoglobin (called 
F33Y-CuBMb)9 that possesses a heme center, histidines and a tyrosine similar to HCOs 
and can selectively reduce oxygen to water. To begin understanding the influence of 
heme E° on HCO reactivity, we have systematically tuned the heme E° of HCO mimic by 
~210 mV by modulating its H-bonding interactions to catalytic heme (to obtain the S92A- 
mutant) and using non-native heme cofactors with increased E° such as diacetyl (DA-), 
monoformyl (MF-) and diformyl (DF-) heme.10 In this chapter, we try to understand the 
impact of heme E° on oxygen reduction reactivity, electron transfer, oxygen 
binding/dissociation rates of these HCO mimics.  
5.2. Materials and methods 
All chemicals, unless otherwise specified, were obtained from Sigma (St. Louis, MO) or 
Fisher Scientific (Hampton, NH). Fe(III)-incorporated non-native heme cofactors were 
purchased from  Frontier Scientific (Logan, UT). 
5.2.1. Purification and characterization of F33Y-CuBMb variants 
The purification and characterization of F33Y-CuBMb variants was performed as 
described in Chapter 4 (section 4.2.1). 
5.2.2. Oxygen consumption assay and turnover studies using an oxygen electrode  
The rate of water and ROS production was measured and calculated as reported 
previously with slight modifications.9 Briefly, 6 M of protein was incubated in air saturated 
100 mM phosphate buffer at pH 6. The oxygen consumption assay was initiated by the 
addition of 1500 eq. of ascorbate (10 mM) and 150 eq. of TMPD (1 mM). To calculate the 
percentage of water with respect to superoxide and peroxide (ROS) formation, we 
repeated the measurement of O2 reduction in the presence of superoxide dismutase 
(SOD) (50 units) and catalase (7 M), which selectively reacts with superoxide and 
peroxide, respectively. By comparing the rates of reduction in the absence of and in the 
presence of SOD and catalase, the portion of O2 reduction that is due to H2O formation 
can be calculated, using a protocol reported previously.9 The O2 reduction rates of F33Y-
CuBMb, F33Y-CuBMb (MF-heme) and F33Y-CuBMb (DF-heme) are much lower than 
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those in the presence of TMPD. Interestingly, even in the absence of TMPD, the rate of 
O2 reduction increases in direct correlation with heme Eº. Therefore, our results are 
consistent with the hypothesis that TMPD is a redox mediator to help ascorbate reduce 
the proteins more efficiently. 
The turnover experiment was performed similarly except that after the O2 in the reaction 
chamber was exhausted, the chamber was vented with pure O2 to boost O2 concentration 
to 0.5-0.6 mM. The concentration of ascorbate was kept at 10 mM. 
5.2.3. Stopped-flow UV-Vis kinetic measurements  
Experiments were performed on an Applied Photophysics Ltd. (Leatherhead, U.K.) 
SX18.MV stopped-flow spectrometer equipped with a 256 element photodiode array 
detector. Two-syringe mixing was employed to mix equal volumes of F33Y-CuBMb 
variants with volumetrically prepared oxygen saturated solutions. All reported data sets 
originally consisted of 200 spectra collected over 100 s using logarithmic sampling. The 
integration period and minimum sampling period were both 1 ms. A water bath, connected 
to the syringe compartment and set to 25ºC, provided temperature control. The actual 
temperature in the syringe compartment was measured to be 24.4ºC. The instrument was 
prepared for anaerobic stopped-flow by rinsing its lines out several times with buffer that 
had been degassed by bubbling argon gas through it. Special glass outer syringes fit with 
Teflon stoppers into which an argon line was run maintained an oxygen free environment. 
The ferric protein was degassed on schlenk line and transferred to anaerobic glovebag 
before being taken to stopped-floe apparatus in a degassed syringe. The solution of 0.1 
M TMPD and 1 M ascorbate was prepared inside the glovebag and the required amount 
was transferred onto the stopped-flow using a degassed syringe. 
5.2.4. Oxygen binding affinity measurements 
The affinity for O2 was determined using the Flow-Flash technique with a setup essentially 
described in [2]. In short, the samples were prepared in modified Thunberg cuvettes (5-
30 µM protein, 100 mM KPi buffer, pH 6). Increased protein concentrations were needed 
for F33Y-CuBMb (MF heme) and F33Y-CuBMb (DF heme) since absorbance maxima of 
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the ferrous state and the ferrous CO bound state were relatively close in wavelength (Fig. 
S8 C&D). The samples were made anaerobic with N2(g) on a vacuum line and reduced 
by addition of 100 µM dithionite. The cuvettes were put under 1.5 bar CO(g) and then 
incubated overnight at 4°C. For Flow-Flash measurements a sample was transferred to 
a stopped-flow syringe that was pre-incubated with 100 mM dithionite and washed with 
anaerobic water. The second syringe contained oxygenated buffer (100 mM KPi, pH 6) 
at O2 concentrations ranging from 0.25 – 1.2 mM. The solution of the two syringes were 
mixed in a ratio of 1:5 (protein sample/oxygenated buffer) using a custom-built stopped-
flow apparatus (Applied Photophysics, U.K.). After mixing (200 ms delay) CO was 
dissociated by a short laser flash (10 ns, 200 mJ, 523 nm, Nd-YAG laser, Quantel). O2 
binding kinetics was then studied at different selected wavelengths by a 
spectrophotometer and recorded on a digital oscilloscope. The obtained kinetic traces 
were converted to absorbance changes and the number of points was reduced from 106 
to 2*103 averaging over a logarithmic time scale. The traces were then fitted to a model 
of consecutive irreversible reactions using the software package ProK (Applied 
Photophysics, U.K.). 
5.2.5. Data analysis and fitting 
Oxygen binding to the Mb constructs with substituted hemes was measured after CO 
photolysis in a Flow-Flash experiment. Because of the different optical spectra for each 
construct, different wavelengths were chosen in order to achieve a good signal. Figure S2 
shows O2 binding at 1 mM in the different samples, and Figure S5A shows the data 
normalized to the same amplitudes in order to emphasize the difference in rate constants 
for O2 binding observed. Because there were clear differences in the rate constants 
observed (Fig. S2), with the O2 binding rates increased for those models that have a 
higher reduction potential, we also studied these rate constants as a function of O2 
concentrations. We also observed in all constructs that O2 binding kinetics is biphasic 
with a fast phase of unknown origin, with relatively small contribution to the total 
absorbance change. The fast phase is more obvious in the models containing the MF- 
and DF-heme. This biphasic character in the MF- and DF-heme containing models is not 
explained by residual protein that still contains the wildtype heme, since the rate constants 
of the slow phase observed in the MF/DF-heme containing models does not match the 
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corresponding rate constant seen in F33Y-CuBMb.  Since the contribution of the fast 
phase is in general relatively low, we fitted the complete reaction to only one phase. The 
rates from these one-exponential fits were then plotted and used for calculation of O2 
binding properties. 
5.3. Results and discussion 
5.3.1. Oxygen reduction assays and turnovers with F33Y-CuBMb variants 
 The rates of O2 reduction by these F33Y-CuBMb variants in the presence of the reductant 
ascorbate (E°= 96 mV) and redox mediator, N,N,N',N'-tetramethyl-p-phenylenediamine 
(TMPD) (E°= 260 mV) were measured using an O2 electrode and protocol reported 
previously for both native HCOs and their models. For an oxidase to function efficiently, 
it is required to perform complete 4 e- reduction of O2 into H2O; any incomplete reduction, 
such as 1 e- or 2 e- reduction of O2 to superoxide (O2-) or peroxide (O22-) will result in 
ROS that is detrimental to the biomolecules in living cells or components in fuel cells. 
Therefore, we measured the ratio of H2O formation with respect to superoxide and 
Figure 5.2. (A)Rates of O2 reduction to form either H2O (blue) or ROS (red) catalyzed F33Y-CuBMb 
variants (B)O2 reduction turnover measured during the stepwise addition of O2 for F33Y-CuBMb and 
its (MF-heme) and (DF-heme) variants.  
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peroxide (ROS) as previously reported, by repeating the O2 reduction experiments in the 
presence of superoxide dismutase (SOD) and catalase, which selectively react with 
superoxide and peroxide, respectively. Interestingly, the oxidase activity of the F33Y-
CuBMb variants increased with increasing E° of the heme, while the ratio of water 
produced with respect to the ROS remained almost constant (Fig. 5.2, 5.3C). The F33Y-
CuBMb (DF-heme), with E° of 320 mV exhibits over six-fold increase in oxidase activity 
as compared to F33Y-CuBMb with heme b. Furthermore, all three enzymes tested (F33Y-
CuBMb, F33Y-CuBMb (MF-heme) and F33Y-CuBMb (DF-heme)) are capable of 
Figure 5.3. (A) Nernst fit of the spectral plot for WTMb and its variants. (B) O
2
 consumption 
rates and product selectivity of WTMb, F33Y-Cu
B
Mb and their variants in the presence or 
absence of TMPD, using ascorbate as the reductant. (C) Variation of oxidase activity with 
heme E° for F33Y-CuBMb variants. Dotted blue line indicates E° of WTMb and bovine CcO. 
(D) Rates of O
2
 reduction to form either H
2
O (blue) or ROS (red) catalyzed by F33Y-Cu
B
Mb 
and its MF-heme and DF-heme variants 
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performing hundreds of turnovers, with the more active enzyme possessing highest E°, 
(F33Y-CuBMb (DF-heme)), performing more than a 1000 turnovers under similar 
conditions and over same time (Fig. 5.2). To investigate if TMPD is required for O2 
reduction experiments, we measured O2 reduction rates of F33Y-CuBMb and its variants 
by ascorbate in the absence of TMPD (Fig. 5.3D). In control experiments, we also 
replaced the heme b in WTMb with DA-heme and DF-heme and found that such 
replacement increased the E° value of WTMb from 61 ± 2 mV to 154 ± 3 mV and 268 ± 7 
mV respectively. Thus, the increase in heme E°’ in WTMb shows parallel results with the 
F33Y-CuBMb mutant (Fig. 5.3A-B). Interestingly, even though the increase in heme E°’ 
leads to increase in overall O2 reduction rates for both WTMb and F33Y-CuBMb, the 
percentage of complete O2 reduction to H2O shows opposite trends. While for WTMb 
variants, the higher heme E° results in higher ROS formation, for F33Y-CuBMb variants, 
the higher heme E° results in more H2O formation. This comparison strongly suggests 
the importance of H-bonding network formed by distal mutations (that form the CuB site 
and Tyr) and associated H2O molecules to control the protonation/deprotonation of O2 for 
its reduction to H2O. 
5.3.2. Role of heme E°’ in tuning electron transfer (ET) rates 
The tuning of heme E° is known to make substantial impact on the electron transfer 
rates.18-20 The heme center in the HCO mimics receives its electrons from a mixture of 
Figure 5.4. (A) Spectra obtained for 6 M F33Y-CuBMb starting from the oxidized form (violet) 
going to the reduced form (maroon) in 100 mM phosphate buffer, pH6. Isosbestic points are 
indicated by a star (*). Inset shows the variation in normalized absorbance max. for oxidized 
form (violet) and reduced form (red). (B) Variation in the oxidase activity (green) and electron 
transfer rates (red) for F33Y-CuBMb variants with altered heme E°. 
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N,N,N′,N′-tetramethyl-p-phenylenediamine (TMPD) and ascorbate where TMPD (E°= 276 
mV) is a redox mediator and ascorbate (E°=90 mV) the sacrificial reductant. We reasoned 
that increasing the E° of heme iron and bringing it closer to that of the electron donor 
(TMPD) may increase the driving force and hence the rate of electron transfer to the heme 
iron which, in turn, can increase the oxygen reduction activity. To confirm this hypothesis, 
we measured the electron transfer rates (from Fe3+ to Fe2+ form) of the HCO mimics. The 
strong spectroscopic signature of the heme iron makes it relatively easy to measure its 
rate of reduction from Fe3+ to Fe2+ state which essentially is its electron transfer rate. The 
reduction rates of HCO mimics was measured using stopped-flow absorption 
spectroscopy under strictly anaerobic conditions. Moreover, the electron transfer 
experiments were run under similar protein and reductant concentration as the oxygen 
reduction enzymatic activities such that the two results can be compared. On mixing 
oxidized 6 M F33Y-CuBMb with 150 eq. TMPD and 1500 eq. Ascorbate, we saw a 
decrease in the absorbance at 407 nm, 501nm and 618 nm (corresponding to heme Fe3+ 
form) with a consecutive increase in absorbance at 434 nm and 556 nm (corresponding 
to heme Fe2+ form). The presence of isosbestic points in the spectra confirmed clean 
transformation from Fe3+ to Fe2+ form with formation of no intermediate species (Fig. 5.4.). 
The normalized absorbance at 434 nm and 407 nm with respect to time fit very well with 
first order exponential decay equation to obtain the electron transfer rate from Fe3+ to Fe2+ 
form of F33Y-CuBMb as 0.104 s-1. Similar experiments when performed with F33Y-CuBMb 
variants with increased heme E° also obtained a clean transition from Fe3+ to Fe2+ heme 
Figure 5.5. The stopped-flow UV-Vis measurements of the reaction between 6 M of S92A-
F33Y-Cu
B
Mb (A), F33Y-Cu
B
Mb (MF-heme) (B), F33Y-Cu
B
Mb (DF-heme) (C) and 1 mM TMPD, 
10 mM ascorbate between 0.001s to 100s. The spectra starts from ferric (purple) and goes to 
ferrous (red) form with clean isosbestic points. The inset shows the absorbance at max 
corresponding to Soret of ferric species. 
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form (Fig. 5.5). At the same time, we also observed systematic increase in the electron 
transfer rates with S92A-F33Y-CuBMb, F33Y-CuBMb (MF-heme) and F33Y-CuBMb (DF-
heme) exhibiting electron transfer rates of 0.186, 0.761 and 3.192 s-1 respectively (Fig. 
5.4.).  Thus, increasing the heme E° in the HCO mimics resulted in an almost exponential 
increase in the electron transfer rates. However, this increase in the electron transfer rate 
did not translate directly in corresponding increase in oxygen reduction activity: while the 
electron transfer rate increased by over 30-fold on increasing the heme E°, the oxygen 
reduction activity only increased by 6-fold. This suggests that the increase in activity does 
correlate to electron transfer but probably not directly to the Fe3+ form of heme but any of 
the other intermediates in the O2 reduction reaction, for example the Fe(III)-O2- or Fe(III)-
O22- forms before the O-O bond cleavage. To confirm this, we probed the kinetics of 
oxygen reduction reaction of F33Y-CuBMb using stopped-flow absorption spectroscopy 
that showed an instant formation of a Fe(III)-O2- species (in 0.1 s) that persists for a rather 
long time (~10 min) suggesting the electron transfer to Fe(III)-O2- to be the rate-limiting in 
F33Y-CuBMb. On increasing the heme E°, the rate of electron transfer to Fe(III)-O2- 
increases, which in turn increases the overall rate of oxygen reduction reaction. 
5.3.3. Role of heme E°’ in tuning O2 binding and dissociation rates 
Increasing the heme E° basically decreases the electron density of heme iron. Thus, apart 
from tuning the electron transfer rates, altering the heme E° of HCO mimics can also 
impact their oxygen binding/dissociation rates and overall oxygen affinity. To probe the 
kon rates of oxygen to F33Y-CuBMb variants, we used the “flow-flash” technique wherein 
fully reduced CO-bound heme enzyme is mixed in a stopped-flow apparatus with an 
oxygenated solution. The reaction is initiated by a short laser flash (∼10 ns) breaking the 
photolabile Fe–CO bond and allowing binding of dioxygen and its subsequent reduction 
which can be studied by time-resolved spectroscopy. We prepared CO-bound F33Y-
CuBMb by reacting 5M of fully reduced protein with 1.5 mM CO. The resulting complex 
exhibited UV-Vis signals at 422, 540 nm and 573 nm (Fig. 5.6.) suggesting complete 
formation of the CO-adduct with no other species. The CO-F33Y-CuBMb was then 
subjected to flash-photolysis and subsequently reacted with dioxygen. The reaction 
proceeded in a  mainly monophasic manner to obtain hemeFe(II)-O2 species and the 
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reaction was studied as a function of O2 concentration in the mixing chamber to obtain 
the second-order kon for oxygen binding as 21 mM-1 s-1 (Fig. 5.7.A (black), B and Table 
5.2). Similar experiments when conducted with F33Y-CuBMb variants with increased 
heme E° obtained kon as 48, 70 and 250 M-1 s-1 for S92A-, (MF-heme) and (DF-heme) 
variants (Table 5.2). Thus, increasing the heme E° of these HCO mimics by ~210 mV 
lead to a corresponding increase in oxygen binding rates by ~12-fold. It must be noted 
that this increase in oxygen binding rates is not a direct cause of the increased oxygen 
reduction rates of the HCO mimics with increased heme E°. This is because even F33Y-
CuBMb, the HCO mimic with lowest heme E° and subsequently lowest apparent oxygen 
reduction activity of ~0.002 s-1, exhibits extremely fast oxygen binding rates (~ 4 s-1) under 
conditions of enzymatic reaction (~200 M oxy-gen) . Thus, rate of oxygen binding is not 
rate-limiting for myoglobin-based functional oxidase. However, certain oxidases like the 
cyt. bd oxidase are present in low oxygen concentrations, so possessing a high heme E° 
with catalytic heme d may help them achieve faster oxygen binding rates.  To investigate 
the chemical reason behind the increase in oxygen binding rates with increasing heme 
E°, we look into the electron density of heme iron. As the heme E° increases, its electron 
density decreases, which in turn favors binding of ligands like oxygen and CO which are 
Figure 5.6. UV-Vis spectra of F33Y-Cu
B
Mb (A), F33Y-S92A-Cu
B
Mb (B), F33Y-Cu
B
Mb (MF 
heme) (C), F33Y-Cu
B
Mb (DF heme) (D). Ferric state under N
2
 atmosphere (black trace), 
ferrous state (blue trace) and ferrous CO-bound state (red trace). 
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electron donors to the heme iron. A survey of the different HCO types also supports this 
hypothesis as well; for example C-type HCOs with lower active site heme E° (cbb3 
oxidase) exhibits almost five times slower oxygen binding rates than A-type HCO (aa3 
oxidase).11 Moreover, an NO reductase (cNOR) that also possess a low-potential heme 
b3 in the active site and is capable of reducing oxygen to water, binds oxygen 
approximately four times slower than in aa3 oxidase.12 
Using the oxygen concentration dependence measurements (Fig. 5.7), we also extract 
the koff (intercept), value.  Interestingly, the koff rates also showed an increase as the E°’ 
is increased (Table 5.1). Thus, an increase in heme E°’ leads to a subsequent increase 
in oxygen dissociation rates as well, which can be explained by looking at the properties 
of bound oxygen to heme center. The Fe(II)-O2 (oxy-form) exists in resonance with its 
superoxo form that is Fe(III)-O2-. With increased heme E°, there is low electron density 
on the heme iron, which then pulls the electrons from bound oxygen, in turn, supporting 
the oxy-form over the superoxo-form. The dissociation of oxygen from the oxy-form of 
Figure 5.7. (A) O
2
 binding kinetics in Flow-Flash measurements at 1 mM O
2
. F33Y-Cu
B
Mb 
(black), F33Y-S92A-Cu
B
Mb (red), F33Y-Cu
B
Mb MF (green), F33Y-Cu
B
Mb DF (pink). The 
observed rate constant for oxygen binding is shown as function of the final O
2
 concentration after 
mixing for F33Y-Cu
B
Mb (A), F33Y-S92A-Cu
B
Mb (B), F33Y-Cu
B
Mb (MF heme) (C), F33Y-Cu
B
Mb 
(DF heme) (D).  
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heme is more favored than its superoxo- form. Thus, increasing the heme E°, favors the 
oxy- form over superoxo-form, which increases the oxygen dissociation rates. Finally, 
having obtained the kon and koff of the F33Y-CuBMb variants, we used the values to 
calculate their oxygen affinity (KD). Since both kon and koff are increased in the constructs 
with higher E°’, there is no clear correlation between the resulting KD values and the E°’. 
It should however be noted that the KD of the HCO mimic with lowest heme E°’ (F33Y-
CuMb) is ~3-fold higher than the HCO mimic with highest heme E°’ (with DF heme). 
Table 5.1. Variation of oxygen kon, koff and KD for F33Y-CuBMb variants 
Sample 
O2-affinity measurements CO recombination 
kon  (s-1*mM-1) koff (s-1) Kd (mM) kobs (s-1) 
F33Y-CuBMb 21 ± 2 14 ± 2 0.67 0.7 (*32/0.8) 
F33Y-S92A-CuBMb 48 ± 2 11 ± 1 0.23 2.3 (*100/2.5) 
F33Y-CuBMb (MF heme) 70 ± 20 160 ± 10 2.30 3.1 (*90/3) 
F33Y-CuBMb (DF heme) 250± 10 500 ± 9 2.00 14.8 
*(if fitted to two phases) 
5.4. Conclusion 
Overall, these results show that the HCOs have efficiently tuned their heme E° using 
different heme types and H-bonding patterns to control their electron transfer, oxygen 
binding and dissociation rates along with the electronics of bound oxygen. In fact, most 
of the HCOs exhibit high active site heme E° between 250-365 mV as it helps them 
achieve fast electron transfer rates along with fast oxygen binding , both of which are 
involved in controlling the overall HCO activity. It should be noted that for an enzyme like 
HCO, where oxygen reduction is coupled to energetically uphill proton pumping, if oxygen 
affinity is very high, part of the free energy is lost already upon binding, leaving less free 
energy for the proton pumping steps. These results not only have significant impact in 
bioenergetics but also helps us understand how Nature has efficiently fine-tuned E° for 
various metalloproteins. In particular, heme proteins exhibit a wide variety of heme E°,13 
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and understanding the reason behind the same and associated implications on their 
enzymatic activity will help us understand these proteins in greater detail. 
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Chapter 6 
Role of heme redox potential in tuning nitric oxide reduction reactivity 
Portions of this chapter are a taken from a draft of manuscript under preparation titled 
“Why do nitric oxide reductases exhibit much lower heme redox potentials than heme-
copper oxidases?” (Ambika Bhagi-Damodaran, Yelu Shi, Julian Reed, Shiliang Tian, 
Parisa Hosseinzadeh, Braddock A. Sandoval, Yong Zhang, Yi Lu) 
Abstract: We use a myoglobin-based NOR mimic to explore the reasons for its inherently 
low heme redox potentials. Using a set of systematically tuned NOR mimics, we show 
that the NORs exhibit low heme E° to avoid the formation of stable dead-end hemeFe(II)-
NO. Finally, we use this tuning of hemeFe(II)-NO reactivity and electron transfer rates to 
obtain an NOR mimic which an perform up to 30 turnovers selectively converting NO to 
N2O 
6.1. Introduction 
Nitric oxide reductases (NORs) from denitrifying bacteria catalyze the two-electron 
reduction of nitric oxide (NO) to nitrous oxide (N2O) as part of the conversion of nitrite and 
nitrate to dinitrogen gas.1,2 The NOR reaction has important significance to human health 
as it provides many pathogenic organisms with resistance to high NO concentration 
exposure, and as a whole, to the mammalian immune response.3 In particular, the  
cytochrome c-dependent NORs (cNORs) are integral membrane proteins evolutionarily 
related to the heme/copper oxidases (HCOs). They have a catalytic subunit NorB 
composed of 12 central transmembrane helices that anchor a low-spin heme b and a 
heme/nonheme diiron active site (heme b3/nonheme FeB), analogous to the heme a3/CuB 
center of HCO.4,5 The homology within the two classes of enzyme is not merely restricted 
to their structure but extends to their function as well: the HCOs and NORs exhibit cross-
reactivity, i.e. NORs can perform oxygen reduction and HCOs can perform NO 
reduction.6,7 However, it is interesting to note that the NO reduction cross-reactivity of 
HCOs is very selective. For example, caa3 and ba3 oxidase from T. thermophilus and 
cbb3 oxidase from P. Stutzeri perform selective reduction of NO to N2O, however, E. Coli 
cyt. bd oxidase and bovine CcO are inhibited in presence of nanomolar NO (Table 6.1). 
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In chapter 5, we have showed that heme E°’ can have extensive impact on enzymatic 
activity. It is interesting to note that all of the NORs that perform NO reduction cross-
reactivity exhibit heme E°’ values in the lower spectra, while bovine CcO and bd oxidase 
that exhibit higher heme E°’ values are inhibited by NO (Table 5.1). These results along 
with the low heme E°’ values of 60 mV and -162 ± 8 mV exhibited by NORs from P. 
denitrificans and P. nautica respectively led us to investigate the impact of heme E°’ on 
NO reduction reactivity. These studies are difficult, if not impossible, to conduct in native 
NORs due to their large size (MW ~ 200 KDa), membranous nature and the presence of 
multiple metal centers that makes spectroscopic investigation of the heme-nonheme 
diiron center challenging. In a complementary approach to studying native NORs, we 
have developed a structural and functional mimic of NOR in Mb called FeBMb (Fig. 6.1). 
Here, we have systematically tuned the heme E°’ of FeBMb by tuning H-bonding patterns 
Figure 6.1. Crystal structure of the catalytic center of cNOR (A) and Fe-Fe
B
Mb (B). The variation 
in the heme redox potential for HCOs and NORs. The black bar shows the heme E° values for 
FeBMb variants obtained in the study 
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around the proximal heme ligand and using different heme types. The NOR mimics, thus 
obtained, are used to investigate how heme E°’ tunes NO reduction reactivity. 
Table 6.1. Heme E°’ values of different NORs and HCOs studied till date. The ones 
highlighted in green exhibit NO reduction activity, the ones in red are inhibited by NO. 
Enzyme complex E°’ Heme b3 (mV) E°’ FeB/CuB (mV) Notes/Reference 
cNOR (P. denitrificans) 60 mV 320 mV Redox titrations8 
cNOR (P. denitrificans) 79-86 mV Not reported pH 6.5-8.59 
cNOR (P. Nautica) -162 ± 9 mV -369 ± 14 mV CV (low spin heme b3)10 
T. thermophilus caa3 
oxidase 
180 mV Not reported NO reduction cross-reactivity11 
T. thermophilus ba3 
oxidase 
199 mV Not reported NO reduction cross-reactivity12 
P. stutzeri cbb3 oxidase  -59 mV 395 mV NO reduction cross-reactivity12 
E. Coli bd oxidase 260 mV Not present NO inhibition13 
Bovine CcO 310-365 mV 400 mV NO inhibition11 
 
6.2. Materials and methods 
All chemicals, unless otherwise specified, were obtained from Sigma (St. Louis, MO) or 
Fisher Scientific (Hampton, NH). Fe(III)-incorporated non-native heme cofactors were 
purchased from  Frontier Scientific (Logan, UT). 
6.2.1. Purification of proteins and incorporation of non-native heme cofactors 
The purification of FeBMb and L89S-FeBMb and incorporation of MF-heme and DF-heme 
in FeBMb was performed exactly same as that of F33Y-CuBMb described in chapter 4.  
6.2.2. Characterization of FeBMb variants via UV-Vis spectroscopy  
Table 6.2. enlists the spectral features of oxidized and reduced forms of F33Y-CuBMb 
variants. The oxidized form of the proteins show a Soret band at 400 nm range followed 
by  and  bands in the visible region, typical of a well-folded oxidized myoglobin. 
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Extinction coefficient of the proteins was determined by hemochromogen assay where 
the wavelength maximum (in nm) and extinction coefficient (in mM-1 cm-1) used for the  
peak of heme b, MF- and DF-heme were 556 (36), 583 (28) and 587 (20.5) respectively. 
Protocols of characterization were similar to that described in chapter 4.  
Table 6.2. UV-Vis spectral features of FeBMb variants  
  ferric*  deoxy*  
 Soret vis   Soret vis 
FeBMb 
 
406 501 618 433 556 
L89S-FeBMb 
 
406 502 619 433 556 
FeBMb 
(MF-heme) 
 
422 542 656 443 585 
               FeBMb 
(DF-heme) 
430 509 662 462 575 
 
wavelength maxima reported (in nm) 
 6.2.3. Metal titration and analysis 
The Zn(II), Fe(II) FeBMb variants were prepared as described previously with slight 
modifications. Briefly, the met-form of FeBMb was degassed and transferred in anaerobic 
glovebag, where they were reduced using dithionite and exchanged with a PD10 column 
equilibrated with 50 mM Bis-TRIS buffer at pH 7.3. To obtain Zn(II) and Fe(II)-bound 
FeBMb variants, 1 equivalent (with respect to protein) each of ZnCl2 and FeCl2 solution 
was added to E- FeBMb variant respectively. Metal titrations as discussed in chapter 2 
were used to determine KD for nonheme iron at the FeB center (Fig. 6.2). The binding of 
the metal ion at the nonheme center of FeBMb was confirmed by bathochromic shifts in 
the Soret of UV-Vis spectra as can be seen in Fig. 6.2.  
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  6.2.4. Spectroelectrochemical measurements  
The reduction potential was measured by a spectroelectrochemical method using an 
optically transparent thin-layer cell (OTTLE). The working electrode was made from a 
piece of 52 mesh platinum gauze. A 1 mm diameter platinum wire was used as the 
auxiliary electrode, while a piece of Pasteur pipet filled with agar gel containing 0.2 M KCl 
was used a salt bridge to connect the Ag/AgCl (3 M KCl) reference electrode to the bulk 
solution containing the working and auxiliary electrodes. Generally, the redox titration was 
performed using ~ 0.6 mL of working solution containing 0.2 mM protein, 40 mM 
phenazine methosulfate, 40 mM anthraquinone-2-sulfonate, and 20 mM N,N,N',N'-
tetramethyl-p-phenylenediamine (TMPD) as redox mediators in 50 mM Bis-TRIS buffer, 
pH7.3, 100 mM KCl. The working solution was purged gently with Argon before 
transferring to the OTTLE cell. A model 362 potentiostat from Princeton Applied Research 
was used to control the potential of working electrode. After the potential was applied 
(typically with 25 mV increments), the UV-vis spectra were recorded using a Cary 3E 
spectrophotometer until no further spectral changes occurred. The Ag/AgCl (3M KCl) 
reference electrode was calibrated using ferrocene carboxylic acid as the standard and 
was found to be 220 mV versus NHE. All reduction potentials mentioned in this work are 
Figure 6.2. (A)Spectra of deoxy-Fe
B
Mb (DF-heme) (black) and after 5 eq. Fe(II) addition (B) 
The difference spectra on Fe(II) titration to deoxy-Fe
B
Mb (DF-heme) (black) and (C) the A 
plotted against concentration of Fe(II) added to obtain K
D
 
99 
 
reported against NHE. The system was calibrated using WT Mb; the measured Eº of 61 
± 2 matched closely to reported literature values.14 
6.2.5. Data analysis for spectroelectrochemical measurements 
The spectroelectrochemical titration data over the entire spectra were analyzed by global 
analysis using singular value decomposition (SVD) and nonlinear regression modeling 
with SpecFit/32 (Spectrum Software Associates, Inc.) using a method followed 
previously.15 All of the data were fit with a model of A ↔ B as the Nernst plot at a single 
wavelength gave a straight line fit with n (no. of electrons transferred) value close to 1. 
6.2.6. X-ray crystallography 
Crystals of L89S-FeBMb were set up and grown at 4ºC on hanging drops containing 0.1M 
MES pH 6.57, 0.2M NaOAC.3H2O, 30% PEG 6K as well buffer. Drops contained an equal 
volume of 1 mM S92A-F33Y-CuBMb in 20 mM TRIS.H2SO4 pH 8 and the well buffer. Prior 
to mounting, the S92A-F33Y-CuBMb crystals were soaked in buffer containing 0.1M MES 
pH 6.0, 0.2M NaOAC.3H2O, 30% PEG 6K for ~ 30 min and then frozen in a cryoprotectant 
solution of 50 mM MES pH 6.0, and 30% PEG 400.  Diffraction data were collected at the 
Brookhaven National Lab Synchrotron Light Source x29 beamline. The crystal structure 
was solved using the same method as for F33Y-CuBMb.16 
6.2.7. Electron transfer rate measurements 
Experiments were performed on a Hewlett-Packard 8453 spectrometer. A water bath, 
connected to the cuvette holder and set to 25ºC, provided temperature control. Briefly, 6 
M of met-FeBMb variant was mixed with 3 molar equivalent of ZnCl2 to obtain Zn(II)-
bound variant in 50 mM Bis-TRIS pH 7.3. The reaction was initiated by mixing 300x TMPD 
and 3000x ascorbate to the protein mixture, and kinetics recorded for ~ 8 hrs.  
6.2.8.   NO reduction reaction under single-turnover conditions 
Experiments were performed on a Hewlett-Packard 8453 spectrometer. A water bath, 
connected to the cuvette holder and set to 25ºC, provided temperature control. The 
reaction was initiated by mixing 6 M of reduced Fe(II) added-FeBMb variant with 17 molar 
equivalent of proli-NONOate. The kinetics of the reaction was recorded for ~ 1 hr. 
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6.2.9. GC-MS experiments for NO reduction under multi-turnover conditions 
The product of the reaction of Fe(II)-FeBMb variants with NO was investigated by GC/MS 
through ESI (electrospray ionization) mass spectra as described previously. Typically, ~ 
0.2 mM, ~0.5 mL of protein was mixed with ~50 equivalents of NO in presence of 300x 
TMPD and 3000x ascorbate.  
6.2.10. NO electrode reactions under multi-turnover conditions 
The NO consumption rates were measured with an ISO-NO electrode equipped with ISO-
NO Mark II (World Precision Instruments) in a 2-mL anaerobic reaction chamber at 25 °C. 
The data were recorded on a Duo 18 (World Precision Instruments). The assay solution 
contained 50 mM Bis-TRIS, pH 7.3, 3 mM ascorbate and 0.3 mM N,N,N′,N′-tetramethyl-
p-phenylenediamine (TMPD). After 20 min of Argon flux, proli-NONOate was added to 
the reaction mix at a final concentration of ∼50 μM. Once the background consumption 
of NO was stable, NO reduction (consumption) was initiated by the addition of FeBMb 
(final concentration was 1 μM).  
6.3. Results and discussion 
6.3.1. Tuning heme E°’ of NOR mimic in Mb 
 The heme E°’ of Fe(II)-FeBMb was measured as -59 ± 8 mV which was in between the 
heme E°’ of NORs from P. denitrificans (70 mV) and P. Nautica (-163 mV). In order to 
Figure 6.3. (A) Crystal structure of L89S-Fe
B
Mb showing H-bonding interactions on the 
proximal heme side. (B) Redox potential tuning of Fe
B
Mb variants. 
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cover the heme E°’ value of NORs, we had to both decrease and increase the heme E°’ 
value. Building up from our previous studies where decreasing H-bonding to proximal 
histidine (S92A mutation) increased the heme E°’ by 27 mV, we decided to increase H-
bonding to the proximal histidine to decrease the heme E°’ values. L89 was chosen for 
its proximity to His 92 and was mutated to Ser. The 1.7 Å crystal structure of resulting 
mutant L89S-FeBMb showed this mutation not only increased H-bonding to proximal 
His92 but also brought an extra water molecule close to the heme iron (Fig. 6.3A). Due 
to a cooperativity of both of these effects, the Fe(II)-L89S-FeBMb exhibited ~60 mV lower 
heme E°’ of -130 ± 2 mV (Fig. 6.3B). To increase the heme E°’ of Fe(II)-FeBMb, we 
incorporated MF-heme and DF-heme in apo-FeBMb. Both variants were previously shown 
to increase the heme E°’ by ~100 and ~200 mV respectively. Similar increase was seen 
here as well, with Fe(II)-FeBMb (MF-heme) and Fe(II)-FeBMb (DF-heme) exhibiting a 
heme E°’ value of 53 ± 2 mV and 148 ± 2 mV respectively. The resulting FeBMb variants 
cover the entire range of heme E°’ values reported for NORs (-163 to 60 mV) and go 
beyond those as well (Fig 6.1). 
6.3.2. Single-turnover NO reduction in Fe(II)-FeBMb and electron transfer rates to 
Zn(II)-FeBMb 
 The NO reduction reaction with Fe(II)-FeBMb were investigated under single-turnover 
conditions previously  using stopped-flow kinetics and resonance Raman vibrational 
measurements. The studies revealed that the heme spectra transitioned in A (red)  B 
(purple)  C (green) form (Fig. 6.4A-B). The red species was the reduced deoxy Fe(II)-
FeBMb, while the purple was hemeFe(II)-NO species. The green species was the oxidized 
ferric heme species. Thus, by following the B  C spectra, the rate of hemeFe(II)-NO 
decay and N-N coupling to form N2O can be determined. These experiments when 
performed for L89S-FeBMb, FeBMb, FeBMb (MF-heme) and FeBMb (DF-heme) resulted 
in hemeFe(II)-NO decay rate of 1.9/s, 0.4 /s, 0.03 /s and 0.003 /s respectively (Fig. 6.4C). 
Thus, increasing the heme E°’ value in NOR mimics lead to an exponential decrease in 
N-N coupling rates. The electron transfer rates measured for Zn(II)-bound L89S-FeBMb, 
FeBMb, FeBMb (MF-heme) and FeBMb (DF-heme) on the other hand increased 
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exponentially with increasing heme E°’ as is to be expected as the driving force for 
electron transfer from the redox mediator (TMPD with E°’ of 265 mV) increases as per 
the Marcus theory.  
6.3.3. DFT studies on NO bound heme variants with increased heme E°’ values 
 We reasoned that the increasing the heme E°’ of FeBMb will decrease the electron 
density on heme iron and, in turn, decrease the electron density on NO bound to heme 
which may impact the N-N bond coupling rates as seen in section 6.3.2. To probe if that 
was the case, we ran DFT simulations on His and NO-bound heme, MF-heme and DF-
hemes (Fig. 6.5). The results showed that the electron density on NO indeed decreased 
with increasing heme E°’ with electron density of -0.315, -0.298, -0.281e on bound NO of 
heme, MF-heme and DF-heme respectively.  These results show that NORs exhibit low 
heme E°’ values to control the electron density on heme bound NO since bound NO with 
low electron density will tend to have lower chances of reductive N-N coupling as 
observed for NORs. These results also explain why HCOs with high heme E°’ are 
inhibited by NO. Spectroscopic studies on NO inhibited bovine CcO (under low oxygen 
Figure 6.4. (A) The spectra of Fe-Fe
B
Mb on reaction with 17 eq. NO. (B) The scheme of NO 
reduction by Fe(II)-Fe
B
Mb. (C) Variation of electron transfer rates and heme-NO decay rates with 
heme redox potential. 
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conditions) reveal the formation of very stable heme–NO complex consistent with our 
predicted results.  
 
 6.3.4. NO reduction assays under multi-turnover conditions 
 Fig. 6.4 shows that using heme E°’ the NO reduction and electron transfer rates can be 
modulated. The FeBMb does not show any NO reduction turnovers probably because of 
its extremely low heme E°’ due to which it cannot accept any electrons from the redox 
mediator TMPD (E°’ = 260 mV). We reasoned that FeBMb (MF-heme) with higher heme 
E°’ and resulting higher electron transfer rates will be able to perform NO reduction 
turnovers. Thus, the reaction of Fe(II)-FeBMb and Fe(II)-FeBMb (MF-heme) were 
performed using GC-MS under turnover conditions. Fe(II)-FeBMb (MF-heme) consumed 
all of the NO in the reaction chamber in less than 3 hrs with increasing amounts of N2O 
produced and underwent ~35 turnovers under reaction conditions. The amount of N2O 
produced when compared shows that Fe(II)-FeBMb (MF-heme) is much more efficient at  
catalyzing NO reduction than Fe(II)-FeBMb. The reaction of Fe(II)-FeBMb (MF-heme) 
when performed on an NO electrode showed ~24 turnovers and an initial rate 
corresponding to 1.13 M NO consumed/M protein/s.  Fe(II)-FeBMb (MF-heme) is the 
first NOR mimic that performs selective NO reduction and turnovers (Fig. 6.6.). 
Figure 6.5. DFT optimized structures of NO bound forms of heme (left), MF-heme(center) 
and DF-heme (right) 
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6.4. Conclusion 
By using a model system of NOR mimics with systematically tuned heme E°’ in an NOR 
mimic, we show that E°’ is efficiently modulated in NORs to control their electron transfer 
and NO reduction rates. The NORs typically exhibit a low heme E°’ value to maintain low 
electron density on NO bound on heme such that N-N coupling to produce N2O can take 
place. Hence, bovine CcO with extremely high E°’ values of 365 mV binds and gets 
inhibited by nanomolar concentrations of NO. Finally by tuning NO reduction and electron 
transfer rates, we show that Fe(II)-FeBMb (MF-heme) with heme E°’ close to that of P. 
denitrificans can selectively reduce NO to N2O and perform up to 24 turnovers. 
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Figure 6.6. (A) GC-MS analysis of NO reduction by Fe
B
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Fe
B
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B
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Chapter 7 
Investigating the oxygen reduction mechanism of a myoglobin-based nitric oxide 
reductase 
Abstract: The mechanism of oxygen reduction to water by a myoglobin-based nitric oxide 
reductase (NOR) mimic consisting of a high-spin heme-nonheme diiron center is 
investigated via UV-Vis, EPR, resonance Raman and Mössbauer spectroscopies. The 
results suggest the binding of O2 initially to nonheme iron followed by the formation of a 
-peroxo diiron intermediate. The activated oxygen in the peroxo- form then undergoes a 
heterolytic cleavage, accepts two electrons from heme to obtain heme compound I, which 
ultimately accepts electrons from the protein to form a stable -oxo diiron species ready 
to accept electrons from the donor and perform another turnover of oxygen reduction. 
Overall, these results suggest that the NOR follows an analogues pathway to HCOs for 
oxygen reduction. 
7.1. Introduction 
P. denitrificans NOR and closely related enzymes from Paracoccus pantotrophus and 
Paracoccus halodenitrificans catalyze the complete reduction of oxygen to water with 
Figure 7.1. The putative mechanism of oxygen reduction by HCOs going through a heme 
compound I-like species 
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turnover numbers on the order of 2-10 electron s-1.1,2  Although, it is not clear how 
widespread the ability to reduce oxygen is among the bacterial NORs, studies of mutant 
forms of P. denitrificans NOR have shown that the O2- and NO-reduction activities are 
well correlated.3 An amino acid substitution affecting the rate of NO reduction similarly 
influences the rate of O2 reduction, showing that the same catalytic components are 
involved in both processes. Thus, it is interesting to note that an enzyme whose prime 
function is to perform the two-electron reduction of NO to N2O can also perform four-
electron reduction of O2 to H2O, albeit with lower efficiency and rates. This begets two 
important questions: (1) where does the two extra electrons for the reduction of oxygen 
come from? and (2) what is the mechanism of oxygen reduction in NORs. The reduction 
of oxygen at the NOR catalytic center can take place through two mechanisms: (1) 
Homolytic cleavage of oxygen, wherein the oxygen molecule receives two electrons from 
heme and nonheme iron each and (2) Heterolytic cleavage of oxygen similar to HCOs  
(Fig. 7.1), where the oxygen molecule receives three electrons from heme and one from 
nonheme iron.4,5 Which of these mechanisms does reduction of oxygen happens through 
can be determined by probing the intermediates of reaction. Homolytic cleavage is 
characterized by formation of heme and nonheme bis ferryl intermediate, while the 
heterolytic cleavage is characterized by the formation of heme compound I with a ferryl 
and cation radical on heme.6-8  
In this chapter, we probe the oxygen reduction mechanism of a Mb-based NOR mimic 
(FeBMb) via several time-resolved spectroscopic methods including UV-Vis, EPR, 
resonance Raman and Mössbauer. The observation and complete characterization of 
heme compound I for the first-time establishes the mechanism of oxygen reduction in 
NOR to be heterolytic cleavage of O-O bond. At the same time, we are obtain clues for 
several other intermediates during the reaction including nonhemeFe(II)-O2 and -peroxo 
diiron. Finally, we obtain strong evidence for the end product to be -oxo diiron species 
similar to the resting state of cNOR. 
7.2. Materials and methods 
All chemicals, unless otherwise specified, were obtained from Sigma (St. Louis, MO) or 
Fisher Scientific (Hampton, NH). 
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7.2.1. Purification of proteins 
FeBMb was expressed and purified as reported previously.9 Final yield of the protein was 
~ 40 mg/L. To obtain heme(57Fe) enriched 57FeBMb, similar method was employed except 
that 20 mg of heme(57Fe) was added to 75 mg cyanide during heme incorporation steps.   
7.2.2. Characterization of FeBMb via UV-Vis spectroscopy  
UV-vis data were collected on a Hewlett-Packard 8453 spectrometer. Table 7.1. enlists 
the spectral features of oxidized and reduced forms of FeBMb and 57FeBMb utilized in this 
work. The oxidized form of the proteins show a Soret band at 400 nm range followed by 
 and  bands in the visible region, typical of a well-folded met-myoglobin.10 Extinction 
coefficient of the proteins was determined by hemochromogen assay where the 
wavelength maximum (in nm) and extinction coefficient in used for the  peak of heme b 
was 556 and 36.5 mM-1 cm-1 respectively.  
 
Table 7.1. UV-Vis spectral features of FeBMb   
  ferric*  deoxy*  
 Soret vis   Soret Vis 
FeBMb 406 501 618 432 556 
57FeBMb 406 501 618 432 556 
 
*wavelength maxima reported (in nm) 
 
7.2.3. Metal titration and analysis 
The Fe(II) bound FeBMb variants were prepared as described in Chapter 6. To prepare 
57Fe-FeBMb, 57FeCl2 was used. The preparation of 57FeCl2 was performed as described 
below:  57FeCl2 was synthesized inside the glove bag using the following procedure: 300 
mL of DI H2O and 1 mL of 9.14% methanolic HCl (285.6 L of 32% HCl + 714.4 L 
methanol) was degassed and transferred into the glove bag. 25 mg 57Fe metal (0.44 
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mmol) (Cambridge Isotope Lab) was taken in a small dry NMR tube and transferred into 
the glove bag. The degassed water was transferred into a small water bath and heated 
to ~60 °C using a hot plate equipped with a stir bar. The NMR tube containing 57Fe was 
immersed into the water bath and 350 L of the 9.14% methanolic HCl (0.88 mmol) was 
added into the tube. H2 evolution started immediately. The reaction was allowed to 
proceed for 3-4 hours until the gas evolution ceased. The solution was carefully 
transferred into a tared Schlenk flask with adaptor. The Schlenk flask was removed from 
the bag and immersed in dry ice/ethanol slush bath, and slowly opened to vacuum in a 
Schlenk line. The flask was then slowly warmed to 100°C using a water bath while in 
vacuum. After the solvent evaporated and the solid turned from green to white, the water 
bath was replaced with an oil bath and heated to 160°C, allowing the residual methanol 
to evaporate. The product was cooled to room temperature slowly, purged with Ar, sealed 
and weighed. The yield of 57FeCl2 was ~65%. 
7.2.4. UV-Vis stopped flow kinetic studies 
Experiments were performed on an Applied Photophysics Ltd. (Leatherhead, U.K.) 
SX18.MV stopped-flow spectrometer equipped with a 256 element photodiode array 
detector. Two-syringe mixing was employed to mix equal volumes of Fe(II)-FeBMb with 
volumetrically prepared oxygen saturated solutions. All reported data sets originally 
consisted of 200 spectra collected over 50 s using logarithmic sampling. The integration 
period and minimum sampling period were both 1 ms. A water bath, connected to the 
syringe compartment and set to 4ºC, provided temperature control. The actual 
temperature in the syringe compartment was measured to be between 6.3 and 6.5ºC. 
The instrument was prepared for anaerobic stopped-flow by rinsing its lines out several 
times with buffer that had been degassed by bubbling argon gas through it. Special glass 
outer syringes fit with Teflon stoppers into which an argon line was run maintained an 
oxygen free environment. The protein was degassed prepared in an anaerobic glovebag 
as described before. The oxygen saturated solutions were degassed on the Schlenk line 
followed by bubbling with argon gas for 20 min in containers with only a small opening, to 
allow gases to escape. 
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7.2.5. Rapid-freeze quench experiments  
Rapid-freeze quench (RFQ) experiments were used to obtain oxygen reduction 
intermediates with a few milliseconds to 2 second freezing time. Detailed procedure for 
the preparation of RFQ samples have been described previously.11 Briefly, solutions of 
Fe(II)-FeBMb at 0.6-1 mM  in 50 mM Bis-TRIS, pH 7.0, were loaded in RFQ glass syringes 
inside an anaerobic glovebox (Omnilab System,. Vacuum Atmospheres Co.). O2 
saturated buffer solutions were prepared by injecting 7 mL of 16O2 or 18O2 gas in 10-mL 
serum bottles containing 2.5 mL of degassed buffer and loaded in RFQ syringes after ~1 
h incubation. Two syringes were mounted to the System 1000 Chemical/Freeze Quench 
Apparatus (Update Instruments) and immersed in a water bath at 4 °C. Reaction times 
were controlled by adjusting the displacement rate and the length of the reactor. For RFQ 
time points in the millisecond scale, a total of 250 μL of mixed solution was sprayed from 
the exit nozzle to a glass funnel connected with NMR tubes and filled with liquid ethane 
at -120 °C. Samples with reaction time on the second scale were injected directly inside 
the NMR tube before rapid freezing in liquid ethane. For the removal of the cryosolvent, 
samples were incubated at -80°C for 2 hours. 
7.2.6. EPR data collection 
X-band EPR spectra were collected on a Varian E-122 spectrometer at the Illinois EPR 
Research Center (IERC). The samples were run at ∼30 K using liquid He and an Air 
Products Helitran cryostat with 20% glycerol. Magnetic fields were calibrated with a 
Varian NMR gaussmeter, and the frequencies were measured with an EIP frequency 
counter. 
7.2.7. Resonance Raman and Mössbauer data collection 
The RR spectra were obtained with a 407 nm excitation from a Kr laser (Innova 302C, 
Coherent) using a custom McPherson 2061/207 spectrograph equipped with a liquid-
nitrogen cooled CCD detector (LN-1100PB, Princeton Instruments). A long-pass filter 
(RazorEdge, Semrock) was used to attenuate Rayleigh scattering. Measurements were 
performed in a backscattering geometry with the samples maintained at 110 K inside a 
liquid N2 cooled sample holder and with the laser focused on the sample with a cylindrical 
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lens. The photosensitivity of each sample was evaluated by collecting short spectral 
acquisition with low laser power and spinning the NMR tube and comparing the porphyrin 
skeletal modes in the high-frequency region. The frequencies were calibrated relative to 
aspirin and are accurate to ±1 cm-1. 
Mössbauer data collection was performed as explained previously.12  
7.3. Results and discussion 
7.3.1. Time-resolved UV-Vis studies of oxygen reduction by FeBMb and specfit 
analysis 
The reaction of 30 M reduced Fe(II)-FeBMb with oxygen saturated solution is shown in 
Fig. 7.2. The reduced Fe(II)-FeBMb showing a Soret at 434 nm and split visible bands at 
549 and 576 nm (blue species) spontaneously reacts with oxygen to obtain an end-
product with a Soret at 406 nm and multiple visible bands (red species). While the Soret 
at 406 nm indicates that the end-product is hemeFe(III), the low extinction coefficient at 
Figure 7.2. Time-resolved UV-Vis studies of the reaction of Fe-FeBMb with oxygen 
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Soret along with the presence of multiple bands in the visible region suggests the 
formation of a second species.     
The evolution of this spectra was determined via specfit analysis, which fits the data in 
A B  C  D kinetics. The kinetic parameters of the fit and spectra of A,B,C and D 
species are shown in Fig. 7.3. A is assigned as the reduced ferrous form of the protein 
and D some mixture of oxidized ferric form. B shows a Soret peak centered at 426 nm 
and attenuated visible peaks in comparison with A. The spectral properties of A fit very 
well with that of peroxy bound heme in WTMb (Soret at 428 nm and attenuated visible 
bands) suggesting B to be peroxy bound Fe-FeBMb where both heme and nonheme iron 
are present in ferric forms.13 Further support to this observation comes from kinetics: A 
 B conversion takes place at the rate of 1.2/s comparable to the rate of oxygen binding 
to the heme center in Zn(II)-FeBMb (~2/s). Species B then converts to a species C at rates 
of 0.35/s with Soret at 412 nm and a peak at 670 nm which is more clearly visible when 
the reaction is performed with ~ 0.2 mM of enzyme (Fig. 7.3B). This peak at 670 nm peak 
in species C is very typical of a heme compound I species with a Fe(IV)=O moiety and a 
cation radical on porphyrin ring. Finally, the species C decays to form species D, the 
oxidized ferric form of the enzyme at the rate of 0.03/s.  
Figure 7.3. (A) Specfit analysis of the reaction between Fe-FeBMb and oxygen (B) Inset showing 
the formation of 669 nm intermediate at 0.2 mM (C) Evolution of species A,B,C,D with time. 
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7.3.2. EPR measurements of oxygen reduction intermediates by FeBMb  
To further characterize the oxygen reduction intermediates with FeBMb, we quenched the 
reaction of 0.2 mM Fe-FeBMb with oxygen saturated buffer at different time points (Fig. 
7.4A). We began with reduced Fe(II)-FeBMb at 0s which contained spin-silent hemeFe(II) 
and nonhemeFe(II) and showed no EPR signal. The free-quenched sample at 0.25 s 
started showing signals at ~g=6 corresponding to oxidized ferric protein. At 3s (which 
corresponded to species C in UV-Vis experiments) we saw a huge signal at g=2.06. This 
transient signal then decayed in 30s and finally at 300 s, we saw ferric form of high-spin 
iron which signal at g=6. The huge radical signal obtained at g=2.06 for species C was 
further characterized at various power values (Fig. 7.4B). At high power (~40 dB) and low 
temperatures, when we expect the impurity signals to be minimal, the g=2.06 signal 
resembled that of cation porphyrin radical in heme compound I seen for His ligated 
ascorbate peroxidase.14 Further evidence for the observance of heme compound I comes 
from the power saturation experiments at different temperatures (Fig. 7.4C). The g=2.06 
signal of species C only saturates at temperature below 5 K suggesting that the radical is 
associated with a metal ion as would be expected for a heme compound I species.   
 
 
Figure 7.4. (A) Time-resolved EPR spectra of the reaction between Fe-FeBMb and oxygen, 
Data is collected at 30 K (B) The variation of g=2.06 radical with power reported in DB at 5K (C) 
Power saturation experiments with g=2.06 radical. 
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7.3.3. Resonance Raman (RR) measurements of oxygen reduction intermediates by 
FeBMb 
The RR spectra of the ms-RFQ samples retained strong contributions from the 5-
coordinate high-spin ferrous heme which suggests that an initial reaction of O2 takes place 
with the nonheme FeB(II) site without effect on the heme iron(II) spectroscopic signatures 
(Fig. 7.5B). The v4 from the ferrous heme at 1354 cm-1 is slowly replaced by a new band 
at 1370       cm-1 characteristic of a ferric heme; other porphyrin skeletal modes gaining 
intensity with increasing RFQ times can be isolated from contributions from the starting 
ferrous modes using difference spectra (e.g.: green trace in figure below 130-ms RFQ 
spectrum minus 20-ms RFQ spectrum). Emerging sets of v3, v2 and v10 modes at 
1482/1508, 1563/1583, and 1615/1644 cm-1, respectively, are indicative of a 6-coordinate 
ferric heme species in a high-spin/low-spin admixture suggesting the formation of heme 
iron(III) with His/aqua axial ligands. Longer RFQ times (bottom trace is 30-s RFQ) show 
new porphyrin vibrations at 1490, 1576 and 1625 cm-1 which are consistent with v3, v2, 
and v10 modes from a 5-coordinate high-spin heme iron(III). None of the RFQ samples 
Figure 7.5. (A) Time-resolved RR spectra of the reaction between Fe-FeBMb and oxygen, 
Data is collected at 77 K (B) The low frequency RR spectra of 30s end-product. 
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show 16O2/18O2-isotope sensitive modes, but the 30-s RFQ samples show a band at 841 
cm-1 which is strongly resonance enhanced with 442-nm excitation, and that shifts to 804 
cm-1 when exposed to 18OH2. The 841 cm-1 band is assigned to a vas(Fe-O-Fe) mode and 
clearly identifies the final state as a -oxo bridged diferric complex (Fig. 7.5A). 
7.3.4. Mössbauer measurements of oxygen reduction intermediates by FeBMb 
Further insights on the reaction of FeBMb with oxygen were obtained by freeze-quenching 
the oxygen reduction reaction of 0.5 mM Fe-FeBMb with 1.9 mM oxygen saturated buffer 
at different time points of 4 ms, 300 ms, 1.3 s and 5 s (Fig. 7.6). To look at the heme iron 
specifically, it was enriched with Fe57. The 4 ms spectra looked very similar to the 0 s 
spectra and there was no observed change in the 57FeBMb signal. The O2 binding to heme 
iron would have a recognizable change in the Mössbauer spectra of heme iron. This is 
consistent with the RR results which also show very slow oxygen binding to heme iron. 
At 300 ms, 50% of the total iron is still present as Fe(II)heme and slowly appearing at 300 
ms is a doublet with parameters consistent with Fe(III) heme (δ = 0.4 mm/s, ΔEq = 0.6 
mm/s). A Fe(III) doublet at 4.2 K indicates electronic coupling with another species, most 
likely the nonheme iron in the Fe(III) state. We call this species Fe(III) dimer and it could 
Figure 7.6. (A) Time-resolved Mossbauer spectra of the reaction between Fe-FeBMb and 
oxygen (B) The 300 ms spectra when compared with oxidized control exhibits ~15% compound 
I-like species. 
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potentially be -oxo-diiron species, however, more results are required to prove this. At 
this stage, we call this species as “Fe(III) dimer”. This Fe(III) dimer grows in intensity as 
the Fe(II)heme signal decays. At 1.3 s, there is 45% Fe(II)heme and 40% Fe(III) dimer. 
By 5s, the Fe(II)heme signal decays to 20% of total Fe, and the Fe(III) dimer represents 
60% of the total Fe. Some evidence for a Compound I-like species was obtained in the 
300 ms quenched sample. A Compound I species uncoupled from the nonheme Fe would 
be S = 1/2, and show a paramagnetic Mössbauer signal at 4.2 K. This would be difficult 
to see. At 100 K, any paramagnetic spectrum should collapse to a doublet due to spin 
relaxation. The 100 K spectrum shows the hint of a doublet with parameters somewhat 
consistent with other Compound I species, with 0.05 < δ < 0.15 mm/s, 1.7 < ΔEq < 2.1 
mm/s. This species represents 15% of the total iron, and is just at the limits of instrument 
sensitivity. 
7.3.5. Mechanism of oxygen reduction in FeBMb  
The UV-Vis, EPR, rR and Mössbauer results on oxygen reduction Fe(II)-FeBMb when put 
together suggest the mechanism as shown in Fig. 7.7. The oxygen comes and binds 
initially to nonheme iron (FeB). The oxygen-bound nonheme Fe(II) will have very 
characteristic EPR and Mössbauer signals which we are currently probing. The nonheme 
iron bound oxygen then interacts with the heme iron to form -peroxy diiron species as 
seen by UV-Vis experiments. Further confirmation of -peroxy diiron intermediate could 
not be performed as this species is very reactive and has been captured and 
characterized in Mb only via pulse-radiolysis in cryogenic temperatures. The -peroxy 
diiron species then undergoes a heterolytic cleavage of O-O bond to obtain the heme 
compound I which has been characterized by UV-Vis, EPR and Mössbauer spectroscopy. 
Finally, the heme compound I accepts electrons potentially from the protein backbone to 
obtain a stable -oxo diiron species as ascertained by rR experiments.  
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7.4. Conclusion 
Here, we present the first complete study of the oxygen reduction reaction of an NOR 
mimic. It is interesting to find out that the mechanism is highly analogues to that of HCOs 
with oxygen first binding at the nonheme metal, followed by heterolytic cleavage of O-O 
bond for the formation of compound I species. These results suggests that HCOs and 
NORs follow very similar mechanism for oxygen reduction and shows how Nature uses 
similar mechanism even for different catalytic centers.  
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Chapter 8 
Role of distal pocket mutations on complete reduction of oxygen by an engineered 
myoglobin 
Portions of this chapter are a taken from the final draft of a manuscript in preparation as 
“The Role of Distal Pocket Mutation on Complete Reduction of Oxygen by Engineered 
Myoglobin” (Arnab Mukherjee, Ambika Bhagi-Damodaran, Kyle D. Miner, Igor D. Petrik, 
Yi Lu) 
Abstract: Two functional models of heme-copper oxidase (HCO) have been designed in 
a small O2 binding protein, myoglobin. These robust models, triple mutant myoglobin, 
show efficient four electron reduction of O2 to water with more than a 1000 turnovers. A 
newly introduced active site tyrosine played a significant role in these mutants like native 
system. Cu2+ independent activity in the HCO mimics indicates a novel mechanism which 
is different from native HCO systems. In this work, we have tried to understand the 
designed HCO mimcs systematically by probing the activities and product distribution of 
all possible single and double mutants, which finally construct the triple mutant HCO 
mimics: F33Y-CuBMb and G65Y-CuBMb. Towards this goal we have made 4 single 
mutations (F33Y, F43H, L29H, G65Y Mb) and 4 double mutants (F33YF43H, F33YL29H, 
G65YL29H, G65YF43H) of wild type myoglobin. O2 reduction activity accompanied by 
the spectroscopic studies of these mutants suggest that the newly introduced histidines 
are key requirement towards the metal independent-novel O2 reduction activity. 
Interactions between distal pocket hydrogen bonding network and heme iron bound 
fluoride in all mutants indicate very different role of individual distal pocket mutation on O-
O bond cleavage. Our result indicates that tyrosine alone hardly plays any role in O-O 
bond cleavage, however a dramatic influence of the same has been observed in final 
triple mutants in the presence of active site histidines (His43 and His29). This study also 
shows how multiple protonation on Fe-OO• increases chance of O-O bond cleavage 
predicted previously for native system by many theoretical studies.   
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8.1. Introduction 
Designing the functional active site of complex metalloproteins in small protein scaffold is 
becoming a demanding area of protein engineering to resolve the kinetic complexity of 
large multifunctional protein. Very often these proteins involve in multiple reactions 
together operated by similar cofactors and cause lot of interference in the investigation of 
a particular reaction mechanism.  Many groups have recently focused on rational 
designing of individual reaction center in small proteins scaffold to unwind the basic 
requirements of complicated reactions involved in life cycle. This approach in one way 
will enhance our knowledge about inner complicated networking of enzymes and on the 
other hand allows us to make tailor made enzymes for biotechnological application. Using 
current development of molecular and computational biology a substantial research has 
been going on towards making artificial enzymes with complex structure, high activity and 
multiple turnovers 1-4.  
A part of our laboratory focusing on designing functional protein which is capable of 
reducing O2 to water with minimum production of reactive oxygen species similar in 
terminal oxidases 5-7. These terminal oxidases (respiratory oxygen reductase) regulate 
the oxidation of respiratory substrate accompanied with eventual reduction of O2 to water. 
This reduction of O2 to water creates a proton gradient across the membrane and 
develops a trans-membrane electrochemical potential which ultimately is used for ATP 
synthesis controlled by an enzyme called ATP synthase 8-10. These respiratory terminal 
reductases are divided mainly in to three categories primarily based on their structure, 
origin and substrate they oxidize; heme copper oxidases (HCOs), alternative oxidase 
(AOX) and cytochrome bd oxidase 11. Surprisingly, the O2 reduction active site structures 
vary considerably from one class to another maintaining high O2 reduction reactivity. 
HCOs contain a binuclear O2 reduction active site composed of a high spin heme iron (a3, 
o3, or b3) and a copper ligated to three histidines (referred to as CuB), one of which is 
crosslinked to a tyrosine residue 12-14. Whereas, alternative oxidase family contains a 
nonheme diiron carboxylate active site as an O2 reduction site 15. The third type, bd 
oxidase family, shows no sequence homology with other two and contains three hemes 
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(b558, b559, d) two of them (b559, d) are believed to form a di-heme site to reduce O2 to 
water 11.  
 A substantial amount of work has been directed towards synthesizing less complicated 
bioinorganic models of HCOs containing heme-copper binuclear center 17-19.  Very 
recently Karlin and Solomon groups successfully demonstrated the role of copper and 
His-Tyr crosslink in synthetic model system 20,21. These synthetic models are  useful in 
answering  questions about the structure and mechanism of the native protein but are not  
an ideal approach to duplicate natural reactivity as synthetic models are prepared using 
small organic molecules in organic solvents and it is often difficult to  duplicate long-range, 
non-covalent interactions and hydrogen bonding networks in them, which have been 
shown to be important for HCOs function 22. In our laboratory, we use native protein 
scaffold to model proteins mainly due to its capability of having similar stability and 
maintaining similar folding pattern after several mutation which helps us to incorporate 
metal binding sites, different channels and many other active site configurations. It is also 
Figure 8.1. Active site configuration of  A) Wild type (crystal stucture), B) F33Y-Cu
B
Mb (Crystal 
Sturcture), C) G65Y-Cu
B
Mb (computer model), D) F33Y Cu
B
Mb crystal structure showing 
prosition of 3 histidines from surface.   
 122 
 
comparatively easier to get crystal when we use native protein scaffold 23. Moreover 
Nature uses similar method to design new proteins with novel activity through evolution. 
In a similar approach we have been trying to incorporate the 4 electron O2 reduction 
activity of respiratory terminal reductases, following active site structural requirement of 
HCOs in a small protein sperm whale myoglobin (Mb), which mostly participates in one 
electron reduction of O2 in the presence of exogenous reductant via autooxidation. This 
work had been started with the introduction of two histidines (F43H and L29H) at the distal 
site of heme in WTswMb 24 to create a metal binding site resembling heme copper 
oxidases. This new mutant (named as CuBMb) was purified as copper free form and could 
bind Cu(II) with x uM affinity as demonstrated by UV-Vis spectroscopy, EPR and 
crystallographic studies 25-27. In second generation, we introduced a tyrosine residue in 
CuBMb through F33Y or G65Y mutation, close to copper binding site, considering the 
requirement of tyrosine in HCO towards oxygen reduction. These two new tyrosine 
containing mutants were named as F33Y-CuBMb (tyrosine at 33 position) and G65Y- 
CuBMb (tyrosine at 65 position Fig. 8.1.).  To avoid the repetition or for simplicity we also 
mentioned them as CuBMb mutants or tyrosine containing CuBMb mutants in some places 
in manuscript. In our very recent work 26 we have demonstrated that the presence and 
position of tyrosine dramatically enhances the  rate of O2 reduction and the selectivity of 
product. These tyrosine containing mutants are capable of cleanly reducing oxygen to 
water with minimal release of superoxide or peroxide, similar to the activity of terminal 
oxidases, with more than 1000 turnovers. These current findings motivated us to 
understand whether this novel activity is originating from an individual amino acid or it is 
a combination of all three mutations and the subsequently formed hydrogen bonding 
network.  
8.2. Materials and methods: 
8.2.1. Protein purification 
All mutants of myoglobin except F33Y Mb and G65Y Mb were purified from inclusion body 
protocol as described before 26,54. F33Y Mb and G65Y Mb were purified from solution 
protocol as mentioned in Zhao et. al. previously 27. In our all assay, protein with R/Z 
(A408/A280) above 4 and 3.5 were used from inclusion body and solution protocol 
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respectively. DNA sequencing for each mutant was performed from DNA sequencing 
facility at the Biotechnology Center of the University of Illinois and ACGT ltd.  
8.2.2. UV-Visible spectroscopy  
UV visible spectroscopy was performed in Agilent 8453 spectrometer (Agilent 
Technologies, Santa Clara, CA). For UV-Vis measurement in each case ferric protein (6 
µM) was taken in a 2 mL  sealed glass cuvette in 50 mM phosphate buffer (pH 6) at 25 
ºC and the head space O2 was purged out by argon to minimize the amount of O2 and a 
faster conversion from met to deoxy. After 3-4 min of argon purging, excess 
(approximately same amount in each case) TMPD (600 μM) and ascorbate (6 mM) was 
injected to initiate the reduction of protein. Reaction was continued for 30 mins to observe 
the partial or complete reduction (depending on mutant) of met Mb to deoxy Mb and then 
excess O2 was purged to get a pure oxy Mb spectra. The λmax of Soret and visible region 
were compared for all listed single and double mutation.   
8.2.3. Fluoride binding experiment 
Fe(III) form of  WT Mb protein and its mutants were produced by oxidation with 20 mM 
potassium ferricyanide. Excess potassium ferricyanide and product ferrocyanide were 
removed by desalting through a PD-10 column, equilibrated in 100 mM pH 6 phosphate 
buffer. After desalting, protein concentration was measured based on its UV/Vis 
absorbance. The fluoride complexes of proteins for spectroscopy were prepared by 
addition of 3 M buffered KF solution to Fe(III) proteins, such that the final concentration 
was 5-10 µM protein and 2.5 M KF. Protein solution was incubated with KF at room 
temperature for 4 h before UV-Vis measurements were taken.  All UV/Vis spectra were 
obtained using a Cary 500 Bio Spectrophotometer (Varian, now Agilent Technologies). 
Measurements were taken between 800 nm and 200 nm, with a step size of 0.2 nm. 
8.2.4. Rate of O2 consumption: The rate of O2 consumption in the presence of excess 
reductant for different mutants were monitored by an oxygen electrode (manufactured by 
two different company Oxytherm System, Hansatech Instruments Ltd., Norfolk, England 
and YSI Model 53 oxygen meter) as described in previous manuscript 26. In short rate of 
O2 consumption was measured in the presence of 18 uM protein and excess reductant 
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(100 equivalent of TMPD and 1000 eq ascorbate) in an air saturated (258 µM O2) pH 6 
buffer. In every case the reaction was initiated with reductant and rate was reported for 
initial 30 sec window where it shows maximum rate. To estimate the water and ROS 
production reactions were performed in the presence of 2.2 µM catalase and 250 unit of 
SOD and rate of water production was calculated with the help of equation 1 on the basis 
of catalytic activity of SOD and catalase (described in equation 2 and 3 respectively). To 
identify the effect of copper, 0.5 to 2 eq of Cu2+ was added in reaction chamber while 
rate of O2 reduction and product distribution was measured in the same way mentioned 
above.   
Rate of water production = {(Rate in the absence of SOD/catalase) – 2 x (rate in the 
presence of SOD/catalase)}                               
8.3. Result and discussion 
8.3.1. Oxygen reduction and product distribution 
To understand the role of each mutant on O2 reduction activity, we prepared a series of 
single and double mutations around distal pocket which includes L29H, F43H, F33Y, 
G65Y and this gave us eight possible mutations; F43H, F33Y, L29H, G65Y, F33Y/F43H, 
F33Y/L29H, G65Y/L29H, G65Y/F43H myoglobin. We excluded other two probable 
combinations for this study i.e. G65Y/F33Y Mb and L29H/F43H Mb, because none of our 
system contains both tyrosines together and L29H/F43H Mb is CuBMb, already reported 
in our previous manuscript. To understand the role of individual mutation on novel O2 
reduction activity of tyrosine containing CuBMb mutants we first concentrated on the O2 
reduction activity of all possible single and double mutants mentioned at the beginning of 
this paragraph. The rate of O2 consumption was measured for all mutants in the presence 
of 1000 equiv of ascorbate and 100 equiv of TMPD with respect to final protein 
concentration (18 µM), a similar procedure was used for native HCO 31.  Native HCOs 
perform a clean reduction of O2 to water with minimal release of reactive oxygen species 
like superoxide or peroxide.  In our previous work 26 we reported that the presence and 
position of tyrosine close to CuB site increases the rate of O2 consumption and water 
production. To differentiate between water and reactive oxygen species we monitored the 
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O2 consumption rate in the presence and absence of super oxide dismutase (SOD) and 
catalase. Catalase/SOD react with peroxide/superoxide respectively and evolves O2, 
which decreases the total rate of O2 consumption when enzymatic reaction involves with 
partial or complete ROS production. The detailed description for calculation of ROS 
production has been mentioned in Material and Methods section. Fig. 8.2. describes the 
summary of O2 consumption rate and product distribution for all the  mutants including 
WTswMb,  F33Y-CuBMb and G65Y-CuBMb(reported in our previous work) 26. The rate of 
water and ROS production was indicated as blue and red bar respectively whereas the 
black bar indicates the total rate of O2 consumption. Like our previous report F33Y-CuBMb 
and G65Y-CuBMb converted more than 75 % of O2 to water whereas wild type Mb mostly 
produced ROS (more than 20 % water). The partial reduction of O2 to ROS by WT Mb 
goes through the autooxidation pathway which has been investigated in detail by various 
groups previously 32,33.  To introduce 100 % novel 4 electron O2 reduction activity in Mb 
active site we also need to stop the partial reduction of O2 (autooxidation) and any 
Figure 8.2. O
2
 consumption activity and product distribution for single and double mutants along 
with Cu
B
Mb mutants in the presence of 1000 equiv of ascorbate and 100 equiv of TMPD with 
respect to 18 μM protein. Total rate of O
2
 consumption, water production and ROS production 
are represented by black, blue and red bar respectively.  All rates were measured at pH 6 and 
25 ºC. 
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progress towards either direction must be considered as a stepping stone towards 
engineering catalysts for complete reduction of oxygen..  
F33Y Mb which doesn’t have any histidine at either 29 or 43 position shows similar 
trend as wild type Mb i.e. mostly (>90%) converts O2 to ROS, while G65Y Mb was able 
to produce around 30% water alone. This result clearly indicates that introduction of 
tyrosine alone in WTMb in 33 or 65 position cannot bring significant change in the activity 
though its presence in CuBMb mutants dramatically changes the rate of O2 consumption 
as well as water production (Fig. 8.2.).  Together these indicate, histidine at 43 and 29 
position or extra water molecules must play an important role to bridge between Tyr and 
Fe-O2 species which is formed during the reaction of reduced heme and O2. . Histidine  
at 43 position increases the rate of water production from 15 % to 45 % and on the other 
hand, introduction of histidine at 29 position doesn’t change the ratio (22% water ) from 
wild type but decreases the amount of ROS production to a great extend compared to 
WTswMb by reducing total rate of O2 consumption.  CuBMb (L29H and F43H together) 
shows much different result (65% water and 35% ROS) compared to single mutation 
L29H or F43H Mb which suggests that both histidine at 29 and 43 position plays an 
important role in O2 reduction by CuBMb mutants (result discussed later). Incorporation of 
Tyr at 33 position along with F43H (F33Y/F43H Mb) increases water production up to 52 
%. It is important to mention here that F33Y /F43H Mb is only one mutation away from 
F33Y CuBMb i.e. L29H. But L29H /F33Y Mb shows minimal production of water and 
mostly produce ROS similar to L29H Mb. Interestingly, G65Y containing double mutants 
like G65Y/F43H and G65Y/L29H produce around 65% and 75 % water respectively. 
Product distribution in G65Y containing mutants (G65Y, G65Y/F43H and G65Y/L29H Mb) 
together indicates Tyr65 alone favours water production compared to Tyr33  which also 
supports our observation  in previous publication 26.  
8.3.2. Spectroscopic studies of Oxymyoglobin in different mutants 
To understand the dramatic difference in activity between WTswMb and CuBMb mutants, 
we followed up the oxygen reduction assay with the UV-Vis spectroscopic studies of both 
tyrosine containing CuBMb mutants and WTswMb under turnover conditions in the 
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presence of excess reductant (TMPD/ascorbate) and excess O2. The spectroscopic 
signature of wild type myoglobin in this condition showed a prominent Soret at  417 nm 
and visible bands at 542 and 580 nm which matched  well with previously reported end-
on oxy –product  with heme iron known as oxy myoglobin (Fe(II)-O2) 34. The spectral 
features of CuBMb mutants under similar condition shows very similar spectroscopic 
features like wild type myoglobin except one striking difference, which is a clear 6 nm blue 
Soret shift.  F33Y-CuBMb and G65Y-CuBMb display the Soret band maxima at 411 nm, 
whereas the visible part of the spectra remains unperturbed. This distinguishable Soret 
Figure 8.3. Spectral feature of FeO
2
 intermediate of A) single and B) double mutants 
compared with WT Mb and triple mutants. Red line in the Fig. indicates position of λ
max
 of 
Soret band and the corresponding numbers have been mentioned at left corner of each 
spectrum. Final spectra of FeO
2
 intermediate was collected from reaction of Met form (6 
µM) with 1000 eq of ascorbate and 100 eq of TMPD in the presence of excess O
2
.  The 
visible part of the traces have been included in supporting information (Fig. S2)  
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shift with overall similar feature with wild type myoglobin indicates an identical FeO2 
intermediate with a minute modification.   Considering the position of ligand O2 in reported 
crystal structure of WT Mb 35 and distal pocket mutation in CuBMb, one can speculate a 
role of  H-bonding interactions between iron bound oxy ligand and newly incorporated 
histidines (29 and 43) behind this minute modification hence the Soret band shift.   A 
similar spectroscopic  Fe-O2 intermediate or UV-Vis signature was assigned as first 
intermediate during catalytic O2 reduction to water in HCOs which undergoes O-O bond 
Figure 8.4. Spectral features of  fluoride bound WT Mb, single mutants and F33Y Cu
B
Mb. 
Red line in the Fig. indicates position of λ
max
 of CT band and the corresponding numbers 
have been mentioned at left corner of each spectrum. In each trace protein was incubated 
with X mM potassium fluoride at pH Y for Z mins brfore taking the final spectra. 
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cleavage to form Fe(IV)=O intermediate, known  as PM 5,36. On the contrary wild type oxy 
myoglobin generates reactive oxygen species through autooxidation reaction which was 
demonstrated in our previous work and other literature 32,33. However, CuBMb mutants 
show totally different product distribution where it mostly generates water (~ 80%) 26 
instead of ROS unlike WT Mb. It is also important to mention here that Fe-O2 is the only 
intermediate that has been detected spectroscopically during catalytic turnover of CuB 
mutants. This prominent difference in spectral features and activity between WT and 
CuBMb mutants and specially the similarities in activity between later and native HCO 
drives us to correlate the novel 4 electron O2 reduction activity of CuBMb mutants with 
Soret shift to investigate whether the H-bonding interaction in the Fe-O2 species 
manifests itself as difference in O2 reduction activity.  
To understand the fundamental of Soret shift in oxy spectra of CuBMb mutants, UV-Visible 
spectra were collected for all single and double mutants in the presence of excess 
reductant and excess O2. Excess O2 was used to nullify or minimize the binding affinity 
difference between mutants. In each case, 6 µM protein was incubated with 1000 equiv 
of ascorbate and 100 eq of TMPD at pH 6 in air saturated solution (~ 258 µM of O2 at 25 
ºC) in a sealed cuvette to prevent the air exchange. 0.12 mg/mL of catalase was also 
added in every reaction mixture to avoid any accumulation of reactive oxygen species, 
which may form in the presence of excess reductant. Upon incubation of the protein with 
reductant, a slow conversion of met to oxy and then to deoxy was observed (the deoxy 
spectra was not included in the figure as we didn’t observe any change between wild type 
Mb and tyrosine containing CuBMb mutants, data not shown). Though deoxy forms as an 
intermediate between met and oxy, we only start observing deoxy when O2 concentration 
goes down in cuvette due to formation of ROS or water.  The visible rate of this conversion 
is not identical for different mutants and entirely depends on O2 binding affinity and rate 
of O2 consumption for respective mutant. After complete or semi conversion to deoxy in 
1 hr, O2 was bubbled into solution and the formation of oxy-bound protein was monitored. 
The typical spectroscopic signatures of met (Ferric), deoxy (ferrous) and oxy swMb are 
obtained around {408, 503, 623 nm}, {434, 556 nm} and {417, 541, 583 nm} respectively. 
A comparison of UV-visible signature between single and double mutants has been 
illustrated in Fig. 8.3. A clear indication of Soret shift towards blue was observed for oxy 
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spectra as we increase the number of histidine at the distal pocket. However the position 
and the nature of visible region remained unaffected. The Soret of single mutation F43H 
Mb remains in between 414-415 nm whereas that of L29H Mb is observed at 411 nm. On 
the other hand F33Y Mb indicates almost no Soret shift compared to wild type Mb, 417- 
418 nm, which is consistent with O2 reduction activity of the same.  However the other 
tyrosine single mutant i.e. G65Y Mb showed very small shift compared to WT Mb i.e. 416 
nm. This indicates Try65 interacts with iron bound oxy more strongly as compared to 
Tyr33, and this observation is again consistent with activity studies mentioned before. For 
all the other double mutants F43H/F33Y, L29H/F33Y, F43H/G65Y, L29H/ G65YMb Soret 
band maxima is observed around 412 -413 nm. This histidine dependent Soret shift at pH 
6 could be due to a protonation on oxygen of Fe(III)-O-O- because all of our mutation 
were introduced at distal pocket where O2 binds with Fe in an end-on fashion and all new 
residues are expected to be  protonated at that particular pH. Crystal structure of F33Y 
CuBMb indicates the presence of two more water molecules at distal pocket compared to 
wild type Mb. This suggest new hydrophilic residues like His 43, His 29, Tyr 33 and Tyr65 
individually or together stabilize two new water molecules and one can’t rule out the 
presence of one or both water molecules in single or double mutation mentioned in this 
work. At this point we don’t have sufficient evidence whether FeO2 interacts with distal 
pocket residue directly or through active site water molecules. However, we have 
observed the magnitude of this blue shift of Soret in oxy spectra in CuBMb mutants 
decreases at higher pH like pH 7 for F33Y CuBMb and G65Y-CuBMb (Fig. S1). This pH 
effect again reinforces the fact that histidine directly or indirectly interacts with FeO2 as 
pKa of histidine normally comes around 6.  
8.3.3. Hydrogen bonding interaction of heme-bound oxygen with distal residues 
Through oxygen reduction assays and via spectroscopic studies of FeO2 intermediate of 
myoglobin mutants, we have established that the hydrogen bonding interactions between 
newly incorporated distal histidines (His29 and His43) and iron bound oxy- ligand plays 
an important role on 4 electron O2 reduction activity. The band maxima is significantly 
perturbed by vinyl conjugation to the porphyrin macrocycle and the axial ligand fields. In 
brief, the energy of the heme orbital (dg) increases when it interacts with ligand p or π 
 131 
 
orbital.  The later interaction decreases with increasing number of hydrogen bonding 
between ligand and protein residue or water molecule. This causes decrease of heme 
orbital energy hence the red shift of charge transfer band. Fluoride has been used 
successfully as a spectroscopic probe of hydrogen bonding in three important families of 
heme protein (globin, peroxidase and H-NOX)38 39-41.  Studies on these proteins 
established an empirical relationship between the extent of H-bonding in the active site 
of heme protein and the position of the CT1 band of fluoride-heme protein complexes 
where a consistent red shift of charge transfer band maxima was observed with 
increasing the number of hydrogen bond donating group at distal pocket. 
Fluoride complexes of WT Mb display a Soret band at 406 nm and a CT1 band maxima 
at 607 nm as reported previously 38,39. Incorporation of a His43 to the distal pocket (as 
F43H mutation) causes a red shift to the CT1 band by around 4.5 nm (to 611.5 nm) 
indicating a strong H-bonding interaction between His43 and the fluoride ligand. However, 
L29H mutation does not cause any significant shift of the CT1 band (607.5 nm), while an 
intermediate red shift (CT1 band at 609.5 nm) is observed when the two histidine 
mutations (F43H and L29H) are combined together in CuBMb (Fig. 8.4). Thus, 
introduction of the two histidines in the distal pocket of Mb (in form of CuBMb) increases 
the H-bonding to fluoride ligand of heme iron as compared to WTMb. In order to 
investigate the H-bond interaction of Tyr residues in the active site of myoglobin, we 
further probed fluoride ligated F33Y and G65Y WT; CT1 transition of G65Y WT and F33Y 
WT is at 608 and 603 nm respectively, suggesting that introduction of tyrosine residue at 
the distal pocket of myoglobin does not increase H-bonding to fluoride bound to heme. 
The same result is obtained when the tyrosine residues are introduced in CuBMb systems 
,the CT1 band maxima of F33Y-CuB and G65Y-CuB are at around 609 nm (as for CuBMb). 
No significant shift of CT1 band maxima observed also in double mutant F33Y F43H Mb 
(611), F33Y L29H (608 nm) from corresponding single mutant F43H Mb (611.5), L29H 
(607.5) respectively, indicating again that no or insignificant role of Tyr in tuning H-
bonding network around distal pocket.  
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8.3.4. Role of distal histidines His 29 and His 43  
The increase of water production or decrease of ROS production is associated with blue 
shift of Soret band of oxy spectra, however this relationship is complicated (discussed 
later). The comparison between UV data and activity assay indicates one or more than 
one protonation on oxy bound myoglobin is required for efficient four electron reduction 
of O2 to water. Both single mutant F43H Mb and L29H Mb introduce one more histidine 
at distal pocket and at low pH it can preferably protonate the Fe bound oxy. It was 
previously shown by Watanabe and coworkers that the distance between distal His43-N 
(5.7 Å) from heme Fe in F43H/H64L Mb is very similar to what was observed in 
peroxidases (6 Å). However this distance is significantly different when histidine occupies 
the 29 position (6.6 Å).  This positional advantage of distal histidine in F43H/H64L Mb 
makes it 30 times more efficient peroxidase than L29H/H64L, indicates stronger H+ 
donation or abstraction property of His43 over His29 42-44. The presence of distal histidine 
was found critical for peroxidase activity in native peroxidases 45,46 and replacement of 
the same by any aliphatic residue or residues that cannot deliver proton retards, the rates 
up to 5-6 orders 47-49. In later family a role of general acid was proposed for distal histidine 
which facilitate the heterolytic cleavage of O-O bond by protonating the terminal O2 of a 
plausible intermediate, Fe (III)-O-OH complex.  A similar intermediate can be envisioned 
in our system in the presence of reductant and at low pH’s. In another study by the same 
group it was shown that both L29H/H64L and F43H/H64L are capable of showing 
catalase activity, but former follows a radical pathway whereas later use ionic mechanism 
as a result of more proton transferring capacity of F43H 50. These two evidences clearly 
indicate that the higher H+ donation capability of His43 than His29 towards heterolytic O-
O bond cleavage.    
An interesting thing comes in picture when we compare simultaneously total rate of O2 
reduction and ROS production for F43H Mb, L29H Mb with the same of CuBMb and 
WTswMb. This analysis shows that both L29H containing mutants (L29H Mb and CuBMb) 
rate of total O2 reduction decreases significantly as compared to WTswMb (~ 4 and 2.5 
times respectively) but no major development was observed in total rate of water 
production. On the contrary F43H Mb rather increases the total O2 consumption rate by 
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around 20 % and also increases the rate of water production from 20 % (in wild type) to 
45 %, though does not bring down ROS production. When we combine these two 
mutations in CuBMb, we indeed see a sufficient decrease of ROS production through the 
decrease of total rate of O2 reduction and also a complete change of product distribution 
compared to WTswMb. Therefore, we speculate a door opening and door closing 
mechanism where His29 can close the door for ROS production through decreasing total 
rate of O2 consumption and His43 opens a new door for water production. This histidine 
induced reduction of autooxidation (conversion of oxymyoglobin to met through formation 
of superoxide and ultimately peroxide) is also consistent with previous literature 32,33,51.  It 
was shown previously that the presence of native His64 reduces autooxidation a lot 
compared to mutant lacking His64 or myoglobin without His64. So the further decrease 
of autooxidation after incorporation of two more histidine (L29H and F43H in CuBMb) is 
consistent with previous observation. Though our data suggests both new histidines are 
not equally efficient in stopping autooxidation and indicates a directional requirement of 
this protonation on FeO2. 
The above hypothesis is further supported by fluoride binding studies, which indicate very 
different role played by His43 and His29 in tuning H-bonding network around distal 
pocket. Our study shows significant and maximum red shift of CT1 charge transfer band 
in the presence of His43, indicating a strong hydrogen bonding interaction of His43 with 
axial ligand F-. On the other hand, L29H Mb didn’t show any shift compared to wt Mb, 
indicating very weak or no interaction with axial fluoride. This above difference between 
His43 and His29 should be applicable for other axial ligands like O2 in our study. However 
we need to remember that ligand O2 contains 2 atoms whereas this number is one for 
fluoride. So this fluoride binding study can’t be directly compared with the oxygen which 
is ligated with iron of heme moiety. More precisely from fluoride binding study one can 
interpret His43 strongly interact with O atom ligated with iron of dioxygen ligand and His29 
shows very poor interaction with the same. The decrease of red shift of CT1 charge 
transfer band in CuBMb (F43H and L29H) by 2.5 nm compared to single mutation F43H 
Mb indicates decrease of hydrogen bonding interaction with axial ligand. At this point we 
are not completely sure how His29 decreases H-bonding interaction with axial ligand in 
CuBMb compared to F43H Mb but certainly one can speculate a link between this 
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interaction (with axial ligand) and O2 reduction activity mentioned before. We see both 
total amount of water production and hydrogen bonding interaction with iron bound ligand 
(F-) decreases when we move from F43H Mb to CuBMb. The later comparison indicates 
a direct co-rrelation between water production and protonation of O atom  attached to iron 
as dioxygen ligand.        
8.3.5 Role of Tyrosine 
As compared to the two histidines, Tyr 33 is a little away from Fe of porphyrin group in 
F33Y CuBMb and cannot protonate the oxy ligand of FeO2 directly, as a result of this 
incorporation of F33Y neither increases the water production nor shows any Soret shift. 
But in the presence of His43, it (F43H/F33Y Mb) shows 5 nm Soret shift and around 52 
% water production. Surprisingly, much improvement had not observed in double mutant 
F33Y/F43H Mb, neither in terms of total rate of O2 reduction nor product distribution 
compared to single mutant F43H Mb. This result indicates Tyr33 alone can’t influence the 
interaction between His43 and FeO2. On the other hand the incorporation of Tyr33 on 
L29H increase total rate of O2 reduction around 5 times but doesn’t affect the product 
distribution (both produce mostly ROS). Also if we compare the activity of CuBMb and 
F33Y CuBMb we see a prominent role of Tyr in increasing rate of O2 reduction rather than 
product distribution. However this statement contradicts with similar rate of O2 reduction 
in both F43H Mb and F33Y/F43H Mb. A probable reason of above finding can be 
interpreted from the relative positioning of distal pocket residues in the crystal structure 
of F33Y CuBMb. His43 is much more exposed to solvent compared to L29H which is more 
buried inside the protein (Fig. 8.1.).  Due to this positioning advantage His43 may create 
electron transfer pathway along with protonation of FeO2 so that presence of Tyr33 cannot 
affect the rate much. The total rate of O2 reduction could depend on many things like O2 
binding, product release, electron transfer etc. Introduction of any residue which 
increases the total rate of electron transfer up to reaction center will probably increase 
the ROS or water production depending on nature of the active site.  
On the other hand G65Y Mb shows around 30 % water production alone. This result is 
interesting because unlike Tyr33, Tyr65 can modify the product distribution by itself to 
some extent. A shorter distance of Tyr65 from iron of porphyrin ring (5.2 Å) may help it to 
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interact with FeO2 more strongly and directly compared to Tyr33 which is around 8 Å 
away from Fe of porphyrin ring (Fig. 1 B and C). Incorporation of histidines along with 
Tyr65 increases the water production a lot. The double mutant G65Y/L29H Mb and 
G65Y/F43H Mb shows around 62 % and 70 % water production. Comparison of L29H Mb 
(78% ROS) with double mutant G65Y/L29H Mb (40% ROS) also indicates potential role 
of Tyr65 in product distribution. Altogether every tyrosine containing mutants indicates 
that 65 is much more appropriate position to place a tyrosine towards complete reduction 
of oxygen.  
8.3.6 Comparison of Soret shift with activity 
The relationship between Soret shift in FeO2 intermediate and activity remain very 
complicated. We were interested in the relationship between the wavelength maxima of 
Soret and oxygen reduction activity as  a) FeO2 is the only intermediate we have 
observed, irrespective of any mutant, during catalytic two or four electron reduction of O2 
and naturally this intermediate eventually decomposes to produce water/ROS and met-
form of the protein, b) spectroscopic feature of this intermediate showed distinguishable 
difference in F33Y CuBMb and G65Y CuBMb mutants from WTswMb which again shows 
very different product distribution of O2 reduction from former. Here we tried to find 
whether there is a linear relationship between Soret shift of FeO2 intermediate with 
decrease of ROS or increase of water production. This kind of study is expected to be 
very complicated as incorporation of one residue sometime brings a lot of conformational 
change in neighboring group, solvent network and can be characterized only by using 
multiple probes. This initial study showed in single mutation Soret shift related more with 
decrease of ROS production compared to increase in water formation (Table 8.1). L29H 
Mb shows maximum Soret shift (6 nm) among single mutants. Later produces around 5 
times less ROS compared to WTswMb however no improvement in water production was 
observed. On the other hand F43H, among all single mutation, showed maximum 
increase in water production from WTswMb but only 2 nm Soret shift was observed in 
FeO2 intermediate compared to WTswMb.   F33Y Mb doesn’t show any blue Soret shift 
compared to WTswMb and also shows very similar activity as WTswMb. Whereas G65Y 
Mb shows only 1 nm Soret shift which is also consistent with little change of product 
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distribution (10 % more water production from WT) from WTswMb. All double mutants, 
except L29H/F33Y Mb, showed around 30-40% more water production compared to 
WTswMb and also shows 4 nm Soret shift. Only L29H/F33Y Mb shows similar product 
distribution as WTswMb though 4 nm Soret shift was observed. The probable reasons for 
this contradictory behavior of L29H/F33Y were already mentioned previously (in role of 
tyrosines section). Seven out eight mutants (except L29H/F33Y), described in this 
manuscript, showed a strong relationship between blue Soret shift and increase in water 
production or decrease in ROS production. However, the exact nature of this relationship 
is yet to achieve. This manuscript can be considered as first part of investigation where 
we described the role individual mutant only on activity. We are working towards getting 
the crystal structure of important mutants in their oxy form to understand the orientation 
of water molecule around the distal pocket which could have potential role in activity and 
Soret shift at the same time. 
Table 8.1. Relationship between Soret shift and ROS production in single mutants. 
 
8.4. Conclusion 
Our data strongly supports strong protonation from multiple directions on oxy myoglobin 
is required for four electron reduction of O2 to water in the absence of redox active metal. 
A protonation on oxy can weaken the O-O bond to such an extent where it can accept 
two more electron in the same time scale of electron transfer and complete the four 
electron reduction of O2. Our data also indicates the novel complete O2 reduction activity 
of CuBMb mutants is a combinatorial effect of all three mutations (two histidine and one 
tyrosine) i.e. no one or two mutations are sufficient to achieve the activity what comes 
Protein Soret λmax (nm) Shift (nm)
a
 ROS production (μM s-1) Relative ROSb (%) 
WT Mb 417 0 0.9±0.1 100±17 
F33Y Mb 418 -1 0.5±0.04 59±7 
G65Y Mb 416 1 0.6±0.1 64±11 
F43H Mb 415 2 0.8±0.2 87±23 
L29H Mb 411 6 0.3±0.1 28±8 
a shift Soret λmax with respect to WT Mb,  
b 
percentage of ROS produced with respect to WT  
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after third mutation in each case. However the role of single histidine in increase in water 
production or decrease in ROS production is clear. Result of this work indicates Phe43His 
mutation brings the four electon O2 reduction activity in myoglobin which get enhanced in 
the presence of other mutation whereas Leu29His demolish the ROS production activity 
of WtswMb.  Crystal structure of F33Y CuBMb, published in our previous work 26), 
indicates there are two more water molecules at the active site (total three) compared to 
wild type myoglobin (which has only one). It is possible these residues play a role to bring 
more water molecules to make strong hydrogen bonding network at the active site of 
CuBMb mutants which eventually helps strong protonation on FeO2 hence the O-O bond 
cleavage. The potential role of hydrogen bonding and solvent network in O-O bond 
cleavage in native HCOs has been indicated by many theoretical and computational 
works before 52,53 
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